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Kinesin motors play an indispensable role in intracellular trafficking by driving 
the long-distance transport of protein and vesicular cargoes along microtubules.  My 
thesis work has focused on uncovering regulatory mechanisms that mediate 1) kinesin 
autoinhibition, 2) cargo complex formation, and 3) polarized transport due to preferential 
microtubule track selection.   Kinesin motors generally are kept inactive in the absence of 
cargo.  My work demonstrates that KIF17 (Kinesin-2) is self-inhibited by assuming a 
folded conformation that allows a weak coiled-coil region in its stalk to directly contact 
the motor domain.  This interaction prevents KIF17 from moving on microtubules.  The 
cargo binding tail does not play an inhibitory role, but is nevertheless important in 
regulation as it functions to load KIF17 into cilia.  KIF1A (Kinesin-3) is also inactive in 
the absence of cargo due to inhibitory regions that include the FHA domain and two 
adjacent coiled-coils.  My work further demonstrates that KIF1A motors undergo 
processive motility as dimeric rather than monomeric motors using their neck coil to 
dimerize.  Kinesin motors are relieved of their autoinhibition by cargo binding.  
However, as there are many different cargoes that require transport by the same kinesin 
motor, I have investigated whether specific cargo proteins compete or cooperate with 
each other for transport.  My work shows that while some cargos are transported 
independently, other cargos such as JIP1 and JIP3 do form cooperative complexes with a 
single motor that are essential for efficient transport.  The JIP1/ JIP3/Kinesin-1 complex
 is formed due to an interaction between JIP1 and JIP3 and distinct binding sites on 
Kinesin-1 for each cargo.  Once cargo is loaded, kinesin motors have to transport them to 
their correct subcellular destinations.  I have investigated whether Kinesin-1’s preference 
for certain types of modified microtubules can direct the polarized sorting of cargo into 
the axonal compartment of neuronal cells.  My results indicate that several types of 
microtubule post-translational modifications additively or synergistically mediate 
Kinesin-1’s preference for axonal microtubules and its sorting mechanism.  Overall, my 
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work contributes to our understanding of how kinesin motors are activated and attached 





A cell relies on intracellular transport in order to maintain its proper morphology 
and functions.  Molecular motors of the kinesin, dynein, and myosin superfamilies use 
the cell’s microtubule or actin cytoskeletons as highways to transport cargoes to their 
appropriate cellular destinations.  Typical cargos include large organelles, membrane 
bound vesicles of the secretory and endocytic pathways, cytoskeletal components, and 
protein or mRNA complexes [1, 2].  The mechanisms underlying individual motor 
regulation, cargo recognition and release, and sorting to appropriate cellular locales are 
only beginning to be discovered.   
The kinesin superfamily is divided into 14 families that all contain a well-
conserved motor domain [1, 3, 4].  This ~350 residue domain binds and hydrolyzes ATP.  
The motor domain couples this ATPase activity with its ability to attach to and generate 
movement along microtubules.  Many kinesins contain the motor domain (or head) at one 
end, followed by a stalk region containing short or extensive alpha-helical coiled-coil 
regions which function to dimerize the motor.  Cargo binding regions follow, or in some 
cases are intermixed within the stalk, and are quite divergent among the kinesin 
superfamily, and even within families, allowing for diversity in cargo binding and motor 
regulation [2]. The linker region between the motor and stalk is referred to as the neck, 
which in some cases has been shown to be important in motor regulation or determining 
direction of motility [5, 6].  
In considering kinesin mediated vesicular transport, it is helpful to recognize the 
basic steps likely involved (Figure 1.1).  First, kinesin motors must be activated by 
binding to cargo, possibly with the help of other regulatory complexes or post-
translational modifications.  Second, the activated motor/cargo complex binds to 
microtubules and begins processive movement, defined as taking multiple steps along 
microtubules without dissociating.  Third, the motor reaches its destination where it
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dissociates from the microtubule and its cargo.  This step may occur spontaneously or 
may require the help of an “inactivating” complex or post-translational modifications.  
Finally the motor diffuses or is transported in an inactive state back to where it will be 
used again for cargo transport; although it is also possible that the motor is simply 
degraded at this point.   
My research has focused on three specific questions relating to the first two steps 
of this kinesin transport cycle.  1) What are the molecular mechanisms keeping different 
kinesin family members inactive in the absence of cargo?  2)  How do kinesins attach to 
and coordinate the transport of their various types of cargo?  3) Does kinesin’s preference 
for certain types of modified microtubules direct polarized sorting of cargo to the axonal 
compartment of neuronal cells?  To address these questions, I have focused on a small 
subgroup of the kinesin superfamily that are all well documented in their involvement in 
vesicular transport; specifically, Kinesin-1 (also known as conventional Kinesin or 





 Kinesin-1 was the first kinesin identified and is the most extensively studied of 
the kinesin family members.  It is composed of two heavy chains (KHC), each containing 
an N-terminal motor domain, followed by an extensive coiled-coil stalk with multiple 
flexible hinge regions, and a globular, cargo binding tail.  Two light chains (KLC) bind to 
the heavy chains using heptad repeats and are also composed of six tandom TPR protein-
protein interaction domains that are responsible for binding cargo (Figure 1.2).    
Kinesin-1 is a highly processive motor that coordinates its two motor heads to 
move in an alternating, hand-over-hand stepping manner over long distances.  Each step 
is about 8-nanometers in size, corresponding to the length of a tubulin dimer, the building 
blocks of the microtubule lattice.  Kinesin-1 moves toward the plus-end of microtubules 
or generally towards the cellular periphery [2, 6, 7].   
Because Kinesin-1 uses a considerable amount of ATP to fuel its motility, it is 
essential that this activity be tightly coupled to cargo transport so energy is not 
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unnecessarily wasted.  Consistent with the existence of an inactive state, soon after 
Kinesin-1 was identified, cellular fractionation studies revealed that a majority of 
Kinesin-1 resides in the cytoplasm as a soluble protein with inhibited microtubule-
activated ATPase activity [8-10].  Electron microscopy, sedimentation assays, single 
molecule analysis, and FRET stoichiometry have since shown that without cargo bound, 
Kinesin-1 is inactive and folded head to tail [6, 11-19].  This autoinhibited state is 
maintained by the IAK region (consisting of the three amino acids: isoleucine, alanine, 
and lysine) of the KHC globular tail and by KLC, most likely through multiple weak 
electrostatic interactions with the neck and motor regions [6, 12, 14, 19].  These 
interactions in addition to folding the motor lengthwise, head-to-tail, separate the motor 
domains most likely through an unwinding of the neck coiled-coil [18].  Overall, this 
folded conformation prevents the motor from interacting with microtubules or 
exchanging ADP for ATP when not bound to cargo.  
Autoinhibition of Kinesin-1 is relieved by cargo binding.  As the two regions 
shown to mediate inhibition of motor activity, namely the IAK region of KHC’s tail and 
KLC’s TPR domains, are both regions known to mediate cargo binding, it is a compelling 
theory that cargo binding to either, or both, of these regions activates Kinesin-1.  Indeed 
early studies showed that attaching beads to the KHC tail, as a cargo mimic, resulted in a 
motile Kinesin-1 [11, 12].  More recently, Blasius et al. showed that binding of a known 
cargo to either the KHC tail or KLC TPR domains is not sufficient for motor activation.  
Instead binding of two cargos, FEZ to KHC and JIP1 to KLC, is required in order to free 
the microtubule binding and processive motility activities of Kinesin-1 [20].  Cargo 
binding of Dlg to the motor-binding inhibitory domain of kinesin protein, Gakin/KIF13b 
[21], also relieves Gakin’s autoinhibition, suggesting that the mechanism of cargo 
binding directly to regulatory regions is a general mechanism employed by kinesins for 
activation.  Other mechanisms such as phosphorylation or dephosphorylation of kinesins 
have also been suggested to play a role in motor activation or regulation of cargo binding 
[22, 23].     
 As the motility/ATPase activities of other cargo-transporting kinesins must also 
be tightly coupled to cargo transport, the work on Kinesin-1 has led to the general 
hypothesis that kinesin motors are autoinhibited.  Indeed full-length Kinesin-2 family 
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member Osm-3, homologue to mammalian KIF17 [24], and the Kinesin-3 family 
members, KIF1A/Unc104 and KIF13B/GAKIN [21, 25-27], have been shown to be 
autoinhibited.   However regulatory domains and mechanisms for these kinesins are less 
clear than for Kinesin-1.  Because kinesin superfamily members only share the motor 
domain in common [2], the evolution of diverse cargo binding domains and stalk 
structures must have co-evolved with motor regulatory regions and mechanisms.  
Consequently the detailed mechanisms of each kinesin protein are likely to be unique; 
although, the general principles learned from Kinesin-1 regulation may still be 
applicable.   
 
KIF17 
 KIF17 is a homodimer that like Kinesin-1, moves processively towards the plus 
ends of microtubules.  It has been implicated in the transport of NMDA and Kv4.2 
vesicles in the dendrites of neuronal cells and CNG channels in olfactory cilia [28-31].  
The C. elegans homologue Osm-3 is better characterized, playing an essential role in 
ciliary and flagellar transport [32].  Despite the handful of transmembrane proteins or 
protein complexes that are known to be transported by KIF17/Osm-3, only three direct 
binding proteins are known, Mint1, ACT, and NXF2 [29, 31, 33-37].  In the case of 
Mint1 (also known as mLin10 or X11) the extreme C-terminal residues of KIF17 bind 
one of two PDZ domains in Mint1 [31].  This interaction has been shown to be 
additionally regulated by phosphorylation of a nearby serine residue by CaMKII [23].  If 
KIF17 motor regulation is analogues to Kinesin-1, in that, cargo binding domains 
regulate motor function, it is possible these C-terminal residues, or the tail in general, are 
important in mediating autoinhibition (Figure 1.2).  However other unidentified cargo 
binding regions may also exist.   
    Previous work on recombinant Osm-3 in vitro showed that motility is inhibited 
in the absence of cargo, and that the protein may shift from a folded, more compact form, 
to an extended conformation like Kinesin-1.  A small hinge region between two coiled-
coils in the stalk is essential for this folding and regulation [24].  Because inhibition was 
lost when the Osm-3 hinge was removed or mutated, it was hypothesized that a region C-
terminal to the hinge likely interacts with residues in the motor/neck region; yet, the 
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specific domains and interaction mechanisms were not investigated [24].  Because of 
major structural differences between mammalian KIF17 and C. elegan Osm-3, 
specifically in the hinge and the following coiled-coil regions, it is difficult to conclude 
whether the same hinge mediated folding mechanism is likely to be conserved between 
the two homologues.   
My work, detailed in Chapter 2, confirms that KIF17, like Kinesin-1 and Osm-3, 
is autoinhibited,in the absence of cargo.  Processive motility is inhibited by direct contact 
of the motor domains with a region of the coiled-coil stalk that is only somewhat 
conserved with Osm-3.  The cargo binding tail does not play a detectable role in motor 
regulation, but is essential for loading KIF17 into cilia. 
 
KIF1A 
KIF1A and the C. elegans homologue, Unc104, structurally look much different 
from Kinesin-1 and KIF17 because their stalk regions are not composed of large coiled-
coiled regions.  Rather the motor domain is followed by two very short and relatively 
weak coiled-coils, a forkhead-associated (FHA) domain, two more short coiled-coils, a 
large undefined region, and a C-terminal PH domain (Figure 1.2).  Cargo protein Liprin-
α’s binding site includes a section of coiled-coil 2, as well as, a portion of the undefined 
region [38].  The PH domain has been shown to be important in connecting 
KIF1A/Unc104 motors to vesicular membranes via interactions with 
phosphotidylinositols (specifically PtdIns(4,5)P2; [39, 40]).   
Full-length KIF1A/Unc104 is autoinhibited in the absence of cargo [25, 26, 41].  
Inhibition of microtubule binding, and thus motility, is prevented by the FHA domain and 
adjacent c-terminal coiled-coil (CC2), although neither of these domains directly contact 
the motor nor neck domains, leaving the mechanism of regulation largely unknown [25].  
The two coiled-coils adjacent to the motor also have suggested roles in regulating KIF1A 
activity in that they can pair with themselves on adjacent KIF1A molecules to form an 
intermolecular coil (dimer) or pair with each other in an intramolecular coil (monomer) 
(Figure 1.3)[27].   
KIF1A has some of the highest velocities reported for kinesin molecules, running 
between 1-2 µm/second [26, 27, 42, 43]; yet, its mechanism of motility is controversial.  
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KIF1A/Unc104 has been postulated to function as a monomer.  Recombinant and 
endogenous KIF1A proteins act like monomers in sedimentation and gel filtration assays 
[44-46] and truncated KIF1A proteins that are confirmed monomers, have motile 
properties in vitro [47-49].  A novel, biased-diffusion model of motility has been 
proposed to explain the motility of a single-motor driven KIF1A, used in place of the 
hand-over-hand model generally accepted for dimeric, or two-motor driven, kinesins [7, 
47-49].  However, recent studies have brought into question the monomer-based 
movement hypothesis, and suggested instead that KIF1A and/or closely related family 
members do indeed dimerize, but may require high concentrations [26, 41, 45, 50-52].  
Tomishege et al additionally showed this dimerization is likely required for processive 
motility [26].  Thus, a second model has been proposed where KIF1A binding to 
clustered cargos on a vesicle locally concentrates KIF1A and mediates a monomer to 
dimer switch, which has also been suggested, although not yet experimentally supported, 
to activate KIF1A’s motile properties.  In this model, KIF1A moves like Kineisn-1 in a 
coordinated hand-over hand fashion that allows the motors to take successive, 
unidirectional steps along a microtubule without dissociating [25, 26, 39, 40].   
Because of unresolved questions about whether KIF1A moves as a monomer or 
dimer and whether a monomer to dimer transition relieves autoinhibition, I was interested 
in investigating KIF1A’s regulation and motile properties in relation to dimerization state 
using some new and old experimental tools.  My work, and that of my lab colleges, 
detailed in Chapter 3, shows that a significant population of endogenous and 
overexpressed KIF1A exists as a dimer, yet is still inactive for microtubule-based 
motility.  Thus, dimerization is not sufficient to relieve the autoinhibition mediated by the 
FHA domain.  KIF1A constructs without the FHA domain that dimerize via the short 
neck coiled-coil do move at a constant velocity of 1.3 µm/second over long distances.  
Although shorter, monomeric, constructs do display some motile properties, their 
motility is very short in duration and does not require ATP.  Thus we support the 
conclusion that KIF1A moves as a dimer and that motility is regulated by both the FHA 
domain and the neck coiled-coil which functions to dimerize and coordinate the two 
motor heads in the full-length molecule.   
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MOTOR/CARGO COMPLEXES 
 As mentioned above, kinesin cargos take various forms ranging in size from large 
organelles to smaller protein complexes.  Recent work has identified multiple binding 
partners for individual motor proteins and in many cases, these binding partners are 
soluble adaptor proteins that mediate the attachment of motor proteins to membrane-
bound cargoes or other protein or mRNA complexes [2, 53].  KIF17 binds directly to the 
soluble adaptor protein Mint1, which mediates the transport of NMDA receptors through 
complexing first with at least two other adaptors, mLin-2 and mLin-7 [31].  Kinesin-1 
transports the transmembrane proteins APP and ApoER2 via the JIP family of adaptor 
proteins [53-55].  Kinesin-1 also likely transports AMPA receptors via binding to GRIP1 
[56]. 
  The fact that it takes at least two proteins to activate Kinesin-1 and that it is 
easier to see motor binding to a particular cargo than to reconstitute active motility of 
kinesins with that particular cargo in vitro, suggests that cargo/motor complex formation 
and motor activation is often more complex than a single protein interaction or 
phosphorylation event [20, 57].  It is therefore critical to decipher not only the identity of 
cargo proteins and their direct or indirect binding mechanisms to kinesin motors, but also 
the combinations of cargo proteins (and/or other modifications) that are required for 
motor activation and thus truly define a kinesin cargo.  Additionally, as more and more 
direct binding cargo proteins are identified for KLC or KHC, it begs the question of how 
one motor can coordinate and carry out the transport of its many different cargoes at 
specific times and to correct cellular locations.   
In Chapter 4, I set out to investigate the transport of different Kinesin-1 cargoes 
that bind directly to the TPR domains of KLC, specifically JIP1, JIP3, Kidins220/ARMS, 
and PAT1 [54, 58-60] asking the specific question of whether these cargo proteins 
compete or cooperate for transport.  For most cargo combinations, no competition or 
cooperative activity was found, suggesting independent transport by a non-limiting 
Kinesin-1 pool.  Yet, in the case of JIP1 and JIP3, the two cargos cooperate for Kinesin-1 
transport.  JIP1 and JIP3 interact with each other and with independent sites on KLC 
forming a tri-molecular complex that is necessary for both proteins to be efficiently 
transported in neuronal cells.  Thus, the complexities of the Kinesin-1 motor/cargo 
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complex grows as three binding partners, FEZ, JIP1, and JIP3, likely make up a 
functional motor activating and transportable unit.  However, other essential, unidentified 
members of this particular cargo complex could still exist.  JIP1 and JIP3 are scaffolding 
proteins known to bind and modulate the JNK signaling pathway [61], thus the 
JIP1/JIP3/Kinesin-1 transport complex likely contains many additional kinases as well as 
other transmembrane and soluble proteins. 
 
MICROTUBULE PREFERENCE AND ITS ROLE IN POLARIZED TRANSPORT 
 Once a kinesin motor binds cargo and its autoinhibition is relieved, it is able to 
bind microtubules and begin processive transport.  For Kinesin-1, KIF17, and KIF1A that 
involves moving towards the plus-end of microtubules or generally towards the cell 
periphery.  However, like in a city where not all roads lead to one specific destination, in 
a cell, not all microtubule tracks lead to the cargos’ targeted cellular endpoint.  This is 
especially true in polarized cells were cellular compartments that require their own 
unique subset of proteins for proper function, like the axonal and dendritic processes of 
neuronal cells or the basolateral and apical membrane surfaces of epithelial cells, reside 
at rather opposite ends of the cell.  Yet, it is also true in the case of non-polarized cells, 
where although most microtubules point towards the cell periphery, some microtubule 
tracks may still be under construction or are actively being removed and thus poor 
choices for transport.  The necessity to transport cargo to its correct cellular destination 
through the use of complete microtubule roadways, suggest kinesins may have evolved 
intrinsic microtubule preference mechanisms or separate regulatory partners that direct 
them to preferred microtubule tracks and/or cellular destinations.  
 In neuronal cells, Kinesin-1 transports cargo primarily down microtubules of the 
axon [62, 63].   As truncated Kinesin-1 constructs show this same preference for axons 
over dendrites, the axonal sorting cue is thought to reside within the motor/microtubule 
binding interface [62].   However, a separate cargo directed sorting model has also been 
proposed [56].  The first model is especially intriguing when combined with multiple 
studies showing Kinesin-1, in vitro, has a binding preference for microtubules post-
translationally modified by acetylation, detyrosination, and/or polyglutamylation [64-68].  
These same post-translational modifications (PTMs) tend to accumulate on, or mark, 
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stable or long lasting microtubules and are enriched in axons over dendrites [69, 70].  
Thus, this pool of microtubules marked with PTMs and preferred by Kinesin-1, could 
serve as an axonal signal.  This seems to be the case in fibroblast cells, as Kinesin-1 
preferentially uses the subset of microtubules that are acetylated and/or detyrosinated [64, 
67] .  
  In chapter 5, I test the possibility that microtubule modifications direct  
Kinesin-1’s axonal sorting in primary hippocampal neurons.  My results indicate that 
there are probably several types of PTMs that together mediate Kinesin-1’s preference for 
axonal transport.  Drug treatments that increase multiple PTMs (i.e. taxol and GSK3β 
inhibitors), redirect Kinesin-1 to all neuronal processes; however, increasing microtubule 
acetylation alone is not sufficient to alter polarized transport.      
 
DISSOCIATION FROM CARGO AND FATE OF KINESIN MOTORS AT THE 
TRANSPORT DESTINATION 
Once kinesin/cargo complexes have transported along microtubules and reached 
their cellular destinations, kinesin motors must be inactivated and released from cargo 
and microtubules.  The exact order of events, specific mechanisms, or accessory 
regulatory complexes mediating this step are still unclear.   Phosphorylation of the motor 
or cargo is the most experimentally supported mechanism at this time mediating cargo 
release.   Phosphorylation of Kinesin-1 by GSK3β or other unidentified kinases inhibits 
anterograde transport and has been shown to reduce the amount of kinesin bound to 
vesicles [71, 72].  Stagi et al recently showed that the JNK signaling pathway releases 
Kinesin-1 cargoes from microtubules [73].   Phosphorylation of KIF17 at Ser1029 by 
CaMKII, releases cargo protein Mint1 complexed to NMDA receptors likely in the 
vicinity of the synapse where it is needed [23].  
The final step in the kinesin transport cycle requires that the motor return back to 
a place of cargo loading where it can be used again.  Once more, details are very unclear; 
yet, multiple mechanisms have been proposed including diffusion of the motor, 
retrograde transport of the motor in an inactive state by dynein or other minus-end 
motors, or even the possibility that the motor is simply degraded at the transport end-



































































Figure 1.2:  Schematic of Kinesin-1, KIF1A, and KIF17.  The catalytic motor domains shown in 
blue are conserved among all kinesin motors while cargo binding and regulatory stalk/tail regions 
are unique.  KHC, kinesin light chain; KLC, kinesin heavy chain; CC, coiled-coil; FHA, 

















Figure 1.3:  Two conformations of KIF1A’s  neck coil (NC) and coiled-coil 1 (CC1).  Only the 
motor, NC, and CC1 regions of KIF1A are depicted.  The NC and CC1 can from an 
intramolecular coiled-coil that may limit KIF1A to a monomeric state.  Alternatively the NC and 
CC1 can form intermolecular coils with their counterparts on a separate KIF1A peptide 
consequently shifting KIF1A to a dimeric state with motor domains well coordinated for motility.  
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KIF17’s Coiled-Coil 2 Region Inhibits Processive Motility by  
Directly Interacting with the Motor Domain. 
 
Kinesin motors use the energy of ATP to move membrane-bound organelles and 
protein or mRNA complexes along microtubules.  The activity of kinesin motors in cells 
must be tightly coupled to cargo transport to ensure that energy is not wasted on futile 
movement.  It is additionally important that motors transport the correct cargo, to the 
proper subcellular destination, at the relevant time.   
A large body of work has shown that, in the absence of cargo, Kinesin-1 is 
inactive due to a folded conformation that allows the tail to directly interact with the 
motor domain and neck [1-6].  This interaction prevents Kinesin-1 from binding 
microtubules or exchanging ADP for ATP [5-7].  Additionally, in this autoinhibited state, 
Kinesin-1’s motor domains are separated to ensure that the motor heads are unable to 
coordinate long-distance movement [6].  Studies on the Kinesin-3 family members, 
KIF1A and Gakin/KIF13B, show that these motors are also autoinhibited in the absence 
of cargo.  For KIF1A, a coiled-coil and FHA domain region inhibit microtubule binding, 
while the neck coiled-coil folds with a second coiled-coil to inhibit motility [8, 9].  For 
Gakin, a MGB domain located in the stalk binds the motor domain and impairs motor 
function [10].  Thus, although the precise molecular details may be different between 
kinesins, autoinhibitory mechanisms are commonly used in motor regulation. 
Whether the Kinesin-2 family member, KIF17 is likewise autoinhibited in the 
absence of cargo is currently unknown.  Kif17 is specifically involved in transporting 
vesicles containing NMDA receptors and Kv4.2 channels in the dendrites of neuronal 
cells [11-13], as well as mRNA/protein complexes in multiple cell types [14, 15].  Work 
from C elegans has revealed an important role for the KIF17 homologue, Osm-3, in 
anterograde intraflagellar transport (IFT) which is essential for proper cilia formation, 
maintenance, and function [16-20].  Recently KIF17 has also been implicated in IFT, as it
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carries CNG channels in olfactory cilia, and is crucial for the proper development of 
vertebrate photoreceptors, particularly the sensory outer segment [21, 22].   KIF17 and 
Osm-3 appear to have some unique IFT functions in certain types of cilia, but play a 
redundant role with the Kinesin-2 (KIF3A/B/KAP) in other cases [16, 19, 21, 23].   
Previous work on recombinant Osm-3 in vitro, showed that Osm-3’s motility is 
inhibited in the absence of cargo, and that the protein may shift from a folded, more 
compact form, to an extended conformation like Kinesin-1.  A small hinge region (~15-
20 residues in length) between two coiled-coils in the stalk is essential for this folding 
and regulation, suggesting an autoinhibition mechanism where stalk/tail domains are 
brought into proximity of the motor domain in order to inhibit motility [24].  As KIF17 
and Osm-3 differ most in this hinge region, it is particularly unclear whether Kif17 is 
regulated in the same way.  It is also unclear what regions of the stalk or tail may be 
responsible for negative regulation.  Like Osm-3, KIF17, has an N-terminal motor 
domain, followed by a neck coiled-coil (NC) and coiled-coil 1 (CC1).  In Osm-3 this 
CC1 is followed by the small hinge, but KIF17 has an approximate 300 residue insertion 
of undefined structure.  This region is then followed by two more somewhat weak coiled-
coils (CC2 and CC3) and a tail domain known to directly bind two, KIF17 cargo proteins 
Mint1 (also known as  mLin10 or X11) and NXF-2 (Figure 1, [13, 15, 25]). 
In this study, we confirm that Kif17, in the absence of cargo, is inhibited from 
binding microtubules and moving processively (that is taking many steps along the 
microtubule, without detaching).  Removal of the CC2 region relieves the autoinhibition 
mechanism activating motor functions.  As the CC2 region can inhibit constitutively 
active KIF17 motors in trans, the CC2 region is both necessary and sufficient for 
inhibition of processive motility.  A direct interaction between CC2 and the motor was 
found to be responsible for this negative regulation.  We additionally show that the cargo 
binding tail is required for loading KIF17 into cilia regardless of whether the motor is 




Molecular mechanism of KIF17 autoinhibition  
To investigate the regulatory and motile properties of mammalian KIF17 we first 
tested whether full-length (FL) HsKIF17 is able to generate processive movement, or 
whether it is inhibited in the absence of cargo.  Previous studies have shown that active 
kinesin motors often accumulate at the tips of cell processes [9, 26, 27].  Thus, we tagged 
KIF17 on its C-terminus with mCit (monomeric citrine—a yellow fluorescent protein 
variant) and analyzed its subcellular localization in the neuronal-like cell line, CAD.  
KIF17-mCit was localized diffusely throughout the cytoplasm and not concentrated in 
neurite growth cones (Figure 2.2 A, far left images).  Thus we conclude KIF17 is 
inhibited for motility in mammalian cells.   
For the autoinhibited motors, Kinesin-1, KIF1A, and GAKIN/KIF13B; truncation 
studies have been very helpful in identifying the structural domains that inhibit motor 
activity.  Accordingly, we made mCit-tagged truncated versions of KIF17 that ended 
after each predicted coiled-coil region or the middle region of unknown structure (Figure 
2.1 B and C).  Deletion of the C-terminal cargo binding tail (1-846) or CC3 (1-795) had 
no affect on the processive motility of KIF17 (Figure 2.2 A).  Like FL KIF17, these 
truncations when expressed in CAD cells showed a diffuse cytoplasmic localization.  
However, further truncation of CC2 resulted in a drastic change as the 1-738 construct 
accumulated at the ends of neurites.   The ability to accumulate at neurite tips was 
maintained for truncation 1-488, but was lost upon further truncation where the CC1 (1-
369) or the NC (1-347) was removed.  Thus, the CC2 region (738-795) is critical to 
keeping KIF17 in an inactive state where it cannot move processively in mammalian 
cells.  Additionally the NC is not sufficient to maintain KIF17’s processive movement.  
As a second method of testing whether or not FL or truncated KIF17 motors are 
active for processive movement, we tested the KIF17 constructs in an in vitro single 
molecule motility assay.  We tagged the constructs on their C-terminus with three tandem 
copies of mCit and expressed them in COS cells.  This 3xmCit tag results in a better 
signal-to-noise ratio, is less affected by photoblinking, and photobleaches much slower 
than a single mCit tag [28].  Lysates from COS cells expressing KIF17-3xmCit motors 
were added to a casein and BSA coated flow chamber containing polymerized 
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microtubules and assayed on a total internal reflection fluorescence (TIRF) microscope 
for motility.  By timelapse imaging at 100ms intervals, individual motors could be seen 
moving along microtubules (representative tracks are shown in Figure 2.2 E).  Only 
motility events that lasted at least 300ms were included in the analyzed data set to ensure 
that the same motor could be tracked through at least 3 timelapse images.   In order to 
directly compare the number of motility events and the motile properties of velocity and 
track length for each KIF17 motor construct, the amount of expressed protein was 
normalized by western blot and each construct was analyzed for the same total amount of 
time.   
Consistent with the in vivo processivity assay in CAD cells, KIF17(FL)-3xmCit 
and KIF17(1-369)-3xmCit were primarily inactive in the in vitro single molecule motility 
assay (Figure 2.2 B-F).  These motors each showed very few motility events (n=21 and 
n=40 respectively) and when they did move along microtubules, they only moved for 
short distances (average track lengths: FL, 0.36 +/- 0.18 µm; 1-369, 0.45 +/- 0.39 µm) 
(Figure 2.2 C-F).  KIF17(1-738)-3xmCit, on the other had, moved quite efficiently in 
vitro, as a large number of motility events were observed (n=112) (Figure 2.2 B-F).  1-
738 moved with an average speed of 0.77 +/- 0.26 µm/second and for track lengths that 
were as long as 6-7 µm but averaged 1.13 +/- 1.06 µm/event.  These motile properties are 
consistent with previous reports on KIF17 that showed in vitro microtubule gliding 
speeds of 0.8-1.2 µm/second [13] and in vivo KIF17 driven vesicle speeds of 0.76 
µm/second [12].  Although data is not shown for the 1-846 and 1-795 truncations, they 
like full-length had limited single molecule motility.  Thus, the dramatic activation of 
processivity in KIF17(1-738) again points to the critical role played by the CC2 region in 
repressing the processivity of KIF17.     
 
FL and truncated versions of KIF17 dimerize 
 KIF17 has been shown to be a homodimer by gel filtration and sucrose gradient 
centrifugation experiments [13].  A large body of work on Kinesin-1, shows that it 
coordinates its two motor domains to step in an alternating hand-over-hand fashion from 
one tubulin dimer to the next tubulin dimer of the microtubule lattice.  This hand-over-
hand model of processive movement is generally thought to be conserved among cargo 
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transporting kinesins, including KIF17 [29].  As expected from this model, Kinesin-1 
truncations that are monomeric are not processive [28].  Thus it was concerning that 
Imanishi et al reported truncation of Osm-3’s tail domain resulted in unstable Osm-3 
dimers [24].  In order to rule out the possibility that our KIF17 truncations also resulted 
in monomeric motors whose limited processivity would not be due to inhibitory regions, 
but the fact that they had only one motor domain, we analyzed their ability to dimerize 
using co-immunoprecipitation (Co-IP).  As these Co-IP experiments were done with COS 
lysates basically identical to those added to single molecule motility assays, confirmation 
of dimerization by Co-IP is a good indication that our KIF17 motors were able to 
maintain dimerization in the in vitro motility assay.   
We first confirmed that FL KIF17 is a dimer by co-expressing Flag- and mCit- 
tagged versions of FL KIF17 in COS cells.  Cell lysates were then precipitated with 
antibodies to the Flag tag or with control antibodies (IgG).  mCit-KIF17 was pulled down 
with Flag-KIF17 only in the presence of Flag antibodies confirming that FL KIF17 exists 
as a homodimer (Figure 2.3 A).  Similar Co-IP experiments were done for the C-
terminally tagged KIF17 truncations 1-846, 1-738, 1-490, and 1-369, except Myc tags 
and antibodies were used in place of Flag.  In all cases, the mCit-tagged truncations co-
precipitated with their Myc-tagged counterparts in the presence of Myc, but not control, 
antibodies (Figure 2.3 B).  This confirms they maintain the dimeric state of FL KIF17.  
As KIF17(1-369) was able to dimerize efficiently, the NC is sufficient for KIF17 
dimerization.  However, dimerization by only the NC is not sufficient to maintain 
processive motility.   
 
FL KIF17 is prevented from binding microtubules and truncation of KIF17 relieves 
this inhibition 
 The autoinhibition mechanism of Kinesin-1 restricts processive motility by first 
preventing the motor from binding microtubules [1, 6, 30].  Kinesin-1 is made up of two 
heavy chains (KHC) and two light chains (KLC); with the light chains being particularly 
important for preventing the motor from interacting with microtubules in the absence of 
cargo [6, 30].  The ability of kinesin motors to bind microtubules can be tested in live 
COS cells.  Expression of Kinesin-1’s KHC domain alone, at low levels, results in a 
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steady state cytoplasmic localization despite the fact that the motors are binding and 
falling off the microtubules (Figure 2.4 A).  Treating the cells with the non-hydrolysable 
ATP analog, AMPPNP after permeabilizing the cells with sreptolysin O (SLO), causes 
active motors to be trapped on the microtubule because they cannot be released from their 
strong microtubule bound conformation by hydrolyzing ATP to ADP (Figure 2.4 A) [6, 
31].   Co-expression of Kinesin-1’s KHC and KLC domains, however, results in the 
motor being inhibited from binding microtubules, so AMPPNP treatment does not cause 
them to redistribute from a cytoplasmic to a microtubule-trapped localization (Figure 2.4 
A and B) [6]. 
To determine whether inhibition of microtubule binding is also an important step 
used to prevent KIF17 from moving along microtubules in the absence of cargo, we 
tested the microtubule binding ability of KIF17 constructs tagged with mCit on their C-
terminus in live COS cells.  In the absence of AMPPNP, KIF17 constructs: FL, 1-846, 1-
795, and 1-369 are diffusely localized in the cytoplasm similar to their localization in 
CAD cells (Figure 2.4 B).  1-738 and 1-490, are also largely cytoplasmic, but do show 
peripheral accumulation on microtubules, reflecting their ability to move processively.  
Surprisingly, after AMPPNP treatment, a significant portion of KIF17-mCit is present on 
microtubules showing it is active for microtubule binding.  Indeed, all KIF17 truncations 
(1-846mCit, 1-795mCit, 1-738mCit, 1-490mCit, and 1-369mCit) are able to bind 
microtubules as they also accumulated on microtubules after AMPPNP treatment (Figure 
2.4 B).  The percentage of cells showing this microtubule accumulation was somewhat 
higher for the FL-mCit and 1-846-mCit motors than the other truncations (Figure 2.4 D).  
This suggests the possibility that residues 795-846 or CC3 may have some role in 
facilitating microtubule binding, either by interacting directly with the microtubule as has 
been reported in the case of Kinesin-1’s KHC tail domain, or by promoting a 
conformation of the KIF17 motor that is more conducive to microtubule binding and/or 
keeping AMPPNP in the nucleotide pocket.  It should also be noted, that while KIF17 
motors do bind microtubules in the presence of AMPPPNP, all KIF17 constructs 
maintain a pool of motor in the cytoplasm (Figure 2.4B).  This is in contrast to Kinesin-1 
KHC, where AMPPNP treatment traps a vast majority of the expressed motors on 
microtubules, clearing the cytoplasm almost completely (Figure 3.4 B and C).  Whether 
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this indicts that KIF17 does not bind to microtubules as strongly as KHC in the presence 
of AMPPNP, or whether KIF17 motors are partially inhibited for microtubule binding is 
unclear. 
 As the  cargo protein Mint1 has been shown to bind KIF17’s extreme C-terminal 
residues, we considered the possibility that the mCit tag on the tail of FL KIF17 may 
actually mimic cargo binding and thus lead to a partial activation of the motor.  Although 
fluorescent protein tags do not interfere with the autoinhibitory mechanisms of Kinesin-1 
or KIF1A,  attaching beads to the tail of Kinesin-1 does mimic cargo binding resulting in 
an active, processive motor [2, 6, 24, 32].  Thus, we also generated FL KIF17 constructs 
that were tagged with mCit on the N-terminus (or motor) using both short and long 
flexible linkers (4 amino acids (4aa) and 18 amino acids (18aa) in length).  We also used 
a smaller Flag tag in case the bulky mCit protein sterically hindered proper folding or 
regulation.  COS cells expressing these N-terminally tagged FL KIF17 constructs, were 
permeabilized with SLO then treated with AMPPNP.  Attachment of mCit to the motor 
domain with a 4aa linker gave similar results to KIF17-mCit; that is, it was active for 
microtubule binding (Figure 2.4 F).  However, Flag-KIF17, mCit-18aa-KIF17, and mCit-
Flag-KIF17 remained cytosolic after AMPPNP treatment, showing that they were 
inhibited for microtubule binding.  As the smaller Flag tag, or a mCit that is attached with 
a longer linker, is less likely to interfere with motor regulation and/or folding 
conformations, we conclude that FL Kif17 is regulated by an autoinhibition mechanism 
that prevents microtubule binding in absence of cargo.  But unlike other motors tested to 
date, presence of a fluorescent protein with short linkers on the N- or C- terminus of 
Kif17 interferes with autoinhibition, resulting in interaction with microtubules.  As FL 
KIF17 tagged on the C-terminus with mCit or 3xmCit did not active KIF17 for 
processive movement (Figure 2.2), it appears that there two mechanisms to KIF17 
autoinhibition.  First, KIF17 is inhibited from binding microtubules.  The exact region 
that mediates this inhibition is still unclear.  Second, if KIF17 can bind microtubules, it is 
prevented from moving along them by the CC2 region.   
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Further analysis of CC2 
 As truncation results suggest CC2 is capable of negatively regulating KIF17’s 
processive movement, we investigated whether CC2 is also required for negative 
regulation in the context of C-terminal regions using a KIF17 construct with an internal 
deletion of CC2 (∆739-799) (Figure 2.5 A).  In transfected CAD cells, ∆739-799 
accumulated at neurite tips, in contrast to FL KIF17, which was diffusely localized 
primarily in the cell body (Figure 2.5 C).  Thus the CC2 region is both necessary and 
sufficient for the autoinhibition of KIF17.   
 The CC2 region, is a rather weak predicted coiled-coil that contains a few helix 
breaking residues and many charged residues.  To gain a better understanding of how 
CC2’s coiled-coil structure and amino acid make-up contribute to regulation, we made 
two mutation constructs.  First, we mutated the glycine residue at 754 to a glutamate 
(G754E).  In Osm-3 a similar point mutation, G444E, activates the motor for processive 
motility.  In Osm-3 this residue clearly lies in the small hinge between CC1 and CC2.  
KIF17, however, has a ~300 amino acid insertion into this same hinge.  G444 and 
surrounding residues, although not well conserved, align with residues in the C-terminal 
portion of CC2 and in our estimation G444 corresponds best to G754 of KIF17.  The 
G745E point mutant, results in a stronger coiled-coil prediction for the CC2 region 
(Figure 2.5 B).  When expressed in CAD cells, the G754E point mutant accumulated 
strongly to neurite tips, showing this CC2 mutation was sufficient to relieve the 
autoinhibition of full-length KIF17.   
 A stretch of basic residues (KEKHKRRKR) in CC2 is also a rather conspicuous 
feature.  We mutated these nine residues to alanine.  Not surprisingly, this 764-772A 
mutation caused the coiled-coil prediction for CC2 to decrease in strength (Figure 2.5 B).  
When expressed in CAD cells, the 764-772A mutation also showed peripheral 
accumulation in neurites (Figure 2.5 C).  As both increasing and decreasing the strength 
and rigidity of CC2 give the same effect—an active, processive motor—we propose that 
the predicted coiled-coil structure of CC2 is not necessarily a key feature to the 
mechanism by which it mediates KIF17’s autoinhibition.  Rather the charged and less-
than-ideal coil forming residues in CC2 may have specific roles in mediating contact of 
CC2 with other motor regions.  
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CC2 directly interacts with the motor and can inhibit processive motility in trans  
 To test whether CC2 or any of the surrounding C-terminal regions interacted with 
the N-terminal domains of KIF17, we generated a series of constructs (Figure 2.6 A), co-
expressed them in different combinations in COS cells, and then tested their interactions 
via co-immunoprecipitation.  We first tested whether the Myc tagged constructs 
containing KIF17’s undefined middle region and CC2 (466-846), the undefined middle 
region alone (466-738), CC2 and CC3 (735-846), CC2 alone (735-795), or CC3 and the 
tail (801-1028) could pull-down 1-738mCit (a motor construct truncated before CC2) in 
the presence of Myc-antibodies.   We found that 1-738mCit was co-precipitated with all 
Myc-tagged CC2 containing constructs, including the Myc-735-795 construct which 
consisted of only CC2, but not constructs without CC2 (466-738 and 801-1028) (Figure 
2.6 B).  This suggested CC2 was both necessary and sufficient for the contact with 1-
738mCit.   
To further define what region of 1-738mCit CC2 interacted with, we tested 
whether the myc-466-846 construct could pull down constructs containing the motor and 
neck (1-369mCit), the motor domain only (1-347mCit) or CC1 (Flag-370-490) when 
precipitated with Myc antibodies.  These experiments showed that CC2 interacts directly 
with the motor domain as both 1-347mCit and 1-369mCit co-precipitated with myc-466-
846.  The CC1, Flag-370-490 construct was not co-precipitated (Figure 2.6 C).   
To confirm that this contact between the motor domain and CC2 mediates the 
autoinhibited state of KIF17, we investigated whether any of our Myc-tagged construct 
series could inhibit 1-738mCit’s neurite tip accumulation in trans.  CAD cells co-
expressing 1-738mCit with Myc-tagged constructs containing CC2 (466-846, 735-846, or 
735-795) showed no accumulation of 1-738mCit in neurite growth cones (Figure 3.6 D-
E).  However, 1-738mCit expressed alone, or with Myc-tagged constructs lacking CC2 
(466-738 and 801-1028), showed efficient peripheral accumulation.  Taken together these 
results show that the intramolecular interaction of CC2 with the motor domain inhibit 
motor function by preventing it from taking multiple steps along the microtubule. 
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Cargo-mediated activation of Kif17? 
 Evidence from Kinesin-1 suggests that cargo binding relieves its autoinhibition 
mechanism.  Indeed, the regulatory regions that mediate autoinhibition are the same 
regions that bind cargo (KLC TPR domains and KHC tail) [1, 2, 4, 7, 33].  As of yet, no 
cargo has been shown to bind to KIF17’s CC2 region.  Cargo proteins, Mint1 and NXF-2, 
instead bind KIF17’s tail domain (846-1028).  We did explore whether or not binding of 
Mint1 could activate FL KIF17.  Although we saw by co-immunoprecipitation that 
KIF17 and Mint1 did interact, this binding was not sufficient to activate the microtubule 
binding activity of FL KIF17 in our live-cell AMPPNP assay or its ability to move 
processively to neurite tips in CAD cells (data not shown).  Why attachment of mCit to 
the C-terminus of KIF17 is sufficient to relieve the negative regulation on microtubule 
binding, but binding of Mint1 to the tail is not sufficient is unclear.  As activation of 
Kinesin-1 requires the binding of two proteins, JIP1 and FEZ [33], activation of KIF17 
may also require more cargo interactions, likely involving the CC2 region, or a specific 
phosphorylation state, to be relieved of its autoinhibition mechanism.   
 
KIF17 tail domain is essential for sorting KIF17 to cilia 
As Kif17 and Osm-3 have important roles in the intraflagellar transport (IFT) of 
cargo in cilia [19, 20, 22], we questioned whether a regulatory role for KIF17’s cargo 
binding tail could be elucidated in a cilia context.  We thus expressed mCit-tagged, 
KIF17 proteins in an olfactory sensory neuron cell line (Odora , [34]).  Cells were fixed 
and stained with an antibody to acetylated tubulin to identify primary cilia.  FL KIF17, 
regardless of whether the mCit tag was placed at the N- or C-terminus, did not 
accumulate at the cell periphery consistent with it being autoinhibited.  However, FL 
KIF17 did accumulate at the tips of cilia (Figure 2.7).  In contrast, the autoinhibited 
KIF17 constructs, 1-846 and 1-795, were unable to accumulate in cilia or the cell 
periphery.  This suggests that the tail (846-1028) plays an essential role in sorting KIF17 
into cilia.  Indeed, constitutively active truncations that do not contain the inhibitory CC2 
region or the tail (i.e. 1-738 and 1-488) are able to accumulate at the cell periphery in 
olfactory cells, but not in cilia.  This confirms that the tail contains the cilia targeting 
signal.   FL KIF17 with a G754E mutation accumulates both in cilia and at the cell 
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periphery.   Together, these results confirm that in olfactory cells, like neuronal cells, the 
CC2 region is required to negatively regulate motor activity.  However, activating the 
motor by removal or mutation of CC2 is not sufficient to direct the motor to where it is 
most needed in olfactory sensory cells that is to cilia.  The C-terminal tail (846-1028), is 
required for loading KIF17 into cilia.  As the tail is a known cargo binding region, this 




Autoinhibition Mechanism of KIF17 
 We have shown that KIF17 is self-inhibited by assuming a folded conformation 
that allows the weak coiled-coil region of its stalk (CC2) to directly contact the motor 
domain.  This interaction prevents KIF17 from moving on microtubules, but not 
necessarily from having interactions with the microtubule.  The region that negatively 
regulates microtubule binding was not clear from our studies, but could reside in the 
cargo binding tail.  Additionally, the cargo binding tail was shown to be essential for 
sorting KIF17 into cilia.  These data support a model where KIF17 exists in the 
cytoplasm in an autoinhibited state.  Binding of cargo targets the motor to specific 
cellular compartments, like cilia, and relieves the autoinhibitory mechanism allowing 
KIF17 to processively move along microtubules. 
Autoinhibitory mechanisms appear to be a common feature of motor proteins.  
Kinesin-1, KIF1A, GAKIN/KIF13B, Osm-3, and KIF17 have now been shown to be 
autoinhibited in the absence of cargo [1, 8-10, 24, 33].  As only the motor domain is 
conserved among these and other kinesins [35], various divergent stalk/tail regulatory 
regions have been employed to inhibit motor activity.  Despite the fact that these 
unconserved stalk regions may have developed their own methods to inhibit motor 
function, a few generalizations can be made about kinesin autoinhibition mechanisms.  
First autoinhibition often involves two different levels of regulation, prevention of 
microtubule binding and hindered processive motility.  This two-level motor regulation 
has now been shown for Kinesin-1, KIF1A, and KIF17 [1, 4].  For these kinesins, 
sequences can be deleted or mutated that enable microtubule binding, yet the motors are 
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not capable of processive motility.  Alteration of a second sequence activates motility. 
Second, motor activity is negatively regulated by direct interactions of the motor and/or 
neck with C-terminal stalk/tail regions.   
 More data is needed for KIF17 to pinpoint what residues of CC2 and the motor 
domain are responsible for this inhibitory intramolecular interaction.  Additional 
structural data would be especially helpful to understand how this CC2/motor contact 
functions to inhibit the processive motility of KIF17.   Recently, Dietrich et al showed 
that in Kinesin-1, tail residues QIAKPIRP directly interact with the switch 1 region of the 
motor [4].  As the Switch I region participates in nucleotide binding and release [36], this 
interaction likely prevents Kinesin-1’s initial microtubule stimulated ADP release step, 
consequently, preventing Kinesin-1 from productively interacting with microtubules [1, 
4, 5, 7].  As the tail can simultaneously interact with microtubules, it could also function 
to limit processive movement of Kinesin-1 when bound to microtubules [4].  This 
tail/switch I inhibitory interaction mechanism is strikingly similar to how GDI proteins 
function to inhibit small G proteins whose nucleotide binding pocket is similar in 
structure to that of kinesin motors [37, 38].  Thus, although the CC2 region of KIF17 is 
not conserved with the QIAKPIRP containing tail of Kinesin-1, the two kinesins could 
have co-evolved a similar inhibitory switch I-motor interactions.  
 
Comparison of autoinhibition mechanisms of KIF17 and Osm-3  
Osm-3, like KIF17, has been shown to be autoinhibited.  For either motors, 
mutation or deletion of a central stalk region—CC2 for KIF17, or the hinge 2 region 
between CC1 and CC2 in Osm-3—results in an active, processive motor.  For KIF17 we 
show that CC2 functions to inhibit motor activity by directly interacting with the motor 
domain.  Imanishi et al showed that increased motor activity correlated with a less 
compact conformation of the protein.  Thus, they proposed that Osm-3 folds at the hinge 
2 region bringing more C-terminal regions in contact with the motor to mediate 
inhibition[24].  The stalk regions of Osm-3 and KIF17 are fairly well conserved, with the 
exception that KIF17 has a ~300 residue insertion of unknown domain structure, into the 
hinge 2 region.  This insertion makes it difficult to conclude whether Osm-3 and KIF17 
are likely regulated by the same mechanism, or whether they might have a slightly 
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different molecular basis for their autoinhibition.  Both studies mutated a conserved 
glycine (G444, Osm-3; G754, KIF17) to glutamate.  In Osm-3 this glycine and 
surrounding residues compose a region that has no predicted coiled-coil structure.  As 
there are flexible residues, this region is defined as hinge 2.  In contrast, KIF17 has a few 
alterations in the residues surrounding G754 which increase the coiled-coil probability 
for this same region causing it to be grouped with CC2 rather than the ~300 amino acid 
insertion that has no coiled-coil probability.   Future studies will have to determine 
whether the hinge 2/CC2 regions should be considered together as the region that directly 
binds the motor domain, or whether there is a flexible part of KIF17’s CC2 that serves as 
a hinge to facilitate binding of more C-terminal residues of CC2 to the motor domain. 
 
Cargo-mediated activation and sorting of KIF17 
 The inhibitory mechanism of KIF17 is likely relieved by cargo.  Attachment of 
beads as a cargo mimic to Kinesin-1 or Osm-3 activates their processive motility [1, 24, 
32].  In our studies, we saw that attachment of a fluorescence protein to the C-terminus of 
KIF17 was enough of a cargo-mimic to activate the microtubule binding activity of 
KIF17, but not processive motility.  This could indicate that the CC2-motor interaction 
requires additional cargo binding or post-translational modifications in order to be 
broken.   As there are currently no know binding partners for the CC2 region, testing of 
this hypothesis will have to wait.  KIF17’s known direct binding cargo, Mint1 and NXF-
2, interact with the tail region[13, 15, 25].  In the case of Mint1, phosphorylation of a 
serine residue in the tail, by CaMKII, regulates the ability of the cargo to bind KIF17 
[25].  Whether this same phosphorylation event or others play a role in KIF17 motor 
regulation is unknown.   
We show that the cargo binding tail is necessary for KIF17 to accumulate in the 
tips of cilia.  This loading into cilia is likely dependent on interactions with IFT 
machinery, presumably cargo.  As constitutively active motors without the tail were 
unable to accumulate in the distal cilia, loading into cilia is an additional level of 
regulation used by KIF17.  KIF17 has also been shown to be important in vesicular 
trafficking in dendrites.  Cargo binding to the tail of Kinesin-1 has been shown to be 
important for localizing the motor to dendrites as opposed to axons which the Kinesin-1 
 31
motor intrinsically prefers [27, 39].  It will be interesting to see if cargo binding to 
KIF17’s tail could also be important in sorting KIF17 to dendrites. 
 
MATERIALS AND METHODS 
Plasmids and antibodies:  Full-length or truncated KIF17 constructs tagged with 
mCit , Flag, or Myc were generated by PCR amplification from the Sport6-HsKIF17 
cDNA vector.  PCR products were cloned into the mCit-N1 or C1 vectors (modified from 
Clontech’s EYFP-N1/C1 vectors by replacing EYFP with sequence for monomeric 
Citrine) the 3xmCit-N1 vector  previously described [28], or the pcDNA3-Flag vector 
using convenient restriction sites.  Additional KIF17 internal deletions and mutations 
were made by overlapping PCR.  All plasmids were sequence verified.  KHC-mCit and 
CFP-KLC have been described previously [6].   The following antibodies were used: 
Myc (Sigma and 9E10 hybridoma ascites), Flag (Sigma), GFP (used to recognize mCit; 
Invitrogen), and acetylated α-tubulin 6-11B-1 (Sigma). 
Cell culture and immunofluorescence:  COS and CAD cells were cultured, 
transfected, and processed for immunofluorescence as previously described (COS, Cai 
2007; CAD, Verhey 2001 and Blasius 2007).  Images were collected with a Nikon 
TE2000 microscope using a Plan-Fl 40X/NA 0.75 or a Plan-APO 60X/NA 1.4 objective 
and Photometrics CS ES2 camera.  Odora cells were plated on uncoated glass coverslips 
in DMEM, 10% FBS, and PennStrep then maintained at 33 degrees C, in 5% CO2.  Cells 
were transfected with Lipofectamine 2000.  After 24 hour expression, cells were fixed 
and processed for immunofluorescence as described previously [22].  Images were taken 
on an Olympus Fluoview 500 confocal microscope with a 100x/NA 1.35 objective. 
 Co-immunoprecipitation:  COS cells were first resuspended in lysis buffer 1 
(LB1; 25 mM Hepes/KOH, 115mM potassium acetate, 5 mM sodium acetate, 5 mM 
MgCl2, 0.5 mM, EGTA, 1% Triton X-100, and protease inhibitors; pH 7.4) or in Sabatini 
lysis buffer (SLB; 40mM Hepes pH 7.5, 120 mM NaCl, 1 mM EDTA, 10mM sodium 
pyrophosphate, 10mM ß-glycerophosphate, 50 mM NaF, 0.5% NP40, 0.1% Brij-35, and 
protease inhibitors).  After removing insoluble material by centrifugation at 20,000xg at 
4°C for 10mins, extracts were incubated with the specified antibodies for 2.5-18 hr at 
4°C.  Protein A agarose beads were then added and mixture was incubated for and 
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additional 20-40 mins at 4°C.  Beads were pelleted and washed two times with lysis 
buffer, resuspended in Laemmli sample buffer, and analyzed by SDS-PAGE and Western 
blot. 
In vivo microtubule binding assay:  COS cells were plated onto glass-bottomed 
dishes (MatTek) and transfected with plasmids encoding the proteins of interest.  
Twenty-four hours later, cells were viewed on a Nikon TE2000 inverted microscope.  
Cells were treated with 0.1 µg/ml Streptolysin O in permeabilization buffer 1 (25 mM 
Hepes/KOH, 115mM potassium acetate, 5 mM sodium acetate, 5 mM MgCl2, 0.5 mM, 
EGTA, and 10mg/ml BSA; pH 7.4) for 1 min.  After washing 3 times with Buffer 1, cells 
were incubated with Buffer 1 containing 2mM AMPPNP.  Cell were monitored every 
minute for an additional 15 minutes.  Alternatively, cells were treated with SLO and 
AMPPNP in the presence of taxol for 10 minutes.  Then, cells were fixed with 3.7 % 
formaldehyde and processed for immunofluorescence using Flag antibodies.   
In vitro single molecule motility assays:  Motility assays were performed in 
flow chambers as previously described [28] except P25 buffer (25 mM Pipes/KOH, 1 
mM EGTA, and 2 mM MgCl2, pH 6.8) was used in place of P12.  Briefly, motor proteins 
were prepared by lysing transfected COS cells in SLB with 1mM ATP.  5-10µl cell lysate 
was added to flow-chambers containing taxol-stabilized microtubules and 40-45 µl of 
oxygen scavenger buffer (1 mM DTT, 1 mM MgCl2, 2 mM ATP, 10 mM glucose, 0.1 
mg/ml glucose oxidase, 0.08 mg/ml catalase, 10 mg/ml BSA, and 10 µM taxol in P25).  
An objective-type total internal reflection fluorescence microscope and a back-
illuminated EMCCD camera (Cascade 512B; Roper Scientific) were used to image single 
molecule motility events at intervals of 100 ms.  Single molecule tracking measurements 
for each construct come from at least two independent protein preparations and include 
motile events lasting at least 0.3 seconds.  Velocity and track length measurements were 





































Figure 2.1:  KIF17 and Osm-3 coiled-coil prediction and construct schematic.  (A)  Coiled-coil 
prediction for Osm-3 (C. elegan NP_001023308) and domain map.  Gray dotted line, prediction 
using a window of 14 amino acids; Blue line, prediction using a window of 21 amino acids (based 
on COILS; Lupas method [40]). (B)  Coiled-coil prediction for KIF17 (homo sapiens NP_ 






Figure 2.2:  KIF17 processivity is inhibited by coiled-coil 2.  (A)  Cell based-motility assay.  
CAD cells were transfected with full-length (FL) or truncated KIF17 constructs (C-terminally 
tagged with mCit) and differentiated for 40-48 hrs. Scale 20µm.  (B-F)  In vitro single molecule 
motility assay.   COS cells were transfected with 3xmCit tagged FL or truncated KIF17 
constructs.  Motor proteins in cell lysates along with 1mM ATP were incubated with Taxol-
stabilized microtubules and assayed with TIRF microscopy for motility.  (B)  Velocity 
histograms. (C) Track length histograms. (D) Distribution of track lengths as a function of time 
spent in 1-directional motility. (E)  Representative kymographs for each motor construct.  Scale 
























Figure 2.3:  Full-length and truncated KIF17 proteins dimerize.  (A-B)  Co-immunoprecipitation.  
COS cells were co-transfected with plasmids encoding Flag and mCit tagged FL KIF17 
constructs (A), or Myc and mCit tagged truncated KIF17 constructs (B).  Lysates were analyzed 
by western blot either directly (input lysate) or after immunoprecipitation with anti-Flag and 





Figure 2.4:  Full-length KIF17 is inhibited from binding microtubules.  Truncation of KIF17 or 
using a fluorescent protein to mimic cargo relieves this inhibition.  (A-F) Live cell microtubule 
binding assay.  COS cell expressing the indicated Kinesin-1 or KIF17 proteins were 
permeabilized with SLO, washed, and treated 15 mins with AMPPNP.  (A) Representative before 
and after AMPPNP treatment images shown for cells expressing Kinesin-1’s KHC (mCit tagged) 
and KLC (CFP tagged, not shown) subunits (left); or the KHC subunit alone (right). Scale, 20µm.  
(B)  Percent of cells where Kinesin-1 relocates from a cytoplasmic to microtubule (MT) bound 
localization after AMPPNP treatment.  Averages from 3 experiments ~50 cells each.  Error bars 
+/- SEM.  (C)  Representative before and after AMPPNP treatment images for FL or truncated 
KIF17 constructs C-terminally tagged with mCit.  Scale, 20µm.  (D)  Percent of cells where 
KIF17 relocates from a cytoplasmic, to microtubule (MT) bound, localization after AMPPNP 
treatment.  Averages from 3-5 experiments ~100 cells each.  Error bars +/- SEM.  (E-F)  Tag type 
and location influences the microtubule binding ability of FL KIF17.   (E)  COS cells expressing 
FL KIF17 tagged on N-terminus with mCit or Flag after 15 mins AMPPNP treatment.  For Flag-
KIF17 cells were additionally fixed and immunostained with anti-Flag antibodies.  Scale, 20µm. 
(F)  Percent of cells with FL KIF17 localized to microtubules (MT) after AMPPNP treatment. 
Flag or mCit tags placed on N- or C- terminus (NT or CT respectively) as indicated.  Error bars 









Figure 2.5:  Removal or mutation of coiled-coil 2 results in an active, processive motor.  (A)  
Construct schematic of FL KIF17 or constructs with internal deletions or mutations.  Blue region, 
CC2; Red region, CC3.  For G754E and 764-772A constructs, the mutated residue(s) are 
highlighted in yellow and the surrounding residues are shown.  Amino acids within the predicted 
CC2 are boxed in blue.  (B)  Coiled-Coil predictions for constructs in A.  Regions altered by 
deletions or mutations are marked *.  Gray dotted line, prediction using a window of 14 amino 
acids; Blue line, prediction using a window of 21 amino acids (COILS, Lupas Method).  (C)  Cell 
based-motility assay.  CAD cells were transfected with the indicated KIF17 constructs (tagged 








Figure 2.6:  Coiled-coil 2 inhibits the motor by direct contact and can inhibit in trans.  (A)  
Construct schematic.  NC, neck coil, CC, coiled-coil. (B-C)  Co-immunoprecipitation.  COS cells 
expressing 1-738mCit, 1-369mCit, 1-347mCit, or Flag-370-490 and the indicated Myc C-
terminal fragments were lysed and analyzed by western blot either directly (input lysate) or after 
immunoprecipitation with anti-Myc or control IgG antibodies.   In C, the control and Myc-466-
846 pairs for 1-369, 1-347, or 370-490 are from the same gel.  ** indicates bands due to Myc 
antibody heavy chains. *background bands in total cell lystate. (D-E)  Cell based-motility assay.  
Expression of Myc tagged constructs containing the minimal CC2 region, 735-795, can inhibit, in 
trans, the processivity or tip accumulation of KIF17 1-738.   (D) CAD cells were transfected with 
1-738 mCit alone or with the indicated Myc constructs and differentiated for 40-48 hrs. Scale 
20µm.  (E)  Percentage of cells with 1-738 accumulated at neurite tips in the presence of the 
indicated Myc tagged construct.  Averages from 2-3 experiments, 50-100 cells each.  Students T-





Figure 2.7:  The KIF17 tail is required for peripheral accumulation in cilia. (A-D) Olfactory cells 
were transfected with the indicated mCit tagged KIF17 plasmids and allowed to differentiate for 
48hrs.  Cells were then fixed and immunostained with anti-acetylated tubulin antibodies to reveal 
cilia location (shown in red).  Full cell images shown in (A), with cilia regions enlarged in (B).  
(C)  KIF17 accumulates at the distal tip of cilia.  A line was drawn down the proximal-to-distal 
length of the cilia shown in B, for mCit-KIF17.  Fluorescence intensity (AU, arbitrary units) of 
mCit-KIF17 was measured and graphed as a function of cilia length.  (D) Quantification of the 
percent of transfected cells that had KIF17 accumulated in cilia.  *Chi-squared test, p < 0.002.  
Acknowledgements:  This figure was generously contributed by Paul Jenkins, from Jeffrey 
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Motile Properties of Dimeric KIF1A Motors  
Upon Release of Autoinhibition 
 
 Molecular motors of the kinesin superfamily use the energy of ATP to move 
along or modify the microtubule cytoskeleton.  Kinesin-3 family members, mammalian 
KIF1A and C. elegans Unc104, specifically couple this ATP driven motility to transport 
many types of intracellular cargo including synaptic vesicle precursors [1-3].  Labeling 
KIF1A or Unc104 proteins with GFP has allowed motors clustered on vesicular 
membranes to be visualized and tracked.  These motors move at 0.8-1.0 µm/second in an 
anterograde direction down axons of murine primary hippocampal neurons or in live 
worms [4-6].  
 To ensure that ATP is not wasted by kinesin motors uncoupled to cargo, kinesin 
motors must be tightly regulated.  Indeed, many studies have shown that the first 
identified, and most well-characterized kinesin motor, Kinesin-1 (also known as 
conventional kinesin or KIF5), is autoinhibited in the absence of cargo ([7-9] and reviews 
[10, 11].  This work has led to the general hypothesis that all cargo transporting kinesins 
must have both active and inhibited states.  Recently more examples of kinesin 
autoinhibition have come to light as the Kinesin-2 family member, Osm-3, and Kinesin-3 
family members, Gakin/KIF13B, KIF1A, and Unc104 are also inhibited [12-17].  
Autoinhibition of KIF1A/Unc104, is mediated by two different regions.  First 
microtubule binding is inhibited by the forkhead-associated (FHA) domain and the C-
terminally adjacent coiled-coil (CC2) [14, 15].  Second, the neck coil (NC) and first 
coiled-coil region (CC1) of Unc104 has been suggested to play a role in the transition 
from a monomeric state incapable of long-distance motility to an active dimeric state 
[14].  Whether this regulatory mechanism is also conserved in mammalian KIF1A has not 
yet been tested.    
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 KIF1A/Unc104 motors have some of the fastest reported velocities and longest 
run lengths of the kinesin superfamily [2, 4-6, 18-20].  However, the most unique or 
controversial quality of KIF1A is that it has been proposed to act as a monomer [16, 21, 
22].  Most cargo transporting kinesins are dimeric and are believed to coordinate their 
two motor heads in an alternating hand-over-hand fashion, moving in 8nm steps down the 
microtubule [23].  However, results from hydrodynamic analysis of recombinant and 
endogenous KIF1A/Unc104 motors suggest they are monomers [2, 17, 19, 24].   Thus, a 
novel motility mechanism was proposed to explain how KIF1A/Unc104’s single motor 
domain could generate processive movement.  In the model, KIF1A/Unc104 diffuses 
along the microtubule with ATP hydrolysis powering a slight rotation of the head that 
provides enough mechanical force to bias diffusion towards the plus-ends of 
microtubules.  The processivity of KIF1A/Unc104 also depends heavily on a positively 
charged K-loop inserted near the motor domain’s microtubule binding interface.  
Electrostatic interactions between this lysine rich region and the negatively charged C-
terminal tails of tubulin help the single-headed motor stay attached in a weak binding 
state while diffusing [16, 21, 22, 25, 26].  
The biased diffusion model has been controversial because in vitro experiments 
report that monomeric KIF1A motors move at very slow velocities (0.14µm/second) 
compared to the fast velocities reported for GFP-tagged KIF1A/Unc104 motors 
expressed in vivo [5, 6, 16, 20-23].  Monomeric KIF1A motors  also stall under low load 
(0.15 pN), which is likely not sufficient to drive vesicle transport in a crowed cellular 
environment [21].  Finally, monomeric Unc104 constructs do not show the same biased 
diffusion movement as KIF1A [19, 20].  Thus, a second model for KIF1A/Unc104 
motility was put forth, suggesting that in vivo, KIF1A/Unc104 dimerize on vesicular 
membranes in order to achieve processive transport of cargo.  This model is supported by 
several lines of evidence.  First, studies show that Unc104 constructs artificially 
dimerized by the addition of a leucine zipper or the coiled-coil stalk region of Kinesin-1, 
are highly processive.  The forced-dimer Unc104 motors show motile properties similar 
to other dimeric kinesins and to the motility properties of GFP-tagged KIF1A/Unc104 
motors expressed in vivo [20].  Second, Unc104 proteins can drive the processive 
transport of liposomes by binding phosphotidylinositol(4,5)bisphosphate (PIP4,5P2) 
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molecules.  This processive transport is greatly enhanced by high concentrations of 
PIP4,5P2, or experimental conditions that locally concentrate PIP4,5P2 on the liposome 
membrane.  This suggests locally concentrating the Unc104 motor on cargo vesicles 
facilitates its dimerization and consequently its ability to move processively [4, 27].  
Third, recombinant KIF1A motors expressed in reticulocyte lysates can dimerize [17].  
Finally, the fact that the closely related Kinesin-3 family members, Dictyostelium 
Unc104 (DdUnc104) and Kif1C exist in a dimeric state, also lends support to the 
KIF1A/Unc104 processive dimer model [28, 29].  Yet, a KIF1A motor that is dimerized 
via its own sequences and that moves processively has not yet been demonstrated. 
What are the KIF1A/Unc104 regions that may facilitate dimerization?  The short 
predicted coiled-coils are likely candidates, but as they are much shorter, and in some 
cases, significantly weaker than the extended coiled-coil segments present in other 
kinesin family members, they have largely been overlooked and understudied.  However, 
the NC is likely to be important as mutations in this region, abolished the ability of 
Unc104 forced dimers to move processively, suggesting it must function in some way to 
coordinate the two motor domains of the forced dimer [20].   Additionally cryoelectron 
microscopy studies and studies on synthesized peptides equivalent to the NC of KIF1A or 
Unc104 also suggest this short coiled-coil is capable of dimerization [14, 17, 30]. None 
of the other predicted coiled-coil regions have been implicated in dimerization, but they 
also have not been studied.  
 We set out to examine the overall structure and regulatory regions of KIF1A 
motors and to correlate processive motor activity with dimeric state.  We show that full-
length KIF1A motors can dimerize, but these dimers are still in an autoinhibited state 
where they are prevented from binding microtubules and moving processively.  Our data 
agree with previous studies that this autoinhibition is mediated by the CC2/FHA region 
and CC1.  Dimerization requires the full NC, but likely other coiled-coils contribute.   
Finally, we support the model that KIF1A moves processively as a dimer.  Although we 
observed monomeric motor constructs that moved for short time periods via one-
dimensional diffusion, we show that processive movement for long time periods requires 
dimerization and likely a motility mechanism more reminiscent of kinesins that move 
hand-over-hand.     
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 RESULTS 
Full length KIF1A is inactive in mammalian cells 
 In order to investigate the regulatory mechanisms and monomeric/dimeric state of 
KIF1A, we tagged rat KIF1A with a fluorescent protein (FP) on the N- or C-terminus and 
expressed it in mammalian cells.  Kinesin-1 motors have been successfully labeled and 
studied in their native cellular environment by this approach, thereby avoiding many of 
the pitfalls associated with purifying and labeling kinesin motors in vitro [7, 31].  As 
Unc104 proteins tagged with a FP on their C-terminus are able to rescue the paralyzing 
phenotypes caused by Unc104 mutations in C elegans, the FP tag appears to have no 
deleterious effects on the cargo binding, regulatory, or motility properties of the  
motor [6].    
We first investigated whether full-length KIF1A was able to bind microtubules.  
KIF1A was tagged with a monomeric version of Citrine (mCit, a variant of YFP), and 
expressed in COS cells where it showed a diffuse, cytoplasmic localization  (Figure 3.1 
A).  Previous studies on Kinesin-1 have shown that steady-state expression patterns often 
do not reveal whether the motor is actively binding and moving on microtubules.  
However, by exposing the motors to the non-hydrolysable ATP analog, AMPPNP, active 
motors can be trapped on the microtubule as they are unable to change from a strong 
microtubule bound conformation [7, 32].   Live COS cells were permeabilized with the 
bacterial toxin streptolysin O (SLO) then treated with AMPPNP.  The cytosolic 
localization of mCit-KIF1A was not altered by AMPPNP (Figure 3.1 A and B), revealing 
that full-length KIF1A is inhibited from binding microtubules.  This data agrees with 
previous reports suggesting KIF1A/Unc104 is an autoinhibited motor. 
 
Full length KIF1A forms a compact dimeric protein in mammalian cells 
 As two regulatory mechanisms have been proposed to explain the KIF1A/Unc104 
inhibited state, specifically the presence of inhibitory domains or a monomer-to-dimer 
transition, it is important to determine whether full-length KIF1A exists as a monomer or 
dimer.  Three experimental approaches were taken to address this question, specifically, 
co-immunoprecipitation, chemical crosslinking, and fluorescence resonance energy 
transfer (FRET) stoichiometry.  For co-immunoprecipitation experiments, mCit- and 
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Myc-tagged KIF1A proteins were co-expressed in COS cells. Cells were then lysed and 
immunoprecipitated with either control antibodies (IgG) or antibodies to the Myc tag.  
mCit-KIF1A co-precipitated with Myc-KIF1A in the presence of Myc antibodies but not 
control antibodies.  Similar results were seen for KIF1A motors tagged with mCit on the 
N-terminus and monomeric cyan fluorescent protein (mCFP) on the C-terminus (mCit-
KIF1A-mCFP, Figure 3.1C).  These results support a dimeric, rather than monomeric, 
state for KIF1A when it is expressed in mammalian cells.  
 Chemical crosslinking, the second experimental approach used to test the 
monomeric or dimeric state of KIF1A, has been used previously to demonstrate that 
Kinesin-1 and some Kinesin-3 motors are dimers [20, 29].  Cell lysates from mCit-
KIF1A expressing COS cells were treated with dimethylpimilimidate (DMP) then run on 
a SDS-PAGE gel and blotted for the mCit tag.  The mCit-KIF1A protein ran at the 
expected molecular weight (~170 kD) in the absence of crosslinker, but showed reduced 
mobility in the gel when treated with DMP (Figure 3.1D, lanes 1,2).   The KHC domain 
of Kinesin-1, which is a well proven dimer, also showed an up-shifted bands in the 
presence of DMP when similarly tagged with mCit (Figure 3.1D, lanes 3 and 4).  Control 
experiments with lysates containing the mCit tag alone showed no up-shifted band of 
reduced mobility, proving that the decreased mobility seen for mCit-KIF1A and mCit-
KHC was not due to the tag (Figure 3.1D, lanes 5 and 6).  These results again suggest 
that KIF1A, like Kinesin-1, can exist as a dimer.   
 The final approached used to resolve the KIF1A monomer-dimer question, 
FRET stoichiometry, was chosen as it could also give information about the overall 
conformation of KIF1A.  FRET stoichiometry was recently used to elucidate 
conformational changes that occur in Kinein-1 when it changes from an autoinhibited 
state to an active state [7].  FRET stoichiometry uses three fluorescence images to 
calculate an average FRET efficiency (EAVE; for more details see materials and methods).  
EAVE values vary between 0% (no FRET) for unlinked donor mCFP and acceptor mCit 
fluorophores, and 37% for mCFP and mCit linked by a 16 amino acid polypeptide chain 
[7, 33, 34]. 
 To test the prediction that KIF1A is a dimer, mCFP-KIF1A and mCit-KIF1A 
were co-expressed in COS cells and an average FRET efficiency between the donor and 
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acceptor FPs was calculated.  The motor-to-motor FRET of KIF1A was low, but 
measurable (EAVE = 3.0%) and was very comparable to the motor-to-motor FRET of the 
Kinesin-1 holoenzyme that has its motor domains separated by KLC in its inactive state 
(EAVE = 2.1%, Figure 3.1 E and F) [7] .  As there was a detectable FRET signal for 
KIF1A, these results do not support a monomeric conformation, but rather support the 
idea that KIF1A is dimeric, but in the inactive molecule the motor domains do not reside 
side by side  However, the possibility that KIF1A exists as a mixture of monomers and 
dimers in vivo cannot be excluded.  
 FRET stoichiometry was put to further use in order to test the model that KIF1A 
folds into a compact conformation.  This model is based on previous studies using rotary 
shadowing of recombinant KIF1A [2].  The single motor construct, mCit-KIF1A-CFP, 
was generated in order to put donor and acceptor FPs on KIF1A’s motor and tail 
domains.  When expressed in COS cells with Myc-KIF1A,  mCit-KIF1A-CFP resulted in 
an EAVE that was again low, but detectable (EAVE = 4.8%).  This value was significantly 
different from the motor-to-tail FRET efficiency of the Kinesin-1 holoenzyme, whose 
motor and tail domains are in very close proximity in the folded, inactive state (EAVE = 
15.8%, Figure 3.1 G and H) [7].  These results support the conclusion that KIF1A, in 
native conditions, is not an extended molecule (where we would expect no FRET) nor 
does it have a conformation with the motor or tail domains as closely located as in the 
case of Kinesin-1 (expect high FRET).  Nevertheless, KIF1A is likely folded in a 
compact conformation which places the N-terminal motor and C-terminal tail within at 
least ~8-10 nm of each other.  
 The combination of these results shows that KIF1A can form dimers in vivo, but 
is inhibited from binding microtubules.  Thus, dimerization is not sufficient for motor 
activation and a mechanism other than a monomer-to-dimer transition must be used in 
order to shift KIF1A from and inactive to active state.   
 
Separate mechanisms regulate microtubule binding and processive motility of 
KIF1A motors  
Analysis of the domain structure of KIF1A/Unc104, shows the motor domain is 
followed by two very short coiled-coils (referred to as the neck coil, NC; and coiled-coil 
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1, CC1), a forkhead-associated (FHA) domain, two more short coil-coils (CC2 and 3), a 
large undefined region, and a C-terminal PH domain (Figure 3.2 A and B).  Whether any 
or all of the short predicted coiled-coils are necessary or sufficient for dimerization is 
unknown.  To identify the regions of KIF1A involved in autoinhibition and dimerization 
under native expression conditions, truncated versions if KIF1A were created (Figure 3.2 
B) by placing a mCit tag after CC2, KIF1A(1-726), after CC1, KIF1A(1-491), or after the 
NC, KIF1A(1-393).   
The SLO/AMPPNP assay described above was used first to investigate the 
microtubule binding ability of each truncation.  Live cell imaging of COS cells 
expressing the mCit-tagged KIF1A truncations showed that after SLO and AMPPNP 
treatment, KIF1A(1-726)-mCit remained cytosolic (Figure 3.3 C,D,E), indicating that this 
construct, which has roughly half of the KIF1A residues missing (727-1696), still 
maintains the autoinhibited state of the full-length molecule.  Further truncation of CC2 
and the FHA domain caused KIF1A(1-491)-mCit to relocate from a diffuse cytosolic 
localization, to a microtubule-locked localization after treatment with AMPNP.  Thus, the 
CC2 and FHA domains (residues 492-726) are responsible for keeping KIF1A inhibited 
and unable to interact with microtubules.  These results are consistent with previous work 
on truncated KIF1A/Unc104 [14, 15] which also implicated the CC2/FHA region as 
important in maintaining KIF1A’s autoinhibited state.  Removal of the CC1 domain, 
yielded more interesting results, as KIF1A(1-393)-mCit localized to microtubules even in 
the absence of AMPPNP.  In this case the motor was accumulated on microtubules in the 
periphery of the cell suggesting that it was constantly undergoing processive movement.  
Addition of AMPPNP did result in a shift in the remaining cytosolic KIF1A(1-393) to a 
microtubule bound state which was most apparent in the central regions of the cell.  
Therefore, although the CC2/FHA region prevents KIF1A from binding microtubules, the 
CC1 region may play an additional role in regulating KIF1A’s motile properties. 
To further test CC1’s role in regulating processive motility, we tested all 
constructs in two processive motility assays.  Since multiple studies have demonstrated 
that active kinesin motors often accumulate at the tips of cell processes [15, 35, 36], we 
first analyzed the processive motility of KIF1A in the neuronal-like cell line, CAD.  
Second, we tested processive motility in vitro using a single molecule motility assay.  For 
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this assay, KIF1A constructs were tagged on their C-terminus with three tandem copies 
of mCit for improved signal-to-noise ratio and decreased photobleaching and 
photoblinking [31].  Cell lysates from COS cells expressing the 3xmCit-tagged KIF1A 
constructs were added to a flow chamber containing taxol-stabilized microtubules and 
assayed on a total internal reflection fluorescence (TIRF) microscope.   By timelapse 
imaging at 100ms intervals, individual motors could be seen moving along microtubules.  
Only motility events that lasted at least 500ms were included in the analyzed data set to 
ensure that the same motor could be tracked through 5 timelapse images.   In order to 
directly compare the number of motility events and the motile properties of velocity and 
track length for each KIF1A motor construct, the amount of expressed protein was 
normalized by western blot and each construct was analyzed for the same total amount of 
time.   
As expected from the microtubule binding experimental results, full-length (FL) 
KIF1A and KIF1A(1-726) were inactive for processive movement as they did not 
accumulate at the tips of CAD cell neuronal processes but were instead diffusely 
localized primarily in the cell body (Figure 3.3 A).  They additionally showed very few 
motility events in vitro (Figure 3.3 B-D).   Interestingly, KIF1A(1-491) was also diffusely 
localized in CAD cells and moved only rarely in vitro.  This reveals that while the 
CC2/FHA region of KIF1A regulates microtubule binding of the full-length motor, an 
additional region must control motility.  KIF1A(1-393), on the other hand, showed 
dramatic accumulation to the tips of neuronal processes, with very little cell body 
localization and exhibited a large number of motility events in vitro.  Thus, CC1, or 
amino acids 394-490, must play an inhibitory role in KIF1A, mediating to some degree 
the motility control mechanism.       
KIF1A(1-393)’s average velocity of 1.36 ± 0.04 µm/sec and average track length 
of 1.24 ± 0.06 µm per event (Figure 3.3 D), are comparable to previous in vivo and in 
vitro measurements for KIF1A/Unc104 motors where velocities ranged from 0.8-1.7 
µm/sec with track lengths up to several µm [2, 4-6, 14, 19].  The slight differences in 
velocity and run lengths observed for the FL, 1-726, and 1-491 motors as compared to 1-
393 are likely not significant due to the very few events used to calculate them.  These 
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few motility events are likely due to stochastic activation of the auto-inhibited motors by 
random conformational changes.  
 
The CC1 domain prevents dimerization and processive motility of KIF1A(1-491) 
 What is the mechanism by which processive motility is inhibited in the KIF1A(1-
491) motor?  Results from Albassam et al [14] provide a likely explanation.  Using 
cryoelectron microscopy they noted that CC1 could fold back on the NC forming a 
parallel intramolecular coiled-coil that limited the motor to a monomeric conformation.   
In a second conformation, they reported that the motor was likely dimerized with the NC 
and CC1 forming intermolecular coils with their respective counterparts on the adjacent 
dimer subunit[14].  Thus, the CC1 may inhibit the processive motility of dimeric KIF1A 
by uncoupling its two motor heads.  This would be analogous to the situation in Kinesin-
1 where the KLC subunits prevent processive motility in the inhibited state by unwinding 
the neck and pushing the motor domains apart [7].  In the case of the KIF1A truncation 
(1-491), the CC1 may prevent dimerization altogether.      
 To test this hypothesis and whether or not truncated forms of KIF1A are 
monomers or dimers, chemical crosslinking, co-immunoprecipitation and photobleaching 
experiments were done.  In the absence of crosslinker, all truncations ran at sizes 
representing their approximate molecular weight.  When treated with DMP, however, 
both the (1-726)-mCit and (1-393)-mCit proteins where present in up-shifted bands of 
restricted mobility (Figure 3.4 A), indicating they exist as dimers.  (1-491)-mCit, on the 
other hand, showed only a small fraction of protein shifted to a higher molecular weight, 
with the remaining majority shifted downward to species of faster mobility.  This 
suggests that (1-491) is primarily a monomer.  The novel downshift further indicates that 
the monomer has a compact conformation that permits an intramolecular crosslink.  This 
internal crosslink could be indicative of the parallel coiled-coil between the NC and CC1 
seen by Albassam et al, but could also have occurred elsewhere such as in the motor 
domain.  Co-immunoprecipitation experiments gave similar results with the exception of 
1-491.   Myc- and mCit-tagged versions of the KIF1A truncations were co-expressed in 
COS cells and immunoprecipitated with control antibodies (IgG) or antibodies to the Myc 
tag.  A significant portion of mCit tagged truncations 1-726, 1-508 (a truncation very 
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similar to 1-491, that behaves identically to 1-491 in all assays), 1-491, and 1-393 were 
co-precipitated with Myc constructs of an equivalent length in the presence of Myc 
antibodies.   Thus, 1-726 and 1-393 behave as dimers in both assays, but 1-491 showed 
varied results.   
 The final method used to test the dimeric state of KIF1A truncations involved 
tagging them with 3xmCit tags, then analyzing the fluorescence intensity values of 
individual motors over time as they photobleach.  As each mCit molecule photobleaches, 
the total fluorescence intensity of the motor construct drops at rather consistent intervals.  
Thus, a dimeric 3xmCit-tagged motor would show up to six bleaching steps, whereas, a 
monomeric motor would only have up to three steps.  Dimers and monomers are 
expected to have some variation in their number of bleaching steps as some mCit 
molecules will have the tendency to blink, bleach simultaneously, or bleach prior to 
analysis.  As this assay tests dimerization at the single molecule level, it can potentially 
reveal more information about the pool of motors than the previous assays which treated 
all motors as a group.   
Cell lysates from COS cells expressing 3xmCit-tagged versions of full-length or 
truncated KIF1A motors were added to flow chambers where the 3xmCit-tagged motors 
were adsorbed directly to the coverglass or locked on microtubules in the presence of 
AMPPNP.  The bleaching behavior of single motors over time was recorded in the TIRF 
microscope and the number of bleaching steps for individual fluorescent motors was then 
plotted as a histogram (Figure 3.4 C; representative fluorescence intensity traces are 
shown in Figure 3.4 D).  A truncated Kinesin-1 construct, KHC(1-891)-3xmCit, was used 
as a dimeric motor positive control.  This motor showed a maximum of six bleaching 
steps with a large proportion of the individual motors bleaching with more than three 
steps proving they are dimers.  The histograms for KIF1A full-length (FL), 1-726, and 1-
393 look almost identical to that of KHC(1-891), consistent with the above results that 
they are dimeric. Although truncations 1-491 and 1-508, also had some motors bleach in 
six steps, most of the motors bleached in two or three steps, which is consistent with the 
conclusion that they are monomers.  
Although KIF1A has long been referred to as a monomeric kinesin, the data from 
these three dimerization experiments, provide conclusive evidence that the KIF1A 
 53
truncations 1-726 and 1-393 (Figure 4) can dimerize similar to the FL protein (Figure 1).  
However, KIF1A constructs that are terminated after CC1, (1-491 and 1-508) are 
primarily monomeric.  Formation of an intramolecular coil between the NC and CC1 
would explain KIF1A(1-491)’s monomeric state, as it contains no other regions capable 
of mediating dimerization.  Formation of a NC/CC1 intramolecular coil in 1-726 and FL 
would not necessarily preclude dimerization as CC2 and/or CC3 could compensate.  The 
small portion of dimers detected for 1-491 are likely due to a intermolecular coiled-coil 
conformation of the NC and CC1.  The discrepancy between the three assays for the 1-
491 construct may be due to individual assay conditions that influence the amount of 
motors forming intra- or inter-molecular coils.  In particular, the binding of bulky 
antibodies to the Myc tag may place strain on monomeric intramolecular coils and favor 
instead intermolecular coils and dimerization.    
 
KIF(1-393) moves processively as a dimer   
 As two models for KIF1A’s processive motility have been proposed, one 
involving the biased diffusion of monomers and the other involving the hand-over-hand 
stepping of dimers, we used two-color TIRF imaging to simultaneously track the motility 
of (1-393) motors labeled with two fluorescent proteins, mCit and mCherry in order to 
conclusively prove that our KIF1A (1-393) truncation moves in its dimeric state.  (1-
393)-3xmCit and (1-393)-3xmCherry motors were co-expressed in COS cells and lysates 
were added to flow chambers with polymerized microtubules.  Although mCit labeled 
motors could homodimerize with other mCit motors and thus show motility events with 
only mCit fluorescence, similar to what one would expect if the motors were monomers, 
these homodimers would be brighter than mCit motors heterodimerized with mCherry 
motors, or mCit motors that were monomers.  For 109, 3xmCit fluorescent spots tracked, 
44 tracked with a corresponding mCherry fluorescent spot (a representative track is 
shown in Figure 3.4 E).  As the mCit fluorescence of these two colored motility events 
was significantly less (356.8 +/- 51.4) than the fluorescence of mCit spots moving 
independently of mCherry spots (513.4 +/- 54.0), a majority if not all of the mCit-only 
spots must also be dimers.  At least two factors may explain why the average mCit 
maximum fluorescence intensity measurements of the mCit/mCherry heterodimers (three 
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mCits and three mCherrys) are not half the fluorescence intensity of mCit homodimers (6 
mCits).  First, self-quenching of mCit fluorescent proteins is more likely to occur in 
homodimeric motors (six mCits) than heterodimeric motors (three mCits).  Second, 
because homodimeric motors are brighter (with six mCits) they also have a wider range 
of fluorescence intensity levels that are detectible above the signal-to-noise threshold for 
analysis than the low levels of mCit fluorescence in the heterodimeric motors (with only 
three mCits).  This is the most conclusive demonstration that KIF1A moves in a 
processive fashion as a dimeric motor.  Previous studies have used Unc104 constructs 
that were forced dimers due to addition of leucine zippers or truncations that contained 
the CC2/FHA or CC1 inhibitory regions and thus had only rare motility events [4, 14, 18, 
20].  
 
Dimerization of KIF1A via the Neck Coil  domain 
 Much of the data supporting or refuting the biased-diffusion model of motility 
have used very short KIF1A or Unc104 constructs that contained only the motor domain 
and limited amounts of the NC.  In some cases the constructs tested were monomers, in 
other cases it was just assumed that they were monomeric (for more details see, Figure 
3.5 A) [14, 16, 20-22].  As KIF1A(1-393) is a dimer, but only 12-24 residues longer than 
some reported monomeric constructs, we sought to determine the minimal amount of NC 
that is required for dimerization and processive motility.  Truncations of KIF1A motors 
with varying amounts of the NC, specifically 1-381, 1-377, and 1-369, were constructed 
based on previously described motors (Figure 3.5A).  These constructs were compared to 
1-393 for their ability to dimerize in crosslinking and photobleaching assays.  When 
lysates from cells expressing the mCit C-terminally tagged truncations were treated with 
the crosslinker DMP and run on a SDS-PAGE gel, only the KIF1A(1-393)-mCit protein 
showed an up-shifted band of reduce mobility as compared to untreated lysates.  
KIF1A(1-381)-mCit, KIF1A(1-377)-mCit, and KIF1A(1-369)-mCit showed no change in 
their electrophoretic behavior when treated with DMP (Figure 3.5 B).  Analysis of 
3xmCit tagged truncations in our photobleaching assay yielded complimentary results.  1-
393 showed a maximum of six bleaching steps with a large proportion of the individual 
motors bleaching with more than 3 steps, whereas 1-381 and 1-369 showed primarily 
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only 2 or 3 bleaching steps (Figure 3.5 C and D).  These results suggest that the presence 
of the entire NC, as well as sequences C-terminal to this region, is required for 
dimerization of mammalian KIF1A.  Even small truncations of the NC region convert the 
motor to a monomeric state.   This is consistent with studies on synthesized peptides 
where several residues beyond G387 were required to prevent dissociation of the coiled-
coil [30]. 
 
Motile characteristics of monomeric and dimeric KIF1A motors 
 We next set out to compare the motile properties of monomeric and dimeric 
KIF1A motors.  We first tested the ability of the NC constructs to bind to microtubules 
under native conditions using the SLO/AMPPNP assay.  COS cells expressing (1-393)-
mCit, (1-381)-mCit or (1-369)-mCit were permeabilized with SLO then treated with 
AMPPNP.  Only 1-393 accumulated at the cell periphery in the absence of AMPPNP; 
however, all three constructs became locked on microtubules in the presence of 
AMPPNP (Figure 3.6, A and B).  Expressing all constructs in CAD cells yielded similar 
results where only the dimeric motor, (1-393)-mCit, accumulated in neurite tips whereas 
the monomeric motors (1-381)-mCit and (1-369)-mCit showed a diffuse localization and 
were limited primarily to cell bodies (Figure 3.6 C).  These results confirm that the full 
NC of KIF1A, which confers the ability to dimerize, is required for processive motility in 
mammalian cells, but not for the ability to bind microtubules. 
 To investigate the motile characteristics of monomeric and dimeric KIF1A 
constructs in vitro single molecule motility experiments were carried out.  Lysates from  
COS cells expressing (1-393)-3xmCit, (1-381)-3xmCit or (1-369)-3xmCit were added to 
flow chambers containing polymerized microtubules and motility events were tracked by 
timelapse TIRF microscopy using 100ms intervals.  Again, only motility events that 
lasted at least 500ms were included in the analyzed data set.  As shown before, in Figure 
3.3, dimeric (1-393)-3xmCit motors produce a large number of motility events  with an 
average velocity of 1.36 µm/sec and an average run length of 1.24 µm/run (Figure 3.6 D-
F).  Because the monomeric truncations 1-381 and 1-369 did not show evidence of 
processive motility in vivo (Figure 3.6 C), we were surprised at the number of motility 
events we observed for these same motors in vitro (Figure 3.6 D-F).  However, the 
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number of observed motility events for 1-381 and 1-369 (n=100 and 93 respectively) 
were significantly reduced as compared to 1-393 (n=376).   The velocity and track 
lengths also differed between the dimeric 1-393 truncation and the monomeric 1-381 and 
1-369 truncations.  Both monomeric motors consistently moved over shorter distances 
than the dimeric 1-393, resulting in average track lengths of 0.42 µm for 1-381, and 1.02 
µm for 1-369.  The velocity profiles where a little more varied, as 1-381 moved at a 
reduced average speed (0.80 ± 0.04 µm/second), but 1-369 moved at an increased 
average speed (1.98 ± 0.17 µm/second, Figure 3.6 D-F).  Analysis of the velocity 
histogram for 1-369 reveals a wide variation in measured velocities with no Gaussian 
distribution characteristic of other processive kinesin motors and the 1-393 velocity data 
(Figure 3.6 D).  The track length histogram for 1-369 (Figure 3.6 E) also deviates from an 
exponential decay profile likely reflecting the huge variation in velocities.   
The rather stringent requirement that motility events had to last at least 500 ms, 
did exclude a large proportion of motility events that were short in duration, particularly 
for the monomeric truncations 1-369 and 1-381.   In order to better understand 
monomeric versus dimeric motility mechanisms, we reanalyzed a subset of our single 
molecule motility assays for the constructs KIF1A (1-369)-3xmCit and KIF1A (1-393)-
3xmCit to include motility events lasting at least 300 msec.  This analysis included more 
short motility events, but potentially more false positives as well.  Inclusion of the short 
motility events, resulted in an expected decrease in the average track lengths for both 1-
369 and 1-393 (0.65 ± 0.04 µm and 0.90 ± 0.05 µm, respectively; Figure 3.7 C).  
However, the increase in average velocity was rather surprising (2.19 ± 0.10 µm/second 
and 1.88 ± 0.07 µm/second, respectively, Figure 3.7 B).  Kymographs showing 
representative motility events for both 1-369 and 1-393 motors are shown in  
Figure 3.7 A. 
 Plotting the single molecule velocity and track length data as a function of time 
spent in 1-directional motility reveals that the motile properties of monomeric KIF1A(1-
369) and dimeric KIF1A(1-393) are truly different (Figure 3.7 D and E).  Monomeric (1-
369)-3xmCit motors spent short periods of time (< 1 sec) moving at a wide variety of 
speeds, over a broad range of distances (Figure 3.7 D and E, middle left panels, red 
circles).  The fact that the measured velocities vary so widely and the track lengths are 
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not dependent on the length of time spent in motion suggests that these motors are 
moving by one-dimensional diffusion.  The dimeric construct (1-393)-3xmCit exhibited 
this same diffusive type of motility for a portion of its motility events (Figure 3.7 D and 
E, top left panels, red circles), but added a second type of motility where motors spent 
longer periods of time (>1 sec) moving at a constant speed of ~1.2 µm/second for 
distances that reflected time spent in motility at this same constant speed (Figure 3.7 D 
and E, top left panels, blue circles).  This second type of motion, moving at a constant 
speed for longer time periods, was the only type of motility seen for a truncated version 
of the Kinesin-1 heavy chain subunit, KHC(1-891)-3xmCit, which is known to be a 
dimeric motor that that utilizes a hand-over-hand motility mechanism to drive its 
processive motility (Figure 7D, E bottom left panel, blue circle).  Taken together, these 
results indicate that KIF1A(1-393)-3xmCit motors display motile properties characteristic 
of both single-headed processivity (which is diffusive) and two-headed processivity 
(which is likely due to a hand-over-hand stepping mechanism). 
 
Dimeric but not monomeric KIF1A motors display ATP-driven processive motility 
A key aspect of single-headed processivity is one-dimensional diffusion that relies 
heavily on a weak binding state to microtubules [22].  This weak binding state occurs 
when the motor has ADP in its nucleotide pocket.  Thus, to distinguish whether 
monomeric 1-369 and dimeric 1-393 KIF1A motors move by one-dimensional diffusion 
or another mechanism, we ran the in vitro single molecule motility assays in the presence 
of ADP rather than ATP.  The motility profile of monomeric (1-369)-3xmCit motors was 
not changed in the presence of ADP (compare middle left and right panels of Figure 3.7 
D and E); confirming that it moves processively by one-dimensional diffusion (but for 
relatively short time periods only).  In contrast, the motile characteristics of dimeric 
motors were highly dependent on nucleotide.  In the presence of ADP, dimeric KIF1A(1-
393) motors continued to display short motility events of various velocities and run 
length (Figure 3.7 D and E, top right panel, red circles) similar to the monomeric, 
diffusive 1-369 motors.  However, the switch to ADP eliminated the ability of dimeric 
motors, KIF1A(1-393)-3xmCit and KHC(1-891)-3xmCit, to move for longer periods of 
time, at a constant velocity and over distances that were dependent on the time spent in 
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motion (Figures 7 D and E, top and bottom panels, respectively, blue circles).  Thus, 
although KIF1A(1-393) motors are dimers, they can move to some extent by one-
dimensional diffusion for short periods of time.  However for longer processive motility 
events, they require their two heads and ATP, reminiscent of other kinesins that use a 
hand-over hand stepping mechanism.   
 
DISCUSSION 
Dimerization of KIF1A 
 KIF1A/Unc104 motors have long been referred to as monomeric kinesins and 
indeed, truncated constructs containing only the motor domain do show diffusion 
mediated, processive motility [16, 21, 22].  The proposal that full-length KIF1A/Unc104 
motors are monomeric comes from gel filtration and sucrose density gradient 
centrifugation experimental that show recombinant and endogenous KIF1A/Unc104 
proteins have mobilities that reflect their inherent molecular weight, and not double it, as 
would be expected if they existed as dimers [2, 17, 19, 24, 37].  Here we have used four 
different assays that each demonstrates a dimeric state for full-length KIF1A expressed in 
mammalian cells (chemical crosslinking, co-immunoprecipitation, FRET, and 
photobleaching).  Although these experiments were done with over-expressed proteins, it 
is unlikely that a monomer-to-dimer switch occurred due to high concentrations, as the 
crosslinking, co-immunoprecipitation, and photobleaching assays involved significant 
dilution.  Similar methods have been applied to show that other closely related Kinesin-3 
family members, specifically, KIF1C and Dictyostelium Unc104, are also dimers [17, 28, 
29].  Our FRET analysis confirms the compact conformation seen for KIF1A/Unc104 in 
electron microscopy studies, which leaves open the possibility that this compact 
conformation impacted the mobility of KIF1A in previous hydrodynamic studies leading 
to the conclusion that KIF1A/Unc104 was monomeric rather than dimeric as we 
conclude.  
 We show that the short NC of KIF1A is sufficient for dimerization and processive 
motility.  Importantly, the full NC and likely several residues C-terminal to the NC are 
required for this dimerization, as constructs containing only part of the NC were shown to 
be monomers in our analysis as well as in previous reports [14, 16, 17, 20-22, 30].  The 
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dimerization and processive motility characteristics of Kinesin-1 are also sufficiently 
mediated by its NC [38, 39], but its other coiled-coils in the stalk domain also function in 
dimerization and regulation [10].  Likewise, KIF1A’s CC1 and CC2 regions have 
additional motor regulatory and dimerization functions.  This is demonstrated in part by 
our results showing that truncation of KIF1A after CC1 (or residue 491), results in a 
primarily monomeric motor that can bind microtubules but cannot move processively.  
CC1 is thus inhibitory to the dimerization of this particular construct, and consequently, 
two-headed processive movement.  Results from Al- Bassam et al give an explanation for 
the monomeric conformation of our KIF1A(1-491) as they show by cryo-EM , that a 
Unc104 construct of similar length formed a parallel intramolecular coil between CC1 
and the NC, limiting it to a monomeric state.  In a slightly different experimental 
condition, the CC1 and NC were able to form dimerizing intermolecular coils [40].  As 
full-length KIF1A and the longer truncation, KIF1A(1-726), were both shown to be 
dimeric in all of our assays, presence of CC1 must not impose a monomeric conformation 
on the full-length molecule.    
In the full-length molecule, the CC2 domain could function in dimerization and 
compensate for the NC if it is trapped in an intramolecular coil with CC1 rather than a 
dimerizing intermolecular coil with its counterpart on a second molecule.  The formation 
of the NC/CC1 intramolecular coil could be a critical autoinhibitory mechanism used to 
separate and uncoordinated the two motor domains of dimeric KIF1A.  A similar case is 
true for Kinesin-1 where the TPR domains (or for fungal Kinesin-1, the globular tail) 
unwind the neck coil and physically separate the motor domains [7, 41].  Future work is 
required to determine if the NC/CC1 intramolecular coil exists in the inhibited, full-
length KIF1A motor or whether it is just an artifact of truncation.  
 
Autoinhibition of KIF1A 
 Autoinhibition is a common regulatory strategy used in diverse biological systems 
[42, 43].  Autoinhibition of kinesins ensures that in the absence of cargo, motors do not 
hydrolyze excessive ATP in useless motility.  It also allows for temporal and spatial 
control of motor activity, ensuring kinesins are available and ready when needed for 
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cargo loading and transport [10, 11].  Auto-inhibition has now been shown to regulate 
members of the Kinesin-1, Kinesin-2, and Kinesin-3 families [10, 12, 13, 15].   
Consistent with previous studies [2, 14-17, 19], we show that full-length KIF1A 
expressed in mammalian cells is autoinhibited, being incapable of microtubule binding in 
vivo as well as processive motility in vivo and in vitro.  Our work provides the additional 
conclusion that dimerization is not sufficient for activation. Truncation of KIF1A reveals 
that two regions mediate this autoinhibited state.  First the CC2+FHA region prevents 
microtubule binding.  This is consistent with results from Lee et al, who further showed 
that neither the FHA domain nor CC2 is sufficient for inhibition.   Rather, inhibition 
requires a direct binding interaction between the FHA domain and CC2.  As no direct 
contact of this FHA/CC2 linkage with the motor was detected, it is unclear how 
microtubule binding is prevented [15].  Although their evidence is weak, the authors 
suggest the FHA/CC2 interaction limits dimerization and thus a monomer-to-dimer 
switch may be important for activating the full-length motor.  Our results, however, show 
that full-length KIF1A, and the KIF1A(1-726) truncation which contains the FHA/CC2 
region, are convincing dimers but still inhibited for microtubule binding.  Thus 
dimerization is not sufficient for activation.  More structural data is needed to show 
exactly how the CC2/FHA region prevents microtubule binding.  Possibly, the compact 
conformation of inhibited, dimeric KIF1A, places the motor near these regions, allowing 
the CC2/FHA linkage to sterically block access to microtubules.   
 The second region of KIF1A that mediates its autoinhibited state is CC1.  
Removal of CC1 allows KIF1A(1-393) constructs to not only bind microtubules, but to 
also move processively along them.  This finding is again consistent with the results by 
Lee et al [15].   We add however that this processive movement is due to a two-motor 
mechanism, as KIF1A(1-393) constructs labeled individually with mCit or mCherry tags 
move together in a two-color single molecule motility assay and that constructs truncated 
after CC1 are prevented from undergoing processive movement due to the fact that they 
are primarily monomeric.  As mentioned above, CC1 probably functions to inhibit the 
full-length molecule, not by preventing dimerization, but by locally separating and 
uncoupling the two motor heads. 
  
Mechanisms of KIF1A motility 
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 Understanding the processive motility mechanism used by KIF1A/Unc104 has 
been complicated by the fact that KIF1A/Unc104’s regulatory regions (CC1, FHA, and 
CC2) all lie very close to the motor domain in primary sequence.  In contrast, Kinesin-1’s 
motor domain is well separated from the two regions that mediate its autoinhibited state.  
One resides at the opposite end of the same subunit (IAK region of KHC tail), and the 
other is part of a completely separate subunit (TPR domains of KLC) [10].  Thus, 
processive motility of Kinesin-1 can be seen with very limited truncation of KHC.  
Indeed, truncating Kinesin-1 at various places along the stalk results in active, processive 
motors.   In order to deal with KIF1A/Unc104’s more complicated domain makeup, 
researchers studying KIF1A/Unc104 have opted to study the processive movement of 
constructs that contain only the motor domain (sometimes containing a partial NC) or 
longer constructs that contain either one or both of the CC1 and FHA/CC2 inhibitory 
regions.  This has led to two models for KIF1A motility, first that KIF1A moves 
processively as a monomer via one-dimensional diffusion along the microtubule [16, 21, 
22, 44]; and second, that KIF1A moves processively as a dimer, but requires high local 
concentrations in order to dimerize [4, 14, 15, 18, 20].   
Monomeric Motility.  Our data supports the conclusion that monomeric KIF1A 
constructs have the ability to move processively for short time periods via a one-
dimensional diffusion mechanism.  Specifically, we show that the motility of monomeric 
KIF1A(1-369) and (1-381) motors occurs for at a large range of speeds allowing the 
motor to travel various distances.  Additionally, KIF1A monomers can diffuse along the 
microtubule surface in presence of both ATP and ADP, which is a defining characteristic 
of the one-dimensional diffusion model of processivity and consistent with previous work 
[21, 22].  In contrast to our results, previous studies have reported very slow average 
velocities (0.14µm/sec) and long microtubule dwell times for KIF1A monomeric motors 
[16, 21, 22].  This discrepancy is likely explained by the fact that our analysis 1) 
excluded motors that bound to microtubules but did not move and 2) terminated motility 
events if the motor stopped moving but remained attached to microtubules.  
Consequently our results reflect the fact that monomeric, diffusion-based motility never 
lasts more than a few hundred milliseconds.  Because monomeric motors move for only 
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short time periods and as others have reported stall under low loads (0.12 pN) [21], it is 
unlikely to be sufficient to carry cargos long distances in vivo.   
KIF1A is rather unique among the Kinesin superfamily because it shows this one-
dimensional diffusion.  The only other kinesin protein shown to exhibit diffusion along 
microtubules is Mitotic Centromere Associated Kinesin (MCAK), a member of the 
Kinesin-13 family [45].  It’s reported one-dimensional diffusion is similar to KIF1A in 
that can be very fast,  does not require ATP hydrolysis, and is due to electrostatic 
interactions between positively charged residues on the motor domains and negatively 
charged residues on the C-terminal tails of α/β-tubulin [16, 21, 22, 45].  Also like 
KIF1A, the one-dimensional diffusive motion of MCAK is not thought to contribute to 
the motor force that drives cellular function but may serve to position and/or tether the 
motors increasing the probability of a successful event.  For KIF1A this tethering could 
possibly explain why KIF1A dimeric motors have some of the longest reported track 
lengths in single molecule motility assays, running up to 10 µm in a single motility event, 
and on average, about double the track length of Kinesin-1 (Figures 3.3 and 3.7 and [20]).  
Indeed a positive correlation between track length and strength of electrostatic 
interactions with tubulin was clearly demonstrated by Thorn et al who saw increased 
processive run lengths with Kinesin-1 after adding positively charged residues to the neck 
coiled-coil [46].  
Dimeric Motility.  Although we did see monomeric KIF1A constructs move, we 
conclude that KIF1A must dimerize for long distance, long lasting, processive motility to 
occur.  KIF1A(1-393) constructs move as dimers, and in the presence of ATP they travel 
much farther distances at one constant speed (1.36 µm/second) with motility events 
lasting up to several seconds.  This motion occurs with an average velocity and run 
lengths that are comparable to the motility reported for 1) full-length KIF1A/Unc104 
motors in in vitro microtubule gliding assays (1.2 µm/sec [2]; 1.7 µm/sec [19], 1.7 µm/sec 
[20]) and 2) KIF1A/UNC104 driven vesicles in vivo (1.0 µm/sec [5, 6]).  Thus, the 
physiological form that drives processive motion of cargoes in cells is likely to be the 
dimeric motor.  We propose the mechanism driving this dimeric processive motility is the 
conventional hand-over-hand mechanism; yet, we acknowledge that more detailed studies 
are required to confirm this hypothesis. 
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Although similar dimeric processivity has been reported previously [20], this is 
the first time motile properties have been evaluated for a KIF1A/Unc104 construct that is 
dimerized via its own endogenous sequences without the inclusion of inhibitory domains.   
Previous studies that utilized constructs with inhibitory regions concluded that high 
motor concentrations were required to drive KIF1A/Unc104 into a dimeric, active state 
[18, 20].  It is possible, however, that by including inhibitory domains, high 
concentrations of motor were necessary to capture enough rare motility events for 
analysis.  Indeed we saw limited motility events for the inhibited but dimeric full-length 
KIF1A, as well as, the KIF1A(1-726) motor construct which is truncated after CC2.  This 
construct is similar in length to the Unc104(1-653) motor that was used to conclude the 
necessity for high motor concentrations [18, 20].   Although we cannot directly compare 
the protein concentrations used in the two cases, our KIF1A(1-393) motor that is dimeric 
and uninhibited has significantly more motility events when tested at similar expression 
levels to KIF1A(1-726), proving that motility events for KIF1A(1-726) were primarily 
limited by the FHA/CC2 region and not protein concentration.  In the studies of 
Klopfenstein et al who used Unc104 motors truncated after CC1 (Unc104(1-446)), high 
local concentrations may have, indeed, been required to drive the truncated Unc104 
motor into a dimeric, active state.  By adding the PH domain back to the end of their 
truncated Unc104(1-446) motor, they could drive the processive motility of PIP4,5P2 
containing liposomes.  They found that by clustering PIP4,5P2  on membranes by the 
addition of cholesterol, they increased Unc104’s ability to processively move the 
liposomes.  As we and Al-Bassam et al show that the NC and CC1 form an 
intramolecular coil that limits constructs truncated after CC1 to be monomers, locally 
concentrating the Unc104(1-446:PH) motor could facilitate a monomer to dimer switch 
that would allow processive motility of liposomes to occur.  As full-length KIF1A can 
exist as a dimer independent of cargo binding, this “high concentration” model of motor 
activation may be limited in application.  Future studies looking at full-length KIF1A, 
with real cargo, will be necessary to determine whether or not local concentration of the 
motor has any role in regulating activity state or processivity.  
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MATERIALS AND METHODS 
Plasmids and antibodies:  Full-length or truncated KIF1A constructs tagged with 
mCit, 3xmCit, or Myc were generated using convenient restriction sites or by PCR 
amplification from a rat KIF1A cDNA vector (gift of Bruce Schnapp) and cloned into the 
mCit-N1 or C1 vectors (modified from Clontech’s EYFP-N1/C1 vectors by replacing 
EYFP with sequence for monomeric Citrine) the 3xmCit-N1 vector  previously described 
[31], or the pRK5-myc vector.  Rat KIF1A(1-393)-mCit, however, was a gift from Gary 
Banker.  All plasmids were sequence verified.  KHC(1-891)-3xmCit has been described 
previously [31].  The following antibodies were used: Myc (Sigma and 9E10 hybridoma 
ascites), GFP (used to recognize mCit; Invitrogen), HA (12CA5 hybridoma ascites; used 
as control IgG) and FLAG (Sigma, used as control IgG). 
 Cells, transfection and immunoprecipitation:  COS and CAD cells were 
cultured, transfected, and processed for immunofluorescence as previously described 
(COS, [31]; CAD, [47, 48].  For immunoprecipitation experiments, transfected COS cells 
were resuspended in lysis buffer (LB; 25 mM Hepes/KOH, 115mM potassium acetate, 5 
mM sodium acetate, 5 mM MgCl2, 0.5 mM, EGTA, 1% Triton X-100, and protease 
inhibitors; pH 7.4); and, after removing insoluble material by centrifugation at 20,000xg 
at 4°C for 10mins, extracts were incubated with the specified antibodies for 2.5-18 hr at 
4°C.  Protein A agarose beads were then added and mixture was incubated for and 
additional 30-60 minutes at 4°C.  Beads were pelleted and washed two times with lysis 
buffer, resuspended in Laemmli sample buffer, and analyzed by SDS-PAGE and Western 
blot.   
Crosslinking:  For crosslinking experiments cells were lysed in a Borate buffer 
(50mM NaBorate, 100mM potassium acetate, 2 mM MgCl2, 1mM EGTA, 1% Triton X-
100, and protease inhibitors; pH 8.57).  After removing insoluble material by 
centrifugation, lysates were incubated for 30 minutes with 20 mM dimethylpimilimidate 
(DMP, Sigma).  Lysates were then quenched for 10 minutes with an equal volume of 
50mM NH4Cl2 in PBS.  After adding Laemmli sample buffer, crosslinked lysates were 
analyzed by SDS-PAGE and Western blot. 
 In vivo microtubule binding assay:  COS cells were plated onto glass-bottomed 
dishes (MatTek) and transfected with plasmids encoding the proteins of interest.  
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Twenty-four hours later, cells were viewed on a Nikon TE2000 inverted microscope with 
a Plan-APO 60X/NA 1.4 objective and Photometrics CS ES2 camera.  Cells were treated 
with 0.1 µg/ml Streptolysin O in permeabilization buffer 1 (25 mM Hepes/KOH, 115mM 
potassium acetate, 5 mM sodium acetate, 5 mM MgCl2, 0.5 mM, EGTA, and 10mg/ml 
BSA; pH 7.4) for 1 min.  After washing 3 times with Buffer 1, cells were incubated with 
Buffer 1 containing 2mM AMPPNP.  Cells were monitored every minute for an 
additional 15 minutes.     
 The Relocation Index was calculated on a frame by frame basis using ImageJ as 
described [7].  Briefly two image masks were made from the last timelapse frame 
encompassing either the microtubule region (MT) or the rest of the cell, excluding the 
nucleus and regions of aggregated motor (Other).  The total fluorescence pixel 
intensities—SumMT and SumOther—was determined and a ratio (R) of SumMT over 
SumOther was calculated for each frame.  The Relocation index for each frame is defined 
as the percent change of R as compared with R before the addition of AMPPNP.  
FRET stoichiometry:   FP-tagged versions of KIF1A or RnKHC (RnKIF5C) 
were transfected into COS cells.  24 hours later, cells were viewed on wide-field 
microscope equipped for FRET stoichiometry.  FRET stoichiometry uses three 
fluorescence images from a calibrated microscope to calculate three parameters that 
describe each pixel: (a) RM, the mole ratio of acceptor- to donor-labeled proteins, (b) EA, 
the apparent acceptor FRET efficiency (FRET efficiency x fraction of acceptor molecules 
in complex), and (c) ED, the apparent donor FRET efficiency (FRET efficiency x fraction 
of donor molecules in complex).  Because protein expression levels influence the fraction 
of donor or acceptor molecules in FRET complex for non-linked molecules, we analyzed 
cells with RM close to 1.0 and we calculated an average FRET efficiency, EAVE = (ED + 
EA)/2, which is less sensitive to expression ratio [33, 34]. 
In vitro single molecule motility assays and photobleaching analysis:  Motility 
and photobleaching assays were performed in flow chambers created from a 25x25 #1.5 
coverglass and microtubule slide assembled with double-sided tape (~30ul chamber 
volume).  Cy5-labeled microtubules in BRB80 buffer (80mM Pipes/KOH, 1mM EGTA, 
and 2mM MgCl2; pH 6.8) with 10µM taxol were flowed into the chamber, followed by 
addition of 40ul of 0.1mg/ml casein/BRB80 to coat the chamber surfaces.  After 5-10 
minutes, chambers were washed twice in P12 buffer (12 mM Pipes/KOH, 1 mM EGTA, 
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and 2 mM MgCl2, pH 6.8) with 10 µM taxol.  Motor proteins were prepared by lysing 
transfected COS cells in LB with 1mM ATP.  Lysates were cleared by centrifugation at 
20,000xg for 10mins and then flash-frozen by immersion in liquid nitrogen and stored at 
-80°C.   0.25-1µl cell lysate was added to flow-chambers with 50 µl of oxygen scavenger 
buffer (1 mM DTT, 1 mM MgCl2, 2 mM ATP, 10 mM glucose, 0.1 mg/ml glucose 
oxidase, 0.08 mg/ml catalase, 10 mg/ml BSA, and 10 µM taxol in P12; however, in 
photobleaching experiments or motility experiments performed with ADP, the 2mM ATP 
was replaced by 2mM AMPPNP or 2mM ADP respectively).  Then, the chamber was 
sealed with wax and assayed for motility or photobleaching using objective-type total 
internal reflection fluorescence microscopy (TIRFM) on a custom-modified microscope 
(Axiovert 135TV; Carl Zeiss MicroImaging, Inc.) equipped with an 1.45 NA α-plan Fluor 
objective, 2.5x optovar, 505DCXR dichroic and ET510LP emission filters, and a back-
illuminated EMCCD camera (Cascade 512B; Roper Scientific). The 488-nm line of a 
tunable, single-mode, fiber-coupled argon ion laser (Melles Griot) was used for streaming 
images every 100ms for 30-35 second.  For two-color TIRFM, a second 594 nm laser 
diode was coupled with the 488nm laser (535DCXR) for excitation. mCit and mCherry 
fluorescence emissions were first passed though a FT505/590 dual-band dichroic mirror 
and then projected separately onto each halves of the CCD camera by a Dualview beam-
splitter (Optic Insights) equipped with a FT498 dichroic and HQ540/70M and HQ610LP 
emission filters (Filters are all from Chroma Technology Corp).  
 All of the fluorescence imaging analysis, including FRET, Relocation Index, 
single molecule tracking in one or two-colors, and single molecule photobleaching  were 
analyzed using home made plug-ins written for ImageJ (NIH). Single molecule tracking 
measurements for each construct come from at least two independent protein preparations 
and include motile events lasting at least 0.5 or 0.3 seconds. For photobleaching, only 
stationary, diffraction-limited fluorescence spots that were well separated from 
neighboring spots were included in analysis.   Fluorescence intensity (with background 
intensity subtracted) was measured as described previously [31] and plotted as a function 

















Figure 3.1:  Full-length KIF1A exists as a dimeric motor that is inactive for microtubule binding 
in vivo.  (A and B)  Live cell microtubule binding assay.  COS cells expressing full-length KIF1A 
tagged with mCit were imaged while permeabilized with SLO and treated with AMPPNP.  (A) 
Still images from a movie, before and after AMPPNP treatment.  (B)  Quantification of the 
percentage of KIF1A fluorescence that changes from a cytoplasmic localization to a microtubule 
(MT)-associated localization (Relocation Index; see materials and methods for details) over time.  
N=16 cells.  Error bars +/- SEM.  (C)  Co-immunoprecipitation.  COS cells were co-transfected 
with plasmids encoding mCit-KIF1A and Myc-KIF1A, or mCit-KIF1A-CFP and myc-KIF1A.  
Lysates were immunoprecipitated with an anti-Myc antibody or control IgG antibody, separated 
by SDS-PAGE, and immunoblotted with anti-Myc and anti-mCit antibodies.   (D)  Crosslinking.  
Lysates from COS cells over-expressing mCit-KIF1A, mCit-KHC, or mCit were treated with or 
without DMP, then separated by SDS-PAGE, and immunoblotted with anti-mCit antibodies.  (E)  
Motor to motor FRET in COS cells expressing mCit-KIF1A and CFP-KIF1A (top panels); or 
Kinesin-1 (mCit-KHC + CFP-KHC +  HA-KLC).  (G) Motor to tail FRET in live COS cells 
expressing mCit-KIF1A-CFP and myc-KIF1A (top panels); or Kinesin-1 (mCit-KHC-CFP + 
Myc-KHC + HA-KLC) (bottom panels).  (F and H)  Average FRET efficiency (Eave) is 
quantitated.  Error bars +/- SEM.   Acknowledgements: Lynne Blasius from the Verhey lab 
contributed the crosslinking data in (D).  The FRET data (E-H) was contributed by Dawen Cai 







Figure 3.2:  Truncated of KIF1A relieves autoinhibition of microtubule binding.  (A) Coiled-coil 
prediction for KIF1A (NP_032466); Gray dotted line, prediction using a window of 14 amino 
acids; Blue line, prediction using a window of 21 amino acids (COILS, Lupas Method).  NC, 
Neck coiled-coil; CC1-3, coiled-coil 1-3.  (B) Schematic of mCit tagged full-length (FL) and 
truncated KIF1A constructs.  (C-E)  Live cell microtubule binding assay.  COS cells expressing 
truncated KIF1A constructs were imaged while permeabilized with SLO and treated with 
AMPPNP.  (C) Still images from movies taken before and after AMPPNP treatment.  Scale 
20µm. (D) Quantification of the average percentage of KIF1A fluorescence that changes from a 
cytoplasmic localization to a microtubule (MT) associated localization (Relocation Index) over 
time.  Error bars +/- SEM.  1-726, N=17; 1-491, N=11; 1-393, N=12.  (E)  Percent of cells whose 
KIF1A truncations localize to the indicated cellular locations before and after AMPPNP 
treatment.   Averages from 3-5 independent experiments; 50-100 cells each.  Error bars +/- SEM.  






Figure 3.3:  Processive motility of truncated KIF1A constructs.  (A) Processive motility in vivo.  
CAD cells were transfected with full-length (FL) or truncated KIF1A constructs and 
differentiated for 40-48 hrs. Representative images are shown.  Scale 20µm.  (B-D)  Processive 
motility in vitro.   COS cells were transfected with 3xmCit tagged FL or truncated KIF1A 
constructs.  Motor proteins in cell lysates were incubated with Taxol-stabilized microtubules and 
single molecule assays were carried out using a TIRF microscope.  (B)  Velocity histograms. (C) 
Track length histograms. (D) Table of motile properties, Average +/- SEM.
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Figure 3.4:  KIF1A truncations dimerize and KIF1A(1-393) moves processively as a dimer.  (A)  
Crosslinking.  Western blot of lysates from COS cells expressing Myc-tagged KIF1A truncations 
1-393, 1-491, and 1-726 treated with or without DMP.  Arrows indicate bands of reduced 
mobility upon crosslinking, arrowheads and construct labels refer to band sizes in the absence of 
DMP.  (B)  Co-immunoprecipitation.  COS cells were co-transfected with plasmids encoding 
Myc and mCit tagged KIF1A constructs of the same length.  Lysates were analyzed by western 
blot either directly (input lysate) or after immunoprecipitation with anti-Myc or control IgG 
antibodies.  (C and D)  Photobleaching analysis of 3xmCit-labeled KIF1A motors.  Lysates from 
COS cells expressing 3xmCit tagged FL or truncated constructs were either locked onto 
microtubules with AMPPNP or absorbed directly to the coverglass of the flow chamber then 
imaged with TIRF microscopy.  (C) Distribution of the number of photobleaching steps for each 
KIF1A construct or a dimeric truncated Kinesin-1 construct, KHC(1-891). (D) Representative 
examples of the stepwise photobleaching occurring over time for 3xmCit-KIF1A or Kinesin-1 
fluorescent spots located within the light-diffraction-limit. AU, arbitrary units.  (E and F)  Two-
color single molecule  motility assay.  COS cells were co-transfected with 3xmCit- and 
3xmCherry tagged KIF1A(1-393) plasmids.  Lysates containing labeled motors were then 
subjected to a two-color in vitro single molecule motility assay.  Kymograph of a representative 
dual-labeled/dimerized KIF1A(1-393) motor moving along a microtubule.  (H) Table indicating 
the number and average spot intensities of dual-labeled (mCit and mCherry) or single-labeled 
(mCit only) motile tracks detected in two-color single molecule motility assays.  










Figure 3.5:  The full neck coil (NC) and adjacent residues are required for dimerization of 
KIF1A.  (A)  Sequence comparisons of the region around the NC of the KIF1A/Unc104 family.  
Identical residues are in red; similar residues are in orange.   Below the sequence comparison is a 
schematic of KIF1A constructs containing all or portions of the NC  with reference to equivalent 
KIF1A or Unc104 constructs used in previous studies.  (B)  Crosslinking.  Lysates from COS 
cells overexpressing Myc-tagged NC truncations were treated with or without DMP, separated by 
SDS-PAGE, and immunoblotted with anti-Myc antibodies.  Arrow shows the dimer-sized band 
formed only by the longest construct 1-393.  (C and D)  Photobleaching analysis of 3xmCit-
labeled NC constructs by TIRF microscopy.  (C) Histogram of the number of photobleaching 
steps for each 3xmCit tagged NC construct.  (D)  Representative examples of the stepwise 
photobleaching occurring over time for 3xmCit-truncated KIF1A fluorescent spots located within 
the light-diffraction-limit. AU, arbitrary units.  Acknowledgement:  Kristen Verhey compiled the 
alignment and construct schematic in (A).  Lynne Blasius of the Verhey lab contributed the 












































Figure 3.6:  Long-distance processive motility, but not microtubule binding, requires KIF1A 
dimerization.  (A-B) Live cell microtubule binding assay.  COS cells expressing truncated KIF1A 
constructs were imaged during SLO permeabilization and AMPPNP treatment.  (A) 
Representative before and after AMPPNP treatment images shown.  Scale 20µm. (B)  Percent of 
cells whose NC constructs localize to the indicated cellular locations before and after AMPPNP 
treatment.   Averages from 2-3 independent experiments; ~50 cells each.  Error bars +/- SEM.  
MT, microtubules.  (C)  In vivo processive motility assay.  CAD cells were transfected with 
truncated KIF1A constructs and differentiated for 40-48 hrs. Scale 20µm.  (D-F)  In vitro single 
molecule motility assay.   COS cells were transfected with 3xmCit tagged truncated NC 
constructs.  Motor proteins in cell lysates were incubated with Taxol-stabilized microtubules in a 
flow chamber and assayed with TIRF microscopy for motility.  Images were taken every 100ms 
and measurements include motile events lasting at least 0.5 seconds.  (D)  Distribution of 







































Figure 3.7:  ATP-dependent processive motility is a property of dimeric but not monomeric 
KIF1A motors.  (A-E)   In vitro single molecule motility assay.  COS cells were transfected with 
dimeric (1-393)-3xmCit or monomeric (1-369)-3xmCit KIF1A constructs.  Motor proteins in cell 
lysates along with 1mM ATP were incubated with Taxol-stabilized microtubules in a flow 
chamber and assayed with TIRF microscopy for motility.  Images were taken every 0.1 seconds 
and measurements include motile events lasting at least 0.3 seconds. (A) Representative 
kymographs.  (B) Velocity histograms.  (C) Track Length histograms.  (D and E)  Comparison of 
monomeric and dimeric motile properties in the presence of ATP or ADP.  Distribution of 
velocities (D) or Track Lengths (E) for KIF1A(1-393), (1-369), or Kinesin-1, KHC(1-891) in the 
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Chapter 4: 
Cooperative Versus Independent Transport of 
Different Cargoes by Kinesin-1 
 
Motor proteins of the kinesin, myosin, and dynein families utilize the energy of 
ATP hydrolysis to transport organelles, membrane vesicles, and protein complexes along 
the cytoskeleton in order to organize cellular components for proper cell morphology and 
function [1, 2].  Critical to understanding the cellular roles of motor proteins is 
deciphering how motors attach to specific cargoes.  Recent work has identified multiple 
binding partners for individual motor proteins.  In some cases, these binding partners are 
soluble adaptor proteins that mediate the attachment of motor proteins to membrane-
bound cargoes [2, 3].  How motor proteins distinguish cargo partners and bind to specific 
cargoes at specific times and cellular locations is unknown.  
The founding member of the kinesin superfamily, Kinesin-1 (formerly 
conventional kinesin or Kif5), is a heterotetramer composed of two kinesin heavy chain 
(KHC) and two kinesin light chain (KLC) subunits.  Both KHC and KLC have been 
implicated in cargo binding [4, 5].  For KLC, most cargoes bind to the TPR bundle, 
although a role for the alternatively spliced C-terminal sequences has also been 
demonstrated [6, 7].  TPR bundles are protein-protein interaction domains comprised of 
tandem TPR motifs.  Each TPR motif contains a degenerate 34-amino acid repeat 
arranged in two antiparallel α-helices linked by a tight turn.  Adjacent TPR motifs then 
pack against each other to form a half-cylindrical bundle [8, 9].  Structural and 
biochemical analyses of the protein-protein interactions mediated by TPR domains have 
described two distinct mechanisms for partner protein binding.  In several cases, the 
extreme C-terminal residues of the binding partner have been shown to bind in an 
extended conformation to the concave face (groove) of the TPR domain [10-12].  
Alternatively, internal sequences of the partner protein can bind to the loop regions that 
connect helices on the edge of the TPR bundle [13].  Thus, target recognition by TPR 
domains is likely to be versatile and may enable the assembly of multi-protein 
81 
complexes.  Such an assembly function has been proposed for structurally similar helical 
repeat domains such as armadillo repeats, ankyrin repeats and 14-3-3 proteins [14-17].   
The first cargo proteins identified to bind Kinesin-1 via the TPR bundle were the 
c-Jun NH2-terminal kinase (JNK)-interacting protein (JIP) group of scaffold proteins [18-
20].  Based on their sequence similarities, JIP’s can be divided into two classes [21].  
JIP1 (also called islet brain 1) and JIP2 share a similar domain structure consisting of an 
N-terminal JNK-binding domain and C-terminal SH3 and PTB domains.  JIP3 (also 
known as JSAP1) and JIP4 (also known as JLP) contain a JNK-binding domain and 
several coiled-coil domains.  Despite this disparity in domain structure, the JIP proteins 
function as scaffolding proteins to coordinate the cellular localization and activity of JNK 
signaling complexes [21].  Interestingly, the extreme C-terminal sequences of JIP1 and 
JIP2 are required for binding to the TPR bundle of KLC whereas internal segments of 
JIP3 and JIP4 are required for KLC binding [18, 20, 22, 23], suggesting that JIP1 binds in 
the TPR groove whereas JIP3 binds outside of the TPR groove.  Through their 
interactions with Kinesin-1, the JIP proteins likely also play a critical role in membrane 
trafficking as loss-of-function alleles of JIP homologs in C. elegans and Drosophila 
cause defects in axonal transport with phenotypes similar to KHC loss-of-function alleles 
[18, 24, 25].  
In recent years, other cargoes that bind to Kinesin-1 via the TPR bundle have 
been identified, including Kidins220/ARMS, Calsyntenin/Alcadein, Collapsin Response 
Mediator Protein-2, Huntington Associated Protein-1, Alzheimer Precursor Protein 
(APP), torsinA, 14-3-3 and Vaccinia virus’s A36R protein [26-34].  The identification of 
multiple cargoes for Kinesin-1 raises the question of how one motor coordinates the 
transport of its many potential cargoes.  One possibility is that binding sites for different 
cargoes may not be accessible at the same time such that cargoes compete with each 
other for binding and transport (competitive transport model).  A second possibility is 
that different cargoes may undergo cooperative transport whereby one cargo facilitates 
the binding and transport of another cargo (cooperative transport model).  A third 
possibility is that different cargoes neither compete nor cooperate for transport but rather 
are transported independent of each other (independent transport model).  We set out to 
test whether the transport of different cargoes by Kinesin-1 is competitive, cooperative or 
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independent of each other.  Our results suggest that transport of most Kinesin-1 cargoes 
that bind via the TPR bundle of KLC is not competitive but rather independent of each 
other.  However, transport of JIP1 and JIP3 is cooperative due to interactions of JIP1 and 
JIP3 with KLC as well as with each other.  
 
RESULTS 
Independent transport of the JIP proteins and other Kinesin-1 cargoes  
Since many different cargoes have been identified for Kinesin-1 [4, 5], we 
focused on known binding partners of Kinesin-1 rather than organelles that can employ 
multiple motors via unknown linkage mechanisms.  In addition, since both the KHC and 
KLC subunits have been implicated in Kinesin-1 cargo binding, we focused on cargo 
proteins that bind via the KLC subunit, specifically JIP1, JIP3, Kidins220/ARMS, and 
PAT1.  Kidins220/ARMS is a transmembrane protein whose cytoplasmic tail binds to 
KLC [27].  Kinesin-1 activity is required for the transport of JIP1, JIP3 and 
Kidins220/ARMS to neurite tips in neuronal cells [19, 20, 27].  PAT1 was identified as a 
binding partner of KLC in a yeast two-hybrid screen using the TPR motifs of KLC as the 
bait, and the interaction between KLC and PAT1 has been confirmed by Dichtenberg et 
al [35] as well as by co-immunoprecipitation of GST-tagged PAT1 and HA-tagged KLC 
expressed in COS cells (Figure Supp 4.1).   
To test whether distinct cargoes are transported together or independent of each 
other, we first used live cell imaging of fluorescent protein (FP)-tagged cargoes. 
Unfortunately, we were unable to visualize JIP proteins undergoing transport in live cells, 
presumably due to the low number of molecules on a transport cargo [36].  In addition, 
such studies cannot distinguish independent versus competitive transport.  Thus, to test 
whether distinct Kinesin-1 cargo proteins are transported competitively, cooperatively or 
independently of each other, we used competition experiments in neuronal cells.  We 
hypothesized that over-expression of one cargo should result in reduced transport and 
mislocalization of other cargoes if the two proteins compete for Kinesin-1-mediated 
transport, enhanced transport if the two proteins are transported cooperatively, and no 
effect on transport if the two proteins are transported independently.   
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We first explored the effect of over-expression of a cargo protein on the 
localization of its endogenous protein. Such experiments were feasible for JIP3 and 
Kidins220/ARMs using antibodies that recognize the endogenous proteins but not 
truncated KLC-binding constructs. Differentiated CAD cells (a neuronal-like cell line) 
were transfected with plasmids encoding the KLC-binding regions of JIP3 [Myc-
JIP3(138-621), Figure 5 D] or Kidins220/ARMS [cyan fluorescent protein (CFP)-
Kidins220/ARMS(1129-1426), [27] and Figure Supp 4.1].   Over-expression of Myc-
JIP3(138-621) resulted in mislocalization of the endogenous JIP3 protein (Figure 4.1 
A,B) and over-expression of CFP-Kidins220/ARMS (1129-1426) interfered with 
transport of the endogenous Kidins220/ARMS protein (Figure 4.1 C,D). These results 
indicate that competition for Kinesin-1 transport exists between transfected and 
endogenous cargo proteins.  Thus, transport of individual Kinesin-1 cargoes is saturable.  
We then tested the effect of over-expression of a cargo protein on the localization 
of other cargo proteins. Differentiated CAD cells were transfected with plasmids 
encoding GFP-tagged Kidins220/ARMS and the localization of endogenous JIP1 and 
JIP3 proteins was analyzed in transfected and untransfected cells. Over-expression of 
GFP-Kidins220/ARMS had no effect on the localization of JIP1 (Figure 4.2 A,D) or JIP3 
(Figure 4.2 A,E) to neurite tips.  Since Kidins220/ARMS is a transmembrane protein and 
accumulates in the endoplasmic reticulum when over-expressed (Figure 4.1 A), we also 
tested whether over-expression of the KLC-binding region of Kidins220/ARMS as a 
soluble fragment could compete with JIP1 or JIP3 for Kinesin-1 transport.  As with the 
full length Kidins200/ARMS protein, over-expression of CFP-Kidins220/ARMS (1129-
1426) had no effect on JIP1 (Figure 4.2 A,D) or JIP3 (Figure 4.2 A,E) localization.  In the 
converse experiments, over-expression of Myc-JIP1 or Flag-JIP3 in differentiated CAD 
cells had no effect on the localization of endogenous Kidins220/ARMS protein to neurite 
tips (Figure 4.2 B,F).  These results indicate that Kidins220/ARMS and the JIP proteins 
do not compete for Kinesin-1 transport.  Moreover, immunoprecipitation experiments 
indicate that there is no competition between Kidins220/ARMS and JIP1 or JIP3 for 
Kinesin-1 binding (Figure Supp 4.2).  Thus, the transport of distinct Kinesin-1 cargoes is 
saturable but not competitive with other cargoes.  
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Similar experiments were carried out to assess whether PAT1 and the JIP proteins 
could compete with each other for Kinesin-1 transport to neurite tips.  Differentiated 
CAD cells were transfected with plasmids encoding Flag-tagged PAT1 and the 
localization of endogenous JIP1 and JIP3 proteins was analyzed in transfected and 
untransfected cells.  In cells overexpressing Flag-PAT1, the localization of endogenous 
JIP1 (Figure 4.2 C,D) and JIP3 (Figure 4.2 C,E) proteins was similar to that of 
untransfected cells, suggesting that there is no competition between PAT1 and the JIP 
proteins for Kinesin-1-mediated transport.  Similar experiments to investigate the effect 
of JIP1 or JIP3 over-expression on PAT1 localization could not be performed due to a 
lack of suitable antibodies.   
We further analyzed the ability of Kinesin-1 cargoes to be transported 
cooperatively, independently or competitively by analyzing whether cargoes that bind via 
the KHC subunit could compete with JIP1 or JIP3 for Kinesin-1 mediated transport in 
neuronal cells.  Over-expression of p120catenin constructs that bind to KHC (full length 
or an N-terminal truncation ∆N [37]) had no effect on the localization of JIP1 or JIP3 
(Figure Supp. 4.3).  These results indicate there is no competition or cooperation for 
Kinesin-1-mediated transport, but rather that transport of different Kinesin-1 cargoes is 
independent of each other.   
 
JIP1 facilitates JIP3 transport by Kinesin-1 and vice versa 
We next set out to determine whether different JIP proteins, namely JIP1 and 
JIP3, are transported by Kinesin-1 in a competitive, cooperative, or independent manner.  
Differentiated CAD cells were transfected with plasmids encoding Myc-tagged full 
length JIP1.  In cells expressing high levels of Myc-JIP1, the amount of endogenous JIP3 
localized at neurite tips was similar to that in untransfected cells (Figure 4.3 A,C), 
suggesting that there is no competition between JIP1 and JIP3 for Kinesin-1-mediated 
transport.  Surprisingly, in differentiated CAD cells expressing Myc-JIP1 at levels similar 
to the endogenous JIP1 protein (based on localization of the myc-tagged protein to the 
neurite tip), there is a 2 fold increase in the amount of JIP3 at the tips of neurites (Figure 
4.3 B,C).  Similar results were obtained (Figure 4.3 C) upon expression of a truncated 
version of JIP1 that binds both JIP3 and KLC but not JNK [Myc-JIP1(307-711), Figure 
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4.6].  In contrast, low level expression of Myc-JIP1 had no effect on the localization of 
endogenous Kidins220/ARMS and vice versa (Figure 4.2 D,F).  These results suggest 
that JIP1 facilitates transport of JIP3.  
Similar experiments were carried out to test whether JIP3 could affect the 
transport of JIP1 by Kinesin-1.  In differentiated CAD cells expressing high levels of full-
length Flag-JIP3 or a truncated version that binds both JIP1 and KLC [JIP3(138-621), 
Figure 4.6], there was no change in the amount of endogenous JIP1 at neurite tips (Figure 
4.3 D,F).  But in cells expressing low levels of Flag-JIP3 or JIP3(138-621), there was an 
approximately 2-2.5 fold increase in the amount of JIP1 at neurite tips (Figure 4.3 E,F).  
Low level expression of Flag-JIP3 had no effect on the localization of endogenous 
Kidins220/ARMS and vice versa (Figure 4.2 E,F).   Thus, JIP3 facilitates transport of 
JIP1 by Kinesin-1. 
 
JIP1 and JIP3 bind to different sites on the KLC TPR bundle 
To undergo cooperative transport by Kinesin-1, JIP1 and JIP3 may cooperate for 
binding to the KLC subunit.  To test this, Myc-JIP1, Flag-JIP3, and HA-KLC proteins 
were expressed separately in COS cells.  Equal amounts of cell lysates were mixed 
together in various combinations prior to immunoprecipitating KLC with an anti-HA 
antibody.  More Myc-JIP1 and Flag-JIP3 were coprecipitated with HA-KLC when all 
three proteins were present in the mixture than when the JIP proteins were present 
individually (Figure 4.4 A,B).  These results suggest that JIP1 and JIP3 cooperate for 
binding to the KLC TPR bundle and transport to neurite tips. 
Previous studies on TPR-containing proteins identified two mechanisms of 
partner protein binding that may explain, at least in part, how JIP1 and JIP3 can 
cooperate for binding to the KLC TPR bundle.  To identify sites in the KLC TPR bundle 
responsible for the interactions with JIP1 and JIP3, we undertook two approaches.  In our 
first approach, we targeted specific residues for site-directed mutation based on a 
structural model of the KLC TPR repeats (Figure 4.4 C).  The sequences of TPRs 2-5 of 
rat KLC1-C (residues 247 - 411) were overlaid onto known crystal structures of other 
TPR bundles (Figure Supp 4.4).  Residues in the groove and along the edges of the KLC 
TPR bundle that are likely to be involved in partner protein binding (Figure 4 C) were 
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altered to Alanine in the two-hybrid bait vector pGBD [20].  In the BLUE mutant, 
charged residues in the loops that link successive TPR repeats were altered, whereas in 
the ORANGE mutant, charged and/or bulky residues in the tight turns within a TPR 
repeat were altered (Figure 4.4 C).  The YELLOW and GREEN mutations targeted 
residues that (a) are conserved across many TPR bundles and (b) whose side chains have 
been shown to project into the groove of other TPR bundles.  Specifically, the YELLOW 
mutant targeted conserved Asparagine residues which form a continuous ladder through 
the superhelix and play a critical role in binding the C-terminal peptide backbone of 
target proteins [10-12, 38].  The GREEN mutant targeted conserved hydrophobic 
residues in the TPR groove (Figure 4 C).  The ability of the mutant KLC TPR bundles to 
bind JIP1 and JIP3 was then tested in a directed two-hybrid assay.  As shown in Figure 4 
D, mutations along the top of the TPR bundle (BLUE) abolished binding to both JIP1 and 
JIP3.  Interestingly, mutations inside the TPR groove (YELLOW and GREEN) or along 
the bottom of the TRP bundle (ORANGE) abolished JIP1 binding but not JIP3 binding, 
suggesting that the C-terminal residues of JIP1 do indeed bind within the KLC TPR 
groove whereas JIP3 binds via a different site. 
In a second approach to identify residues in the KLC TPR bundle required for 
binding to JIP1 and JIP3, random mutagenesis of the KLC TPR bundle (amino acids 199-
488) was carried out using error-prone PCR (EP-PCR).  Most clones retained the ability 
to interact with both JIP1 and JIP3 in the directed two-hybrid assay.  Sequencing revealed 
either wildtype sequences (e.g. 14A, Figure 4.4 D), single mutations (e.g. 27A, Figure 4.4 
D) or multiple mutations spread across the TPR bundle (e.g. 47A and 63A, Figure 4.4 D).  
We identified several EP-PCR mutants that lost the ability to interact with JIP1 but 
retained an interaction with JIP3 (22A, 28A, 33A, 64A, Figure 4.4 D).  Sequencing of 
these clones showed that a variety of residues are involved in contacting the JIP1 C-
terminal tail.  Surprisingly, only one clone was identified that lost the ability to interact 
with JIP3 but retained an interaction with JIP1 (48A, Figure 4.4 D).  Consistent with 
previous results [23], two pieces of data suggest that the N-terminal half of the KLC TPR 
domain is critical for the KLC-JIP3 interaction.  First, mutations that abolish JIP3 binding 
(clone 48A) are all clustered in the first three TPR motifs and second, a truncated TPR 
domain (clone 28A) that contains only the first 3.5 TPR motifs retains an interaction with 
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JIP3.  The fact that we have identified mutations that selectively abolish JIP1 or JIP3 
binding suggests that the two scaffolding proteins bind to distinct sites and via distinct 
mechanisms to the TPR bundle.  Specifically, these results support the hypothesis that the 
JIP1 C-terminal tail binds in the groove of the TPR bundle whereas internal sequences in 
JIP3 bind outside the groove.  This is the first demonstration that a single TPR domain 
can use distinct surfaces for binding different partner proteins.   
To confirm the binding specificity of these site-directed or EP-PCR mutants for 
JIP1 and JIP3 in mammalian cells, coimmunoprecipitation experiments were performed 
in COS cells as they contain minimal levels of endogenous Kinesin-1 and JIP proteins 
[39, 40].  For these experiments, truncated versions of the mutant KLC proteins were 
created due to ease of cloning, since truncated (amino acids 1-488) and full-length (amino 
acids 1-560) versions of KLC display identical interactions with JIP1 and JIP3 [20].  HA-
tagged wild-type and mutant KLC proteins were coexpressed with either Myc-JIP1 or 
Flag-JIP3.  Lysates were precipitated with antibodies to the Myc or Flag tags.  Similar to 
the results of the directed two-hybrid assay, the YELLOW, GREEN and 33A mutants 
showed reduced binding to JIP1 (Figure 4.4 E, lanes 7-9, Figure 4.4 G) but not to JIP3 
(Figure 4.4 F, lanes 7-9, and Figure 4.4 H), whereas the 48A mutant showed reduced 
binding to JIP3 but not JIP1 (Figure 4.4 E,F, lane 10, and Figure 4.4 G,H).  These results 
confirm that distinct residues in the KLC TPR bundle are responsible for the interactions 
with JIP1 and JIP3.  
 
The two JIP binding sites on the KLC TPR bundle facilitate transport of the JIP 
proteins 
To test whether both binding sites on the KLC TPR bundle contribute to the 
transport of JIP1 and JIP3, we expressed wildtype and mutant KLC TPR bundles in 
differentiated CAD cells.  Over-expression of the wild-type KLC TPR bundle resulted in 
a loss of JIP1 and JIP3 tip localization by trapping cargo away from Kinesin-1 in a non-
motile complex (Figure 4.5 and [20, 41]).  We hypothesized that over-expression of a 
mutant KLC TPR bundle that retains an interaction with JIP3 but lost the interaction with 
JIP1 (e.g. GREEN; Figure 4.4) will have a dominant negative effect on both JIP1 and 
JIP3 transport, and thus neurite tip localization, in the cooperative model, but will 
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selectively abolish only JIP3 transport if the JIP proteins can bind independently to KLC 
(independent model).  As shown in Figure 4.5, over-expression of the GREEN mutant in 
differentiated CAD cells caused a significant decrease in both JIP1 (Figure 4.5 A,C) and 
JIP3 (Figure 5 B,D) tip localization.  Similarly, over-expression of the 48A mutant that 
lost the interaction with JIP3 but retains an interaction with JIP1 (Figure 4.4) caused a 
significant decrease in both JIP1 (Figure 4.5 A,C) and JIP3 (Figure 4.5 B,D) tip 
localization.  In control experiments, over-expression of the BLUE mutant, which lost the 
interaction with both JIP1 and JIP3 (Figure 4.4), had no effect on transport of either JIP 
protein (Figure 4.5).  These results indicate that both JIP1 and JIP3 binding sites of the 
KLC TPR bundle contribute to JIP transport and support the conclusion that JIP1 and 
JIP3 are transported in a cooperative manner by Kinesin-1. 
 
Oligomerization of JIP1 and JIP3  
Binding of JIP1 and JIP3 to distinct sites on the KLC TPR bundle likely 
contributes to their cooperative transport.  Yet the possibility remained that JIP1 and JIP3 
could interact with each other independent of their interaction with KLC.  Binding as a 
JIP1/JIP3 oligomer could allow a stronger interaction with the two binding sites on KLC.  
Previous studies have shown that JIP1, JIP2, and JIP3 homo-oligomerize and that JIP2 
can hetero-oligomerize with JIP1 and JIP3 [40, 42, 43].  To test whether JIP1 can interact 
with JIP3, we performed coimmunoprecipitation experiments in transfected COS cells.  
When lysates expressing Myc-JIP1 and Flag-JIP3 were immunoprecipitated with an 
antibody to the Myc tag, both JIP1 and JIP3 were precipitated (Figure 4.6 B, lane 9).  
Furthermore, the endogenous JIP1 and JIP3 proteins in differentiated CAD cells hetero-
oligomerize as shown by coimmunopreciptation of JIP3 with an antibody to JIP1 (Figure 
4.6 F).  Taken together, these results indicate that JIP1 and JIP3 can form an oligomeric 
complex.  Thus, distinct binding sites on KLC for JIP1 and JIP3 and an interaction 
between JIP1 and JIP3 contribute to cooperative transport.  
To define the regions of JIP1 responsible for the interactions with JIP3 and KLC, 
a series of Myc-tagged truncated and mutant versions of JIP1 were generated (Figure 4.6 
A).  Full length and truncated/mutant JIP1 proteins were coexpressed in COS cells with 
Flag-JIP3 (Figure 4.6 B) or HA-KLC (Figure 4.6 C) and immunoprecipitated with an 
89 
antibody to the Myc tag.  JIP3 was coimmunoprecipitated with all of the truncated and 
mutated JIP1 proteins that contain an intact PTB domain (Figure 4.6 B, lanes 9-13), but 
not with a construct containing just the SH3 domain of JIP1 (Figure 6 B, lane 14).  These 
results indicate that JIP3 interacts specifically with the PTB domain of JIP1.  This 
binding region is distinct from the JIP1 sequences required for interaction with KLC as 
the coprecipitation of HA-KLC was lost upon mutation (Y709A, Figure 4.6 C, lane 11) 
or truncation (307-701, Figure 4.6 C, lane 12) of the C-terminal residues of JIP1, in 
agreement with previous results [20].  Although the extreme C-terminal residues of JIP1 
are necessary for the interaction with KLC, they are not sufficient, as a construct 
containing only the PTB and C-terminal residues of JIP1 failed to coprecipitate KLC 
(Figure 4.6 C, lane 13).  These data indicate that JIP1 can form distinct interactions with 
JIP3 and KLC. 
To define the regions of JIP3 required for the interactions with JIP1 and KLC, 
Myc-tagged truncated versions of JIP3 were created [(138-621) and (138-433), Figure 4.6 
A].  The truncated JIP3 proteins were coexpressed in COS cells with Flag-JIP1 (Figure 
4.6 D) or HA-KLC (Figure 4.6 E) and immunoprecipitated with an antibody to the Myc 
tag.  While the longer construct, JIP3(138-621) coprecipitated both JIP1 (Figure 4.6 D, 
lane 5) and KLC (Figure 4.6 E, lane 5), the shorter fragment of JIP3 containing residues 
138-433 interacted only weakly with JIP1 (Figure 4.6 D, lane 6) and not at all with KLC 
(Figure 4.6 E, lane 6).  These results suggest that residues 138-433 of JIP3 are partly 
sufficient for the interaction with JIP1; however, residues 433-621 are required for 
complete JIP1 and KLC binding. 
 
A JIP1/JIP3/KLC complex is necessary for efficient JIP1 or JIP3 binding and 
transport 
Previously we showed that KLC’s binding sites for both JIP1 and JIP3 contribute 
to efficient transport of JIPs in neuronal cells (Figure 4.5).  Having defined the regions of 
JIP1 and JIP3 required for binding KLC (Figure 4.6), we next tested whether JIP1 and 
JIP3 binding of the KLC TPR bundle is required for efficient transport of both JIP 
proteins.  In control experiments, high level expression of JIP1 constructs that bind both 
JIP3 and KLC [JIP1(307-711), Figure 4.6] or that bind to neither JIP3 nor KLC 
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[JIP1(307-565), Figure 4.6] had no effect on localization of JIP3 to neurite tips (Figure 
4.7 A,B).  Similar control experiments showed that high level expression of JIP3 
constructs that bind to both JIP1 and KLC [JIP3 full length and JIP3(138-621), Figure 
4.6] did not disrupt JIP1 transport (Figure 4.7 C,D).  In contrast, high expression of JIP1 
proteins that bind JIP3 but not KLC [(307-701), Y709A, and PTB, Figure 4.6], resulted 
in a significant decrease in the amount of JIP3 protein localized at neurite tips (Figure 4.7 
A,B).  In addition, high expression of a JIP3 construct that binds weakly to JIP1 but not at 
all to KLC [JIP3(138-433), Figure 4.6] resulted in a significant decrease in JIP1 levels at 
neurite tips (Figure 4.7 C,D).  These results suggest that although JIP1 and JIP3 can bind 
independently to the KLC TPR bundle, binding of both proteins to Kinesin-1 is required 
for efficient transport of the JIP proteins.  
High expression of Myc-JIP1(307-701) may act to disrupt JIP3 localization by 
preventing an efficient interaction of JIP3 with Kinesin-1.  Upon over-expression of 
Myc-JIP1(307-701) in differentiated CAD cells, less endogenous JIP3 protein was 
coimmunoprecipitated with Kinesin-1 (Figure 4.7 E) as compared to the vector control or 
expression of a JIP1 construct (307-711) that binds to both JIP3 and KLC (Figure 4.7 E).  
These results suggest that high expression of Myc-JIP1(307-701) results in a decreased 
interaction between endogenous JIP3 and Kinesin-1 proteins.  
 
JIP1 is required for JIP3 transport and vice versa 
To further explore the cooperative transport of JIP1 and JIP3 by Kinesin-1, we 
tested whether JIP1 is required for transport of JIP3 and vice versa using RNAi to knock 
down expression of JIP1 or JIP3 in differentiated CAD cells.  To establish the 
knockdown efficiency and specificity of our shRNA plasmids, COS cells were 
cotransfected with mouse Flag-JIP1 or Flag-JIP3 and shRNA plasmids directed against 
JIP1 or JIP3.  An empty shRNA vector was used as a control.  Expression of the JIP1 
shRNA plasmid resulted in decreased Flag-JIP1 expression (Figure 4.8 A, lane 2) 
whereas Flag-JIP3 expression was unaffected (Figure 4.8 B, lane 2).  Expression of the 
JIP3 shRNA plasmid resulted in decreased JIP3 expression (Figure 4.8 B, lane 3) 
whereas JIP1 expression was unaffected (Figure 4.8 A, lane 3).  Immunoblotting the 
same lysates for β-tubulin shows that equal protein levels were loaded.  
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The JIP1 or JIP3 shRNA plasmids were then transfected into differentiated CAD 
cells using a CFP plasmid as a marker for transfected cells.  After 48 hrs, cells were fixed 
and immunostained for endogenous JIP1 or JIP3 proteins.  Transfection of the shRNA 
plasmid against JIP1 resulted in loss of staining for endogenous JIP1 protein (Figure 4.8 
C,E), verifying the efficacy and specificity of the JIP1 shRNA construct, as well as a 
significant decrease in JIP3 localization at neurite tips (Figure 4.8 D,F).  Similarly, 
shRNA-mediated knockdown of JIP3 resulted in a loss of JIP3 staining (Figure 4.8 D,F) 
as well as a significant decrease in JIP1 localization at neurite tips (Figure 4.8 C,E).  In 
the case of JIP3 knockdown, only cells that retained normal neurite morphology were 
selected for quantification since, in some cells, knockdown of JIP3 resulted in a complete 
loss of neurites or the formation of short, thin, and highly branched neurites as previously 
observed [44, 45].  Taken together, the RNAi, dominant negative and 
coimmunoprecipitation experiments support the conclusion that transport of JIP1 and 
JIP3 to neurite tips is dependent on the formation of a JIP1/JIP3/KLC complex. 
 
DISCUSSION  
Cooperative versus Independent transport of Kinesin-1 Cargoes 
To understand how motor proteins function in vesicle transport, it is important to 
determine how motors link to their cargoes and how transport is regulated.  In the case of 
Kinesin-1, recent work has identified many proteins that bind to the KHC and KLC 
subunits [4, 5].  This raises several models for how transport of disparate cargoes by one 
motor might be coordinated.  One possibility is that binding sites for different cargoes 
may not be accessible at the same time, such that cargoes compete with each other for 
transport.  Our results suggest this model is insufficient to describe cargo transport by 
Kinesin-1 as over-expression of cargoes that bind via KLC (Kidins220/ARMS, JIP1/JIP3 
and PAT1) did not compete with other cargoes for transport. In addition, no competition 
was detected between cargoes that bind via KHC and those that bind via KLC 
(p120catenin and JIP1/JIP3, respectively).  Overall, our results support a second model 
for coordination of multiple cargoes - that transport of disparate cargoes is saturable yet 
independent of each other.  The third model, cooperative transport, is viable in the case of 
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Kinesin-1 mediated transport of JIP1 and JIP3, as these proteins bind to separate sites on 
the KLC TPR bundle yet facilitate each other’s binding and transport.  
These results are compatible with those of Bracale et al who showed that over-
expression of the KLC-binding region of Kidins220/ARMS does not impair Kinesin-1 
driven transport of vaccinia virus to the plasma membrane [27].  However, Araki et al 
have shown that over-expression of JIP1 caused a reduction in anterograde velocity of 
GFP-Alcadein vesicles and reduced binding of Alcadein to KLC [26].  Likewise, over-
expression of Alcadein caused a reduction in anterograde velocity of APP-GFP vesicles 
[26].  In addition, Horiuchi et al have shown that over-expression of APLIP1, a JIP1 
ortholog, in Drosophila causes defects in axonal transport [24].  Further investigation, 
from the structural to the cellular level, is clearly required to understand how the 
transport of disparate cargoes is coordinated.  
That transport of an individual cargo can be saturated yet not compete with other 
cargoes suggests that the Kinesin-1 motor is not rate-limiting for transport.  It has been 
suggested that the majority of Kinesin-1 protein, particularly in neuronal cells, is not 
participating in microtubule-based transport but rather is in a folded inactive state [4, 39].  
This seemingly excess of Kinesin-1 protein may function to ensure an ample supply of 
motors that can be activated on demand.  A similar mechanism may function in myosin-
driven transport as mammalian Myosin V is also regulated by autoinhibition [46, 47].   
The rate-limiting factor for Kinesin-1 transport may be unidentified accessory 
proteins required for selective cargo loading.  In the case of JIPs, the formation of a 
JIP1/JIP3 oligomer may be rate limiting for Kinesin-1-mediated transport as low level 
expression of either JIP1 or JIP3 enhanced transport of the other JIP protein.  Yet the fact 
that high level expression of either JIP1 or JIP3 did not enhance transport suggests that 
unidentified accessory factors may be diluted out by the over-expressed protein.   
Our results are applicable to other cellular processes in which a diverse set of 
proteins depends on a common component for trafficking within the cell.  Particularly 
relevant are studies showing that the clathrin-mediated endocytosis of disparate receptors 
and their ligands is saturable but not competitive [48].  Recent work has shown that the 
rate-limiting factor is not the common clathrin core components, but rather sorting 
connectors or adaptors that regulate the selective trafficking of specific cargoes [49].  
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Whether kinesin-cargo interactions are regulated by similar mechanisms is unknown.  In 
the case of cytoplasmic dynein, transport of a wide variety of cargoes is thought to derive 
from a diverse set of cargo-binding accessory polypeptides that bind to dynein heavy 
chain [50].  These accessory polypeptides may bind in a mutually exclusive fashion to 
assemble distinct dynein-cargo combinations [51, 52] or may bind simultaneously to 
assemble multi-cargo complexes [53].  While over-expression of the light chain rp3 
displaces the Tctex-1 light chain from dynein and blocks the apical delivery of rhodopsin 
[52], the differential tissue distribution of these light chains suggests that such 
competition may not exist in vivo [54]. 
 
Cooperative transport of JIP1 and JIP3 via a JIP1/JIP3/KLC complex 
Our results show that although JIP1 and JIP3 can interact independently with 
KLC in yeast-two-hybrid and coimmunoprecipitation experiments, they bind with higher 
affinity when part of a complex (JIP1/JIP3/KLC).  This complex is necessary for efficient 
JIP1 and JIP3 transport as evidenced by both RNAi knockdown and dominant negative 
expression experiments.  Our demonstration of an interaction between JIP1 and JIP3 is in 
contrast to a previous report that JIP3 binds to the C-terminal PTB domain of JIP2 but not 
JIP1 [40].  This discrepancy is most likely explained by the fact that the JIP1b splice 
variant (711 amino acids) used in this study contains a complete PTB domain whereas the 
previous study likely used a shorter JIP1a splice variant (660 amino acids) containing 
only a partial PTB domain [43].  Thus, a complete JIP1 PTB domain is required for the 
interaction of JIP1 with JIP3.  
The biological significance of cooperative transport of JIP1 and JIP3 is not clear.  
Some reports have indicated that JIP1 and JIP3 play distinct roles in cellular processes 
such as stress signaling and apoptosis, cell migration, and neuronal development [21, 55].  
In our studies, we noticed that knockdown of JIP1 protein by RNAi resulted in increased 
neurite outgrowth, whereas loss of JIP3 protein resulted in decreased neurite outgrowth, 
similar to a previous report [45, 56].  However, recent reports have suggested that JIP1 
and JIP3 can cooperate to control cellular events such as phosphorylation and 
accumulation of APP at neurite tips [45, 56], axon guidance [57], and JNK activation 
following glucose deprivation [58].  In this respect, cooperative transport of JIP1 and 
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JIP3 by Kinesin-1 could facilitate the inclusion of many proteins into the transport 
complex and crosstalk between unique subsets of JNK regulators and substrates [21, 42, 
59].  Indeed, the macromolecular complex transported by Kinesin-1 via JIP1 and JIP3 
most likely includes multiple other proteins such as members of the JNK cascade and 
transmembrane receptor proteins [21, 60].  
 
Multiple mechanisms for partner protein binding by the KLC TPR domain 
Our experiments indicate that the TPR bundle of KLC uses at least two 
independent regions for partner protein binding.  First, the inside surface of the TPR 
groove binds to the extreme C-terminal residues of JIP1, similar to the binding of other 
TPR repeat-containing proteins such as Hop, PP5, and Pex5 and their interacting partners 
[10-12].  Second, the outer convex surface of the TPR bundle binds to internal residues in 
JIP3, analogous to the binding interface of the TPR-containing protein p67phox and its 
partner Rac [13].  Thus, although previous studies have demonstrated that both the 
groove and outer surfaces of TPR bundles can bind to partner proteins, KLC is the first 
TPR-containing protein known to utilize both mechanisms.  In addition, in the case of 
KLC, these multiple interaction surfaces enable the cooperative assembly of a 
JIP1/JIP3/KLC complex.   
Several features noted in other TPR bundles are important for JIP binding to 
KLC.  First, substrate recognition and engagement by TPR bundles involves a variety of 
residues spread across a large surface area in the groove or along the outside of the TPR 
domain [8].  Consistent with this, single mutations in the KLC TPR domain were not 
sufficient to abolish the interaction with JIP1 or JIP3.  Second, an Asparagine array lines 
the concave face of the bundle and likely contributes to peptide orientation in the groove 
[10-12, 38].  In the case of KLC, mutation of the Asparagine array abolished the 
interaction with JIP1 but not JIP3, supporting the conclusion that the C-terminal peptide 
of JIP1 sits in the KLC TPR groove.   
KLC’s TPR domain is known to mediate binding of Kinesin-1 to other proteins 
including Kidins220/ARMS, Pat1, Calsyntenin/Alcadein, Collapsin Response Mediator 
Protein-2, Huntington Associated Protein-1, APP, torsinA, 14-3-3 and Vaccinia virus’s 
A36R protein [26-34].  In most of these cases, the mechanism of interaction is unknown, 
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as the residues required for binding have not been identified.  In a recent study, quadruple 
mutations at positions L280, L287, A294, and L301 in KLC abolished the interaction 
with JLP, a JIP4 splice variant [23].  Our structural model predicts that these residues 
contribute to helical packing between the second and third TPR motifs.  This is consistent 
with the structural function of residues in similar positions of the Leu7 subclass of TPR-
containing proteins [61].  Thus, it seems likely that the loss of JLP binding was due to 
alterations in overall TPR domain structure rather than a novel leucine zipper interaction 
between KLC and JLP, as was proposed.  Another recent study showed that two 
conserved WDDS motifs in the cytoplasmic C-terminal tail of Calsyntenin/Alcadein are 
required for efficient binding to KLC1 [26, 33].  As one WDDS is internal and the other 
within the last 10 amino acids, Calsyntenin/Alcadein may bind to KLC using either or 
both of the binding mechanisms identified in this study.  Thus, it will be interesting to 
learn whether this diverse group of proteins binds to one of our two identified sites in 
KLC’s TPR domain or whether the TPR bundle contains additional cargo binding 
interfaces.  
 
MATERIALS AND METHODS 
Plasmids:  Plasmids encoding HA (hemagglutinin)-tagged rat KLC1 and the six 
TPR motifs (amino acids 199-488) have been previously described [20, 62].  For co-
immunoprecipitation with JIP1 and JIP3, mutant TPR domains from pGBD-KLC TPR 
were subcloned into pCDNA3-HA-KLC to create truncated mutant KLC proteins (amino 
acids 1-488) using convenient restrictions sites.  For expression of wild-type and mutant 
KLC TPR domains as dominant negative proteins, mutant TPR domains were subcloned 
from pGBD-KLC TPR into pCDNA3-HA-KLC TPR (amino acids 199-488).   
Flag-tagged mouse JIP1, JIP2, and JIP3 [40, 43, 63] were a kind gift of R. Davis 
(University of Massachusetts Medical School).  The splicing variant of JIP1 used in this 
study is JIP1b, also known as islet brain 1(IB1), which contains the full PTB domain that 
the JIP1a variant lacks [43].  Myc-tagged human full length JIP1, as well as the 
truncations or mutants 307–711, Y709A, 307-701, and PTB (554-711) have been 
described previously [20, 64].  Myc-JIP1(307-565) was generated by PCR amplification 
using primers with convenient restrictions sites for cloning into the pRK5-Myc vector.  
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Truncated JIP3 constructs [JIP3(138-433) and (138-621)] were obtained from clones 
identified in a yeast two-hybrid screen [20] and transferred from the two-hybrid prey 
vector pACT2 into the pCDNA3-myc vector.  Flag-PAT1, GST-PAT1(1-351), and GST-
PAT1(352-585) were a gift of J. Dictenberg and G. Bassell (Albert Einstein College of 
Medicine, Bronx, NY).  GFP-Kidins220/ARMS [27] was a gift from G. Schiavo (Cancer 
Research UK).  CFP-Kidins220/ARMS (1129-1426) was subcloned from the full length 
construct using convenient restriction sites.  ECFP-p120catenin and ECFP-
p120catenin∆N2 (deletion of amino acids 28-233) [37] were a gift from K.J. Green 
(Northwestern University, Chicago, IL).   
Antibodies: The following antibodies were used: polyclonal and monoclonal 
antibodies to the Myc tag (Sigma C3956, Millipore 06-549, and 9E10 hybridoma ascites), 
HA tag (Sigma H6908, Upstate 07-221, and 12CA5 hybridoma ascites), and Flag tag 
(Sigma F7425 and Sigma F3165);  polyclonal  JIP1 (#152, [20]); polyclonal JIP3 (against 
Drosophila JIP3 (Syd2) N-terminal residues 1–772, or C-terminal residues 1066-1328 
[65], gifts from L.S.B. Goldstein, University of California, San Diego); Monoclonal and 
polyclonal Kidins220/ARMS ([27], gifts from G. Schiavo, Cancer Research UK); 
monoclonal KHC (H2, Covance); and β-tubulin (E7, Developmental Studies Hybridoma 
Bank, Univ. Iowa).  Polyclonal anti-KHC antibodies (B1-1) were generated against the 
KHC motor domain peptide CDKNRVPYVKGCTER (rat Kif5c amino acids 159-172).  
Secondary antibodies for immunofluorescence microscopy, Fluorescein and Rhodamine 
Red-X, were purchased from Jackson ImmunoResearch.  
Structural Model of KLC TPR motifs 1-5.  The sequences of TPRs 2-5 of rat 
KLC1-C (residues 247-411) were overlaid onto crystal structures of other TPR bundles 
(Figure Supp 4), specifically the TPR region of human Pex5 (PDB code 1FCH; residues 
A451-A552) and the TPR region of p67phox (PDB code 1E96; residues B120-B151) using 
the graphics program O [66].  The first TPR of KLC (residues 210-246) was then 
modeled by spatial alignment with the helical regions of Pex5 (1FCH, residues A383-
A445).  The sixth TPR repeat of KLC could not be accurately represented in the model 
through sequence or structural alignments to other TPR regions due to a long insertion 
between the fifth and sixth TPR motifs that is unique to KLC.  
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Directed yeast two-hybrid assay:  A construct containing the six TPR motifs 
(amino acids 199-488) of rat KLC1 in the two-hybrid bait vector pGBD has been 
described [20].  Two-hybrid prey plasmids containing fragments of JIP1 and JIP3 in 
plasmid pACT2 were obtained in a two-hybrid screen [20].  Directed mutation of specific 
residues in amino acids 199-370 of the KLC TPR domain was carried out by Gene 
Synthesis [67].  EP-PCR to generate random mutations in KLC TPR motifs (amino acids 
199-488) was carried out as described [68, 69].  Briefly, the region was amplified by PCR 
reactions in which MnCl2 was substituted for MgCl2.  Amplified products were 
subcloned back into the pGBD-KLC TPR plasmid using convenient restriction sites.  
Mutant clones were picked randomly and mini-prep DNA was transformed into the yeast 
strain AH109 (Clontech).   
 Screening of the mutant TPR’s ability to bind to JIP1 and JIP3 was carried out by 
yeast mating. Yeast strain AH109 expressing wild-type or mutant pGBD-KLC TPR 
clones was mated to yeast strain Y189 expressing pACT2-JIP1(478-711) or pACT2-
JIP3(138-680) in 96 well plates.  Diploid yeast were sequentially plated on double (-leu,-
trp) and triple (-leu,-trp,-his + 3-aminotriazole and -leu,-trp,-ade) drop-out plates.  
Successful mating was evidenced by growth on double drop-out (-leu,-trp) plates.  A 
positive interaction between the KLC TPR domain and JIP1 or JIP3 was evidenced by 
growth on -leu,-trp,-his and on -leu,-trp,-ade drop-out plates.   
Clones that lost the ability to interact with either JIP1 or JIP3 were selected for 
further analysis.  Yeast plasmids were transformed back into E.coli for DNA sequencing.  
A few clones that retained interactions with both JIP1 and JIP3 were also selected for 
DNA sequencing.  In most cases, no mutations were found, however, in some cases 
single or double mutations were found.  Clones that lost the ability to interact with both 
JIP1 and JIP3 were not selected since these could include truncated KLC TPR domains as 
well as misfolded proteins.  
Cell culture and Fluorescence Microscopy:  COS and CAD cells were cultured 
as described [20] and transfected with TransIT-LT1 (Mirus).  Cells were processed for 
immunofluoresence as in [20] and mounted in 50% glycerol, 0.5% n-propyl gallete in 
PBS or using Prolong Gold (Invitrogen).  Images were collected with either an Olympus 
BX51 microscope with UplanFl 60X/NA 1.25 objective and Olympus DP70 CCD 
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camera, or a Nikon TE2000 microscope Plan-Fl 40X/NA 0.75 or a Plan-APO 60X/NA 
1.4 objective and Photometrics CS ES2 camera.  Quantification of neurite tip 
immunofluorescence intensity was done using Image J (NIH).  Neurite tips were hand-
selected with an elliptical selection tool and the average pixel fluorescence intensity was 
measured.  In order to pool values from two or three independent experiments for 
statistical analysis (student’s t-test), measurements within each sample were normalized 
by first subtracting cell background fluorescence (determined from measurements within 
neurite shafts), then dividing each transfected or non-transfected tip measurement by the 
average intensity of all non-transfected neurite tips within the same experimental sample.       
Immunoprecipitation:  COS or CAD cells were resuspended in lysis buffer 
(40mM Hepes pH 7.5, 120 mM NaCl, 1 mM EDTA, 10mM sodium pyrophosphate, 
10mM ß-glycerophosphate, 50 mM NaF, 0.5% NP40, 0.1% Brij-35, and protease 
inhibitors).  Extracts were incubated with the specified antibodies for 2.5-18 hr at 4°C 
then incubated with protein A agarose beads for 20 min at 4°C.  Beads were washed two 
times with lysis buffer, resuspended in Laemmli sample buffer, and analyzed by SDS-
PAGE and Western blot. 
RNAi:  A shRNA (short hairpin RNA) plasmid targeting mouse JIP1 was made 
using DNA oligos designed with a 19mer sense sequence (selected using Dharmacon’s 
website), 9 nucleotide loop, 19mer antisense sequence, and 6T pol III stop sequence 
(sense: 5’-tttGGCTCACCGTGCACTTTAAttcaagagaTTAAAGTGCACGGTGAGC 
Ctttttt-3’ and antisense: 5’-tagaaaaaaGACCGTGTGTCTCGATCATtctcttgaaATGATCG 
AGACACACGGT-3’).  Annealed oligos were cloned into the Bbs1 and Xba1 sites of the 
pU6-puro vector (modified from pU6pro [70] by addition of a puromycin resistence gene 
into the PvuII site).  The shRNA plasmid targeting mouse JIP3 was made the same way 
using a previously verified JIP3 shRNA sequence [71] (sense: 5’-tttGCAGGCCGAG 
GAGAAATTCAttcaagagaTGAATTTCTCCTCGGCCTGtttttt-3’ and antisense: 
5’-ctagaaaaaaCAGGCCGAGGAGAAATTCAtctcttgaaTGAATTTCTCCTCGGCCTG-
3’).  All plasmids were verified by DNA sequencing.  Knockdown efficiency was 
verified by co-transfecting the shRNA or control plasmids into COS cells with Flag-
tagged mouse JIP1 or JIP3 plasmids.  Protein expression of Flag-JIP1 or JIP3 in control 

































Figure 4.1:  Transport of specific cargo proteins by Kinesin-1 is saturable.  (A,C)  Differentiated 
CAD cells overexpressing the KLC-binding region of (A) JIP3 [Myc-JIP3(138-621)] or (C) 
Kidins220/ARMS [CFP-Kidins220/ARMS(1129-1426)] were fixed and stained for (A) the Myc 
tag and the endogenous JIP3 protein or (C) the Kidins220/ARMS protein.  Arrowheads, neurite 
tips of transfected cells; arrows, neurite tips of non-transfected cells.  Scale bar = 20 µm. (B and 
D)  Quantification of endogenous (B) JIP3 or (D) Kidins220/ARMS fluorescence intensity at 
neurite tips of non-transfected cells (NT) or cells overexpressing the indicated proteins.  * p<0.01.  





Figure 4.2:  Kinesin-1 cargoes that bind via KLC do not compete with each other for transport.  
(A) Differentiated CAD cells expressing GFP-Kidins220/ARMS or CFP-
Kidins220/ARMS(1129-1426) were stained for the endogenous JIP1 (left set of panels) or JIP3 
(right set of panels) proteins.   FP, fluorescent protein. (B) Differentiated CAD cells expressing 
Myc-JIP1 (left panels) or Flag-JIP3 (right panels) were double labeled for the expressed proteins 
(Myc or Flag tags) and for the endogenous Kidins220/ARMS protein.  (C) Differentiated CAD 
cells expressing Flag-PAT1 were double labeled for the Flag tag and the endogenous JIP1 (left 
panels) or JIP3 (right panels).  Arrows, neurite tips of transfected cells; arrowheads, neurite tips 
of non-transfected cells.  Scale bar = 20 µm.  (D-F)  Quantification of (D) JIP1, (E) JIP3, (F) or 
Kidins220/ARMS fluorescence intensity at neurite tips of non-transfected cells (NT) or cells 
overexpressing the indicated proteins.  N>100 neurites for each construct.  Error bars = +/- SEM.  
(p>0.01 for all transfected constructs).  Acknowledgements: Some data collection for this figure 






Figure 4.3:  JIP1 facilitates JIP3’s transport to neurite tips and JIP3 facilitates JIP1’s transport.  
(A and B)  Differentiated CAD cells expressing (A) high levels or (B) low levels of Myc-tagged 
JIP1 were fixed and stained with antibodies to the Myc tag and endogenous JIP3.  Asterisk, cell 
body of transfected cell.  Arrows, neurite tips of transfected cells.  Arrowheads, neurite tips of 
non-transfected cells.  Scale bar = 20 µm.  (C) Quantification of JIP3 fluorescence intensity at 
neurite tips of non-transfected cells (NT) or cells expressing high or low levels of full-length 
(JIP1 FL) or N-terminally truncated JIP1 (307-711). N>75 neurites for each construct and 
expression level.  Error bars = +/- SEM.  * p<0.01.  (D and E)  Differentiated CAD cells 
expressing (D) high levels or (E) low levels of Flag-tagged JIP3 were fixed and stained with 
antibodies to the Flag tag and endogenous JIP1 protein.  (F)  Quantification of JIP1 fluorescence 
intensity at neurite tips of non-transfected cells (NT) or cells expressing high or low levels of full-
length (JIP3 FL) or truncated JIP3 (138-621).  N>150 neurites for each construct and expression 
level.  Error bars = +/- SEM.  * p<0.01. 
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Figure 4.4:  The KLC TPR domain contains distinct binding sites for JIP1 and JIP3 which 
facilitate cooperative binding.  (A and B)  Cooperative binding of JIP1 and JIP3 to KLC.  Lysates 
of COS cells expressing Flag-JIP3, Myc-JIP1, or HA-KLC were combined and analyzed by 
western blot either directly (total lysate) or after immunoprecipitation with an anti-HA antibody.  
(B) Quantification from six independent experiments of the fold increase in JIP1 (J1) or JIP3 (J3) 
pull-down in the absence and presence of the other JIP protein. * p<0.01; Error bars = +/- SEM.  
(C) Structural model of KLC’s TPR motifs 1-5.  The TPRs are depicted as a grey ribbon diagram.  
Residues targeted for mutation are depicted as ball-and-stick.  The conserved Asparagines across 
the concave face are indicated in YELLOW whereas a series of hydrophobic residues that follow 
a similar line are shown in GREEN.  The conserved K(Y/F)K residues within each TPR motif are 
shown in ORANGE whereas the conserved basic residues in the loops that link successive TPR 
motifs are shown in BLUE.  (D) Results of directed yeast-two-hybrid assay.  Yeast expressing 
wildtype or the indicated mutant versions of the KLC TPR domain as bait were mated to yeast 
expressing JIP1 or JIP3 as prey.  The residues targeted for mutation are indicated (BLUE, 
YELLOW, GREEN, and ORANGE).  For random mutation by EP-PCR, the mutated residues 
were determined after sequencing of the indicated clones.  (E-H) Coimmunoprecipitation assay. 
COS cells were transiently transfected with plasmids encoding (E) Myc-JIP1 or (F) Flag-JIP3 
along with wildtype (WT) or indicated mutant (mut)  KLC TPR proteins.  Lysates were 
immunoprecipitated with (E) anti-Myc or (F) anti-Flag antibodies, separated by SDS-PAGE, and 
immunoblotted with antibodies to the HA, Flag, or Myc tags as indicated. (G and H) Western 
Blot band intensities from three independent experiments were quantified using Image J.  Shown 
is the percentage of total KLC (WT or Mut.) that was Co-IPed with (E) JIP1 or (F) JIP3 
normalized to WT. # p<0.05; Error bars = +/- SEM.  Acknowledgements:  The structural model 
of KLC’s TPR bundle (C) was contributed by Jeanne Stuckey from the University of Michigan.  













































Figure 4.5:  KLC TPR mutants functionally block both JIP1 and JIP3 transport to neurite tips.  
(A and B)  Differentiated CAD cells expressing HA-tagged wildtype (WT) or mutant KLC-TPR 
bundles (GREEN, 48A, BLUE) were double labeled for the HA tag and for endogenous (A) JIP1 
or (B) JIP3 proteins.  Arrows, neurite tips of transfected cells; Arrowheads, neurite tips of non-
transfected cells.  Scale bar = 20 µm.  (C and D) Quantification of (C) JIP1 or (D) JIP3 
fluorescence intensity at neurite tips of non-transfected cells (NT) or cells expressing the 
indicated WT or mutant TPR bundles.  Compared to control non-transfected cells, a significant (* 
p<0.01) decrease in JIP1 or JIP3 staining intensity is seen in cells transfected with the WT, 
GREEN, and 48A TPR bundles, but not the BLUE TPR bundle.  N>200 neurites for each 






























Figure 4.6:  Oligomerization of JIP1 and JIP3.  (A) Schematic illustration of full length or 
truncated JIP1 and JIP3 constructs.  JB, JNK binding domain; PTB, phosphotyrosine binding 
domain; CC, coiled coil; LZ, leucine zipper.  (B and C) Mapping of JIP1 domains.  COS cells 
were cotransfected with the indicated Myc-JIP1 (m-JIP1) constructs and either (B) Flag-JIP3 or 
(C) HA-KLC.  Cells were lysed and protein levels were analyzed by western blot directly (total) 
or after immunoprecipitation (IP) with anti-Myc antibodies.  (D and E) Mapping of JIP3 domains.  
COS cells were co-transfected with a control vector or the indicated Myc-JIP3 (m-JIP3) 
constructs and either (D) Flag-JIP1 or (E) HA-KLC.  Cells were lysed and protein levels were 
analyzed by western blot directly (total) or after immunoprecipitation (IP) with anti-Myc 
antibodies.  (F) Interaction between endogenous JIP1 and JIP3 proteins. Lysates of differentiated 
CAD cells were immunoprecipitated with an anti-JIP1 antibody (IP-JIP1) or with the control pre-
immune serum (IP-PreImm).  The presence JIP3 in the immunoprecipitate was determined by 
immunoblotting with an antibody to JIP3.
106 
Figure 4.7:  Interaction of JIP1 with KLC is required for JIP3 transport and vice versa.  (A and 
B) Over-expression of JIP1 constructs.  Differentiated CAD cells expressing the indicated 
truncated versions of Myc-JIP1 were immunostained with antibodies to the Myc tag and the 
endogenous JIP3 protein.  Arrows, neurite tips of transfected cells.  Arrowheads, neurite tips of 
non-transfected cells.  Scale bar = 20 µm.  JIP3 fluorescence intensity at neurite tips was 
quantified (B) for non-transfected cells (NT) or cells expressing the indicated JIP1 constructs.  
N>170 neurites for each construct.  Error bars = +/- SEM.  * p<0.01.  (C and D) Over-expression 
of JIP3 constructs.  Differentiated CAD cells expressing full length (FL) Flag-JIP3 or the 
indicated truncated versions of Myc-JIP3 were immunostained with antibodies to the Flag or Myc 
tags and the endogenous JIP1 protein.  JIP1 fluorescence intensity at neurite tips was quantified 
(D) for non-transfected cells (NT) or cells expressing the indicated JIP3 constructs.  N>200 
neurites for each construct.  Error bars = +/- SEM.  * p<0.01.  (E) Effect of JIP1 dominant 
negative constructs on JIP3 binding to KLC.  Lysates of differentiated CAD cells expressing full 
length or the indicated constructs of Myc-JIP1 were immunopreprecipitated (IP) with antibodies 
to the endogenous KHC protein.  Precipitates were analyzed by western blot for the presence of 










Figure 4.8:  Knockdown of JIP1 abrogates JIP3 transport and vice versa.  (A and B) Specificity 
of RNAi knockdown.  COS cells were co-transfected with Flag-JIP1 (A) or Flag-JIP3 (B) and 
either an empty shRNA vector or shRNA plasmids targeting JIP1 or JIP3.  The levels of 
remaining JIP1 and JIP3 proteins were determined by immunoblotting total cell lysates with an 
anti-Flag antibody. Equal loading of total protein is indicated by blotting with an anti-β-tubulin 
antibody.  (C and D) Differentiated CAD cells were transfected with a plasmid encoding CFP 
alone or together with JIP1 shRNA or JIP3 shRNA plasmids.  Cells were fixed and 
immunostained with antibodies to the endogenous (C) JIP1 or (D) JIP3 proteins.  Left panels: 
transfection with CFP has no effect on (C) JIP1 or (D) JIP3 tip localization or protein level.  
Middle panels: JIP1 and JIP3 shRNA transfected cells show efficient knockdown of endogenous 
JIP1 or JIP3 respectively.  Right panels: JIP3 shRNA-transfected cells show a defect in JIP1 tip 
localization (C) and JIP1 shRNA-transfected cells have a defect in JIP3 tip localization (D).  
Arrows, neurite tips of transfected cells; arrowheads, neurite tips of non-transfected cells.  Scale 
bar = 20 µm.  (E and F) Quantification of the relative JIP1 (E) or JIP3 (F) fluorescence intensity 
at neurite tips in transfected cells as compared to non-transfected (NT) cells.  N>160 neurites for 




Figure Supplemental 4.1:  Binding of Kidins220/ARMS and PAT1 to KLC.  (A) Schematic 
illustration of full length Kidins220/ARMS and the truncated, cytoplasmic construct CFP-
Kidins220/ARMS(1129-1426).  Ank, ankyrin repeats; TM, transmembrane domains; SD, SAM 
domain; KLC BD, KLC binding domain as determined by Bracale et al, 2007; PDZ BM, PDZ 
binding motif.  (B) Coimmunoprecipitation of Kidins220/ARMS with KLC.  Lysate from COS 
cells transfected with CFP-Kidins220/ARMS(1129-1426) was mixed with lysate from 
untransfected cells or cells transfected with HA-KLC .  Mixed lysates were then 
immunoprecipitated with anti-HA antibodies and analyzed by western blot.  (C) Schematic 
illustration of PAT1 and truncated GST-PAT1 constructs. (D) GST-PAT1(1-351) or GST-
PAT1(352-585) recombinant proteins were mixed with lysates from COS cells that had been 
transfected with HA-KLC or left untransfected.  Mixtures were immunoprecipitated with anti-HA 





Figure Supplemental 4.2: Kidins220/ARMS does not compete with JIP1 or JIP3 for binding to 
KLC.  Lysates of COS cells expressing Myc-JIP1, Flag-JIP3, CFP-Kidins220/ARMS(1129-
1426), and HA-KLC were combined and analyzed by western blot either directly (total lysate) or 
after immunoprecipitation with an anti-HA antibody.  (A and B) Kidins220/ARMS and JIP1 do 
not compete for binding to KLC. (A) Representative western blot of co-immunoprecipitation of 
JIP1 and Kidins220/ARMS with KLC. Co-precipitation of Kidins220/ARMS with KLC (lane 6) 
or of JIP1 with KLC (lane 7) is not altered by the presence of the other cargo protein (lane 8). (B) 
Quantification of five independent experiments. Error bars = +/- SEM. p>0.05 for all 
combinations.  (C and D) Kidins220/ARMS and JIP3 do not compete for binding to KLC. (C) 
Representative western blot of coimmunoprecipitation of JIP3 and Kidins220/ARMS with KLC.  
Coprecipitation of Kidins220/ARMS with KLC (lane 6) or of JIP3 with KLC (lane 7) is not 
altered by the presence of the other cargo protein (lane 8). (D) Quantification of six independent 



























Figure Supplemental 4.3:  p120catenin, a KHC-binding Kinesin-1 cargo, does not compete with 
JIP1 or JIP3 for transport.  (A) Differentiated CAD cells expressing CFP-p120catenin or an N-
terminally truncated version of p120-catenin, ∆N, were stained for endogenous JIP1 (left panels) 
or JIP3 (right panels).  Arrows, neurite tips of transfected cells; arrowheads, neurite tips of non-
transfected cells.  Scale bar = 20 µm.  (B and C) Quantification of JIP1 (B) or JIP3 (C) 
fluorescence intensity at neurite tips of non-transfected cells (NT) or cells transfected with the 
indicated p120catenin construct.  N>100 neurites for each construct.  Error bars = +/- SEM.  




Figure Supplemental 4.4:  Alignment of the structural model of KLC TPR repeats 1-5 with 
known TPR domain structures. The sequences of TPRs 2-5 of rat KLC1-C were overlaid onto the 
known crystal structures of human Pex5 and p67phox.  The first TPR of KLC (residues 210 –246) 
was then modeled by spatial alignment with the helical regions of Pex5. The sixth TPR repeat of 
KLC could not accurately be represented in the model through sequence or structural alignments 
to other TPR regions due to a long insertion between the fifth and sixth TPR motifs that is unique 
to KLC.  (A) Ribbon diagrams depicting the structural alignment of the TPR domains of p67phox 
residues B2 – B186 (red, PDB code 1E96) aligned with the model of KLC1, residues 210 – 411, 
shown in yellow.  (B) Manual alignment of the Cα atoms of the TPR region of the KLC1 
structural model with four known TPR crystal structures.  Yellow, KLC1 residues 210 – 411. 
Magenta, PP5 residues 19 – 170 (PDB code: 1A17). Blue, Hop residues A2 – A118 (PDB code 
1ELW). Red, p67phox residues B2 –B186 (PDB code 1E96). Green, Pex5 residues A420 – A602 
(PDB code 1FCH). Depicted in brown are the co-crystallized binding partners of Hop (Hsp70 C-
terminal peptide (C5 – C12), PDB code 1ELW) and p67phox (peroxisomal targeting peptide (C1 – 
C5), PDB code 1E96).  Acknowledgement:  This figure was generously provided by Jeanne 
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Microtubule Post-Translational Modifications  
Direct Kinesin-1 into Axons 
 
 Unidirectional signal transduction by neuronal cells is intimately linked to their 
highly polarized morphology.  The biogenesis and maintenance of distinct axon/dendrite 
compartments depends on transport of specific vesicles and proteins along microtubules 
to their proper cellular locations.  Despite much effort, it is still unclear how polarity is 
established.  Several signaling pathways and proteins have been identified that control 
neurite outgrowth and/or axon specification including: the PI3K/Akt/GSK3β pathway; 
the Par3/Par6/aPKC complex; SAD kinases; Ras, Rac, Cdc42, and Rap1b small GTPases; 
APC, and CRMP-2 [1, 2].  Many of these signaling pathways regulate components of the 
actin cytoskeleton to facilitate growth cone motility, as well as components of 
microtubule-based transport systems for targeted delivery of vesicles and protein 
complexes [1, 2].  As specification and maintenance of neuronal polarity rely on 
microtubule-based transport, understanding the molecular mechanisms responsible for 
the polarized transport of kinesin motors to axons and/or dendrites is critical to 
understanding neuronal organization and polarity.  
 The process of cellular polarization has been studied in cell culture, typically with 
primary hippocampal neurons [3].  Unpolarized (stage 1) cells start their differentiation 
process by extending multiple apparently identical neurites (stage 2).  Polarity is 
established a short time later when one neurite undergoes a period of rapid extension and 
becomes the axon (stage 3).  The remaining neurites will then become dendrites (stages 4 
and 5).  
 Upon polarization (stage 3), several signaling components become localized to 
the growth cone of the developing axon (Par3/Par6/aPKC complex, APC, PIP3, JIP1, as 
well as members of the Rho family GTPases: Rac, Cdc42, and Rap1b and some of their 
activating GEFs)  [4-15].  Several mechanisms have been proposed to account for this
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polarized localization including 1) selective transport down the axon by kinesin motors, 
2) selective degradation by the ubiquitin/proteasome system in minor neurites, or 3) 
localized activation or production of signaling components in the developing axon [1, 2, 
16-21].  In the case of selective microtubule transport, the Kinesin-1 motor and its cargo 
protein JNK-interacting protein (JIP)-1 accumulate preferentially in the developing axon 
[11, 16, 17].  Kinesin-1 also transports CRMP2, a protein essential for axon specification 
[22].  The Kinesin-3 family member, Gakin, delivers PIP3-containing vesicles via its 
interaction with the PIP3-interacting protein, PIP3BP, thus contributing to the PIP3 
accumulation that initiates signaling cascades important for axon specification [13, 15, 
23].  Finally the Kinesin-2 family member, KIF3, has been implicated in transporting 
proteins essential for axon elongation and specification (APC and the Par3 complex), but 
whether this involves selective transport to the developing axon, or general transport to 
all neurites is still unclear [4, 14].   
 How the developing axon in stage 3 is chosen from apparently equivalent neurites 
in stage 2 is still unclear.  Recent work has shown that kinesin motors can distinguish 
between apparently equivalent neurites in stage 2, even before morphological 
differentiation has taken place.  Using live cell imaging of fluorescently-tagged, 
constitutively active versions of the Kinesin-1 motor KIF5C, Jacobson et al showed that 
Kinesin-1 accumulates in a subset of neurites in a very dynamic fashion [16].  The 
Kinesin-1 cargo JIP1 also localizes to a subset of neurites in nonpolarized cells and may 
play a role in axonal specification and growth [11, 24].  Thus, the selectivity of 
endogenous and over-expressed Kinesin-1 motors for specific neurites is one of the 
earliest known molecular differences between seemingly equivalent neurites in stage 2 
cells. 
What are the molecular signals that drive the selective transport of Kinesin-1 
motors in neurites of unpolarized stage 2 neurons and axons of polarized stage 3 neurons?  
Recent work has raised the possibility that Kinesin-1 “reads” biochemical cues that 
specify a qualitatively and/or functionally distinct set of microtubule tracks in selected 
neurites and axons.  Previous work has shown that stage 3 axons are enriched in stable 
microtubules as compared to minor neurites [25, 26].  Stable microtubules comprise a 
subset of the total microtubules in cells whose low turnover enables a long half-life (t ½ = 
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hours) as compared to dynamic microtubules (t ½ = minutes).  Stable microtubules are 
resistant to depolymerization by microtubule-destabilizing drugs such as nocodazole and 
become marked by a variety of post-translational modifications (PTMs) in an age-
dependent manner.  Thus, stable microtubules may serve as an axonal signal for Kinesin-
1.  In support of this possibility, in vitro assays have shown that Kinesin-1 has a binding 
preference for microtubules containing the PTMs of acetylation, detyrosination, and 
polyglutamylation [24, 26-30].  In addition, hyperacetylation of microtubules can 
misdirect Kinesin-1 transport of JIP1 in stage 2 primary hippocampal neurons [24].  
Whether one particular microtubule PTM or a combination of PTMs provides a 
biochemical cue that directs Kinesin-1 to the developing axon in stage 3 cells is 
unknown.  Here we test the possibility that microtubule acetylation directs Kinesin-1 
axonal sorting by analyzing the transport of expressed constitutively active Kinesin-1 
motors and endogenous Kinesin-1 cargoes in primary hippocampal neurons.  We show 
that Kinesin-1 can be influenced by microtubule acetylation in stage 2 neurons but not in 
stage 3 neurons.  Rather, in stage 3 neurons, Kinesin-1 “reads” axonal cues that can 
override the acetylation input.  This axonal cue can be incorporated into dendrites by low 
concentration taxol treatment or inhibition of GSK3β.  Both treatments correlate with an 
increase in multiple microtubule PTMs.  These results suggest that multiple microtubule 




Kinesin-1 prefers neurites and axons with higher levels of modified microtubules 
Kinesin-1 has been shown to preferentially transport down axons in stage 3 and 
later primary hippocampal neurons [16, 17].  However, the molecular mechanism for this 
axonal sorting is unknown.  It is possible that the mechanism is related to a specific 
property of the microtubule population in axons.  Previous work has shown that axons 
contain a higher percentage of stable microtubules than dendrites [25, 26].  Thus, we 
asked whether the microtubule PTMs often associated with stable microtubules are 
enriched in axons.  To do this, we stained stage 3 primary hippocampal neurons with 
antibodies that recognize the known microtubule PTMs of α-tubulin acetylation, α-
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tubulin detyrosination, and polyglutamylation of both α- and β-tubulin.  The ratio of 
modified tubulin to total tubulin in the axon was compared to minor neurites.  The levels 
of acetylated α-tubulin and polyglutamylated α-tubulin were significantly higher in the 
developing axon than in the minor neurites (Figure 5.1 A and B).  Other labs have also 
demonstrated accumulation of  detyrosinated microtubules in axons (Gary Banker, 
personal communication).  We conclude that microtubule PTMs are enriched in axons 
and therefore may provide a biochemical cue for Kinesin-1 that drives polarized 
transport.  
We then tested whether the microtubule PTMs are also enriched in minor neurites 
chosen by Kinesin-1 in unpolarized stage 2 primary hippocampal neurons.  Recent work 
has shown that one neurite in stage 2 neurons is often enriched in stable microtubules 
[25].  Yet it is unknown whether the presence of stable microtubules and/or the PTMs 
that mark this subpopulation correlate with the presence of proteins known to accumulate 
in one neurite of stage 2 neurons.  As Kinesin-1 is one of the earliest known markers of 
the newly specified axon and often localizes to one or a few stage 2 neurites, we tested 
whether the preferential trafficking of Kinesin-1 motors also correlates with increased 
levels of microtubule PTMs.  We used constitutively active versions of Kinesin-1 (CA-
Kinesin-1) that contain a dimeric motor domain required for microtubule-based motility 
but lack the C-terminal tail domains required for autoinhibition and cargo-binding 
[Kif5c(1-560) or Kif5c(1-509)].  When tagged with fluorescent proteins and expressed in 
neuronal cells, such truncated motors provide a direct readout of Kinesin-1 activity 
regulated primarily by the microtubule/motor interface [16, 17, 31].  Stage 2 hippocampal 
neurons expressing CA-Kinesin-1 were fixed and stained for total α-tubulin and the 
various PTMs.  The ratio of modified tubulin to total tubulin was then compared between 
neurites with or without significant CA-Kinesin-1 accumulation.  For the acetylation and 
polyglutamylation modifications, the level of modified tubulin was higher in neurites 
with CA-Kinesin-1 accumulation than in neurites that lack CA-Kinesin-1 (Figure 5.1 C-
E).  These results suggest that the preferential accumulation of microtubule PTMs in one 
neurite of stage 2 neurons may serve to direct Kinesin-1 trafficking into that neurite, thus 
promoting axon growth and specification.   
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Microtubule acetylation influences the localization of the Kinesin-1 cargo JIP1 in 
unpolarized (stage 2) but not polarized (stage 3) neurons 
 That microtubule PTMs regulate Kinesin-1 transport is supported by recent data 
showing that hyperacetylation of microtubules in stage 2 primary hippocampal neurons 
results in a misdirection of Kinesin-1 transport [24].  In this study, the localization of the 
Kinesin-1 cargo JIP1 in fixed cells was used as a read-out of the activity of the 
endogenous Kinesin-1 motor.  In primary neurons, the localization of JIP1 to a subset of 
neurites in stage 2 cells, and to the developing axon in stage 3 cells, is dependent on 
Kinesin-1 activity [11, 24, 32].  Stage 2 primary hippocampal neurons were treated with 
125nM trichostatin A (TSA), a general deacetylase inhibitor, or with 5-10µM tubacin, a 
specific inhibitor of the tubulin deacetylase HDAC6, for 3 hours to hyperacetylate 
microtubules (Figure 5.2 C, F).  Cells were then fixed and stained for acetylated tubulin 
and the endogenous JIP1 protein.  In control cells, JIP1 was localized to a subset of 
neurites whereas hyperacetylation resulted in a redirection of JIP1 to a greater percentage 
of neurites (Figure 5.2 A and B, [24]).  Thus, preferential transport of JIP1 to a subset of 
neurites by the endogenous Kinesin-1 motor can be influenced specifically by the 
acetylation PTM present on microtubules.  
 We thus tested whether microtubule acetylation can influence Kinesin-1 transport 
of JIP1 to axons in stage 3 neurons.  Stage 3 primary hippocampal neurons were treated 
with TSA or tubacin and then fixed and stained for the endogenous JIP1 protein.  
Surprisingly, in polarized stage 3 neurons, increased acetylation (Figure 5.2 D and E) had 
no effect on JIP1 transport.  In both control and treated cells, JIP1 accumulated 
exclusively in the developing axon and not minor neurites (Figure 5.2 D and E).  These 
results suggest that the PTM of α-tubulin acetylation is not sufficient to provide the 
biochemical cue that drives axonal transport of Kinesin-1.  
 
Microtubule acetylation does not influence the motility of CA-Kinesin-1 motors in 
polarized (stage 3) neurons 
That alterations in microtubule acetylation influence JIP1 localization in stage 2 
cells but not in stage 3 cells could be explained by differences in the cellular environment 
(e.g. axonal retention of JIP1) other than Kinesin-1 transport.  Thus, to test directly 
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whether acetylation influences Kinesin-1 motors in stage 3 neurons, we analyzed the 
effects of increased acetylation on CA-Kinesin-1 motors.  Primary hippocampal neurons 
were electroporated with CA-Kinesin-1-EGFP at the time of plating.  Upon reaching 
stage 3, the cells were treated with DMSO control, 2µM tubacin, or 100nM TSA and then 
observed using time-lapse live-cell imaging.  Before treatment, CA-Kinesin-1 
accumulated specifically in the developing axon.  After treatment with TSA or tubacin 
for 1 to 2 hours, no movement of CA-Kinesin-1 motors to minor neurites was observed 
(Figure 5.3 A and B) despite significant increases in the levels of acetylated tubulin 
within the same time period (Figure 5.3 C).   
An alteration of CA-Kinesin-1 localization in this experiment would require that 
CA-Kinesin-1 motors localized at the tip of the developing axon return to the cell body 
before choosing minor neurites.  Thus, we performed a second set of experiments 
designed to allow newly-made CA-Kinesin-1 motors equal opportunity to choose 
hyperacetylated axons or minor neurites without the need to first diffuse out of the axon.  
Stage 3 or stage 5 mouse hippocampal neurons were treated for 3-4 hours with DMSO, 
125nM TSA, or 10µM tubacin.  The cells were then transfected with CA-Kinesin-1-
mCherry together with YFP to illuminate the entire cell, and allowed to express the 
exogenous proteins under additional treatment for 4-5 hours.  CA-Kinesin-1 motors 
accumulated preferentially in the developing axon and not in minor neurites in both 
control and treated stage 3 cells (Figure 5.3, D and E).  Similarly, CA-Kinesin-1 motors 
accumulated in axons rather than dendrites in stage 5 cells (Figure 5.3 E).   
 Thus, although increased microtubule acetylation can influence Kinesin-1 
transport in stage 2 cells (Figure 5.2), it did not alter the preferential localization of the 
Kinesin-1 cargo JIP1 or the preferentially transport of CA-Kinesin-1 motors to axons in 
polarized cells (Figures 5.2 and 5.3).  Hyperacetylation caused by deacetylase inhibitors 
also did not cause multiple axons.  Treating cells with 5µM tubacin from 3hrs after 
plating until 6 days in vitro does not increase the percentage of cells with multiple axons 
(Figure 5.3 F and [25]).  We conclude that acetylation is not the primary signal that drives 
axonal trafficking of Kinesin-1.  Rather, Kinesin-1 apparently recognizes some other 
biochemical property of microtubules present in axons that is absent or decreased in other 
processes (minor neurites or dendrites).   
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Taxol treatment alters microtubule modifications and selective Kinesin-1 transport 
in both stage 2 and stage 3 primary hippocampal neurons 
Although changes in microtubule acetylation are not sufficient to alter the 
preferential transport of Kinesin-1 to axons in polarized cells, treatment of differentiated 
neurons (stage 5) with low doses of the microtubule-stabilizing drug, taxol, has been 
shown to redirect CA-Kinesin-1 motors to dendrites [17].  In our hands, treatment of 
stage 5 primary hippocampal neurons did indeed result in the accumulation of CA-
Kinesin-1 motors in both dendritic and axonal growth cones (Figure 5.4 A and C).  This 
effect was also seen earlier in differentiation, as treatment of stage 3 neurons with low 
levels of taxol also resulted in accumulation of CA-Kinesin-1 motors in minor neurites 
(Figure 5.4 B and C).  These results suggest that promoting microtubule stabilization in 
non-axonal processes is sufficient to override the axonal signal used by Kinesin-1.  
We next explored the dynamics of taxol-induced changes in microtubule PTMs 
and Kinesin-1 transport.  Primary hippocampal neurons that had been electroporated with 
CA-Kinesin-1-mCit at the time of plating, were treated with DMSO control or with 10nM 
or 100nM Taxol and observed using time-lapse live cell imaging.  In unpolarized stage 2 
cells where Kinesin-1 was initially evenly distributed throughout the cell, the motor 
accumulated in all neurite tips within 10-20 minutes after taxol treatment (Figure 5.5 A, 
B, and D), but not after DMSO treatment (data not shown, Figure 5.2 A and B).  In 
treated cells, CA-Kinesin-1 fluorescence stayed relatively constant in all neurite tips for 
the duration of the recording (Figure 5.5 A and B) ; whereas, some untreated cells 
showed transient activity of CA-Kinesin-1 towards one or a few neurites over time as 
previously reported [16] .  It is interesting that in these stage 2 cells, although there are 
plenty of microtubule tracks for constitutively active Kinesin-1 to take to the ends of 
neurites, Kinesin-1’s processivity is still limited.  Upon taxol treatment the biochemical 
properties of the microtubules must be altered such that Kinesin-1 finds the tracks more 
suitable and quickly responds by accumulating at neurite tips.  
In polarized stage 3 cells, CA-Kinesin-1-mCit showed a similar change in 
trafficking upon taxol treatment.  Prior to treatment, most CA-Kinesin-1 was 
accumulated in the axon with only a minor portion present in the cell body.  Within 10-20 
mins of taxol treatment, the minor neurites showed a significant accumulation of CA-
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Kinesin-1 (Figure 5.5 C and D).  The CA-Kinesin-1 fluorescence in minor neurites 
continued to increase at a gradual rate over the 4 hour period imaged.  At the end of the 
imaging period, CA-Kinesin-1 was accumulated at the tips of 95% of axons and 66% of 
minor neurites.  However cells treated with DMSO had CA-Kinesin-1 in axons only 
(98% of axons, 3% of dendrites) (Figure 5.5 E and F). 
 To determine the changes in microtubule PTMs occurring over this time course of 
taxol treatment, a mix of stage 2/stage 3 primary hippocampal neurons were treated for 0-
60 minutes with 100nM Taxol.  Cells were collected, lysed, run on SDS-PAGE gel, and 
then immunoblotted for total β-tubulin and for specific tubulin modifications (acetylated 
α-tubulin, detyrosinated  α-tubulin, or polyglutamylated tubulin).  Like TSA or tubacin 
treatment, taxol treatment caused a rapid (within 7.5 min) increase in the level of α-
tubulin acetylation (Figure 5.5 G).  Importantly, taxol treatment also caused a rapid 
(within 7.5 min) increase in the other known microtubule PTMs, detyrosination of α-
tubulin and polyglutamylation of α- and β-tubulin (Figure 5.5 G).  Importantly, this is the 
same time scale of taxol treatment that results in alterations in CA-Kinesin-1 trafficking 
in unpolarized stage 2 neurites and polarized stage 3 minor neurites.  These results 
demonstrate that alterations in microtubule stability and/or PTMs regulate the selective 
transport of Kinesin-1 in both unpolarized and polarized neurons.  
We thus asked what effects taxol treatment has on the transport of endogenous 
Kinesin-1 motors and on neuronal polarity.  Stage 2 and Stage 3 primary hippocampal 
neurons were treated with DMSO control or with 10nM or 100nM taxol for 3 hours.  The 
cells were then fixed and stained with antibodies to the Kinesin-1 cargo, JIP1, and 
acetylated α-tubulin.  In stage 2 cells, taxol treatment resulted in redistribution of JIP1 
from a subset of neurites to the majority of neurite tips (Figure 5.6 A and B).  In stage 3 
cells, taxol treatment caused JIP1 to accumulate in both future dendrites and axons, rather 
than just specifically in axons, as seen in control cells (Figure 5.6 C and D).  To 
determine the PTM changes associated with this treatment, a mixture of stage 2 and 3 
cortical cells were treated with 10 or 100nM taxol for 3 hours.  Cells were then collected, 
lysed, and analyzed by western blot.  Taxol treatment resulted in a significant increase in 
the amount of tubulin acetylation, detyrosination, and polyglutamylation (Figure 5.6 E; 
increased acetylation levels also visible by immunofluorescence Figure 5.6 A and C).   
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Microtubule stabilization induced by long-term taxol treatment is also sufficient 
to induce multiple axons in differentiated neurons.  Staining of cells with antibodies to 
the axonal marker Tau-1 and the dendritic marker MAP2 demonstrates that untreated 
cells have a single Tau-1-positive axon leaving the cell body whereas taxol-treated cells 
have multiple Tau-1-positive axons that protrude from the cell body (Figure 5.6 F and G; 
[25]).  Thus, taxol treatment results in changes within the microtubule cytoskeleton that 
dictate an axonal-like morphology and assemblage of proteins.   
 
Inhibition of GSK3β signaling abolishes selective Kinesin-1 transport in stage 3 
primary hippocampal neurons 
Alterations in axon/dendrite identity can also be induced by pharmacological 
inhibition of the protein kinase GSK3β.  In hippocampal cells, inhibition of GSK3β 
specifically toward primed substrates like APC and CRMP-2 can induce the formation of 
multiple axons or alternatively axons with increased branching [33-35].  The ability to 
form multiple axons suggests the possibility that events downstream of GSK3β activity 
limit the occurrence of microtubule based “axonal” signals.  We first tested whether CA-
Kinesin-1 motors could recognize and follow the cues provided by the multiple axons 
generated upon GSK3β inhibition.  Cells that were nucleofected with CA-Kinesin-1-mCit 
at the time of plating were cultured in 5µM of the GSK3β inhibitor SB216763 for 6 days.  
Staining cells with antibodies to the axonal marker Tau-1 and the dendritic marker MAP2 
demonstrates that pharmacological inhibition of GSK3β resulted in a significant increase 
in the number of cells with multiple axons (Figure 5.7 A), consistent with previous 
reports [33, 35].  When the treated cells were stained with an antibody to GFP to enhance 
the mCit signal on CA-Kinesin-1-mCit, the active Kinesin-1 motors accumulated in all 
axonal tips (Figure 5.7 B), suggesting GSK3β inhibition generated genuine axons 
containing the microtubule based axonal cue recognized by Kinesin-1.  
 We next asked whether Kinesin-1 could be redirected into the minor neurites of 
early polarizing neurons (stage 3) or the dendrites of fully differentiated (stage 5) neurons 
using shorter time periods of GSK3β inhibition.  Stage 3 or 5 neurons were treated for 2-
4 hours with DMSO control or with 5-10µM SB216763.  Cells were then lipofectamine 
transfected with CA-Kinesin-1-mCherry together with YFP as a whole cell marker.  After 
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additional treatment and expression time of 4-6 hours, cells were fixed and imaged.  
Inhibition of GSK3β for a total of ~ 8 hours resulted in significant CA-Kinesin-1-
mCherry accumulation in minor neurites (stage 3) or dendrites (stage 5) in addition to the 
axon (Figure 5.7 D-F).  Finally, we tested whether GSK3β inhibition could influence 
Kinesin-1 transport in unpolarized stage 2 cells.  Treating stage 2 cells with 10µM 
SB216763 increased the percentage of neurites with JIP1 accumulation (Figure 5.7 G and 
H). 
  As inhibition of GSK3β resulted in an increase in “axonal signal” recognized by 
Kinesin-1, we tested how microtubule PTMs were altered with GSK3β inhibition.  Cells 
were treated with 5-10µM SB216763, lysed, run on SDS-PAGE gels, and then 
immunoblotted for total α-tubulin and for the known tubulin PTMs (acetylated α-tubulin, 
detyrosinated  α-tubulin, and polyglutamylated tubulin.)  Similar to taxol treatment, 
inhibition of GSK3β with 5-10 µM SB216763 resulted in an increase in all microtubule 
PTMs (Figure 5.7 I and J).  We conclude that increased microtubule modifications upon 
inhibition of GSK3β could serve as a signal to influence Kinesin-1 transport in polarized 
primary hippocampal neurons.  
 
DISCUSSION 
Role of microtubule PTMs in regulating Kinesin-1 transport 
 Kinesin-1 has been shown to have increased binding to and motility on acetylated 
microtubules over non-acetylated microtubules [24].  Hyperacetylation of microtubules 
(due to inhibition of the tubulin deacetylase HDAC6) can influence kinesin transport in 
unpolarized cells, promoting transport of the Kinesin-1 cargo, JIP1, to a greater 
percentage of neurites (Figure 2, [24]).  These results indicate that acetylated 
microtubules do play a positive role in regulating the kinesin-1/microtubule interaction.  
However, our results show that hyperacetylation has no effect on kinesin-1 transport in 
polarized cells, as assayed by both the localization of JIP1 and over-expressed CA-
Kinesin-1 motors.  Additionally hyperacetylation does not alter polarity in neuronal 
cultures as one would expect if acetylation provided the key “axonal” signal to 
microtubule motors (this study and [25]).   
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 In polarized cells, it seems the microtubules have additional biochemical signals 
that direct Kinesin-1 transport even in the presence of high levels of microtubule 
acetylation.  Our data shows that the selective transport of Kinesin-1 in polarized neurons 
correlates with increased levels of multiple microtubule PTMs in the axon compared to 
minor neurites.  Thus, another microtubule biochemical modification (i.e. detyrosination, 
polyglutamylation, or other PTMs or microtubule properties not directly tested) or a 
combination of these modifications could provide the “axonal” signal to Kinesin-1.  
Detyrosination, polyglutamylation, and presence of MAPs each have suggested 
regulatory roles in the kinesin-1/microtubule interaction [24, 26-30, 36, 37].  
Additionally, low concentration taxol treatment and GSK3β inhibition (both treatments 
which can transform dendrites into axons) result in increased levels of all PTMs tested.  
In the case of HDAC6 inhibition, where only the level of acetylation is increased, the 
additional biochemical changes occurring on the microtubules of the developing axon, 
must override the hyperacetylation of minor neurites or dendrites allowing Kinesin-1 to 
correctly transport only to the axon. 
 Previous work has shown that Kinesin-1 reacts to the presence of microtubule 
post-translation modifications other than acetylation.  Kinesin-1 shows preferential 
binding to detyrosinated microtubules over tyrosinated microtubules [24], and is more 
likely to transport along detyrosinated tracks than the total number of microtubule tracks 
in a fibroblast cells [29].  Detyrosination microtubules also have been implicated as 
playing an essential role in the cellular localization of recycling endosome compartments 
and the kinesin mediated trafficking of TfR vesicles from these endosomal compartments 
to the plasma membrane [38].  The carboxypeptidase that removes the c-terminal tyrosine 
of α-tubulin has yet to be identified; but tubulin tyrosine ligase (TTL) replaces it, 
resulting a continuous detyrosination/tyrosination cycle [39-41].  In TTL knockout mice, 
the level of detyrosinated tubulin is artificially high, and results in perinatal death due to 
disorganized neuronal networks.  In culture, cortical or hippocampal neurons from these 
mice polarize at a faster rate than wildtype cells and have a small but significant increase 
in the number of cells with multiple axons.  Additionally growth rates of axons and minor 
neurites were increased, but also more erratic [42].   These results suggest that 
microtubule detyrosination may be important for normal polarization and neurite growth.  
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However, because the effect on individual cells is small other microtubule properties may 
also contribute to or dominate the axonal signal.  Future experiments are required to test 
whether detyrosination plays a specific role in directing Kinesin-1 to axons. 
Polyglutamylation is another tubulin modification that could influence Kinesin-1 
trafficking.  Polyglutamylation of α-tubulin influences transport of synaptic vesicles by 
the kinesin family member KIF1A [27].  Kinesin-1 has been shown to have a binding 
preference for microtubules that can be glutamylated [24, 30].  In polarized epithelial 
cells, polyglutamylated microtubules provide preferred tracks for Golgi-to-plasma 
membrane vesicle transport.  The presence of these polyglutamylated tracks require 
septin2 fibers [43], which have been shown in yeast to coordinate polarized membrane 
growth [44, 45].  It is important to note that polyglutamylation has much more variety 
than other post-translational modifications.  Glutamylation occurs on both α- and β-
tubulin and involves the addition of one to six glutamates [40, 41, 46].  Early work has 
suggested that Kinesin-1 and other MAPs may have preference for certain glutamate 
chain lengths [30, 47].  Although recently the family of proteins involved in 
polyglutamylation of both α- and β-tubulin has been identified [48], the enzymes that 
function specifically in developing neurons has not been fully elucidated. Thus, 
alterations of the levels of polyglutamylation in neuronal cells will have to wait until the 
enzymes are more fully characterized.  
Since one can only study tubulin post-translational modifications in fixed cells, it 
is still unclear whether the dynamic changes in kinesin-1 motility seen in stage 2 cells, 
where the motor switches rapidly between apparently identical neurites, are related to 
changes in microtubule stability and/or tubulin post-translational modifications.  Yet, we 
were able to show that the relative levels of acetylated and polyglutamylated tubulin is 
higher in neurites that accumulate kinesin than in the other neurites.   
Also unclear are the signaling cascades that promote PTMs on select microtubules 
or neurites.  Our data suggests that the signaling pathways leading to GSK3β inhibition in 
the axon, which have already been shown to play a role in axon specification and 
maintenance [1, 33], may be sufficient to increase the levels of tubulin post-translational 
modifications in one neurite.  This stabilization of microtubules and increase in PTMs is 
likely due to multiple downstream targets of GSK3β.  APC and CRMP2 bind, stabilized, 
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and/or promote growth of microtubules—activities that are inhibited by GSK3β 
phosphorylation and are required for axon specification and growth [1, 14, 34, 35, 49].   
Additional targets of GSK3β are Tau, MAP1b, MAP2, and neurofilaments [1].  Rac 
activity is also essential for axon specification and growth and may be tied to GSK3β 
activity through positive feedback loops [1, 7, 50].  Rac has been shown to promote 
microtubule growth and stabilization in the axon by locally inhibiting the microtubule 
severing/destabilizing protein stathmin/Op18 [6].   
 
Other regulators of selective Kinesin-1 transport 
Although there is evidence Kinesin-1 is directly influenced by microtubule PTMs, 
we cannot rule out the possibility that the axonal signal may consist to some extent on 
properties secondary to changes in microtubule structure such as the presence or absence 
of MAPs. Previous studies have well established that axonal versus dendritic 
microtubules have differences in the localization patterns and phosphorylation states of 
various MAPs.  Recent work using single molecule in vitro assays has shown that tau 
provides road blocks for Kinesin-1, leading to kinesin dissociation from microtubules or 
reduced attachment rates [36, 37].  In neurons, with over-expressed MAPs, cargo 
transport of all types is significantly reduced, but can be rescued by dissociation of MAPs 
from microtubules by phosphorylation [51].  In fibroblasts, MAP4 plays an inhibitory 
role in vesicle trafficking that is independent of its role in microtubule stability [52].  
Interestingly, microtubule PTMs and MAPs may functionally antagonize each other so 
that PTMs promote and direct kinesin-based transport whereas MAPs inhibit the same 
transport events.  The association of certain MAPs with microtubules has been shown, 
but not always consistently, to be altered upon taxol treatment or GSK3β inhibition.  
Treating cells that are overexpressing tau with taxol (1µM) causes tau to rapidly 
dissociate from microtubules [53].   Another study showed treating neurons with 10µM 
taxol interferes with the binding of some but not all endogenous MAPs (increase binding 
of endogenous tau, but less binding of Map2 and charin MAPs) [54].  Additionally 
GSK3β activity is known to regulate the binding of multiple MAPs such as MAP1b, Tau, 
APC, and CRMP-2 [1, 34, 35, 49, 55]. 
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MATERIALS AND METHODS 
Plasmids and Antibodies:  CA-Kinesin plasmids, KHC 1-509 mCit and KHC 1-
560 mCit, mCherry, or YFP, were generated from rat Kif5c using PCR or convenient 
restriction sites and subcloned into the β-actin expression vector (S. Impey; [16]).  All 
constructs were sequence verified.  For western blots and immunofluorescence the 
following antibodies were used: β-tubulin E7 (Developmental Studies Hybridoma Bank), 
α-tubulin DM1α (Sigma) or ab18251 (Abcam); acetylated α-tubulin 6-11B-1 (Sigma 
T6793), or a rabbit polyclonal antibody we generated against a α-tubulin peptide;  
detyrosinated α-tubulin ab24622 (Abcam) or a rabbit polyclonal antibody we generated 
against a α-tubulin c-terminal peptide; polyglutamylated tubulin, GT335 (recognizes 
mono- and poly-glutamylated α- and β-tubulin; Gift of  Carsten Janke).  Polyclonal anti-
GFP (Invitrogen) was used in some immunofluorescence experiments to enhance the 
GFP signal of transfected CA-Kinesin.  Antibodies to neuronal polarity markers Tau-1 
(Milipore MAB375) and MAP2 (Milipore AB5622) as well as JIP1 152 [56] were also 
used for immunofluorescence.   
Cell Culture:  Primary hippocampal cultures were prepared from either E16 CD1 
embryonic mice or E18 embryonic rats as described in [57].  Neurons from mice were 
cultured in Neuralbasal media with B27 supplement and neurons from rats were cultured 
in DMEM with N2 supplement.  Identical experiments performed in both mouse or rat 
neurons gave the same results.  Transfection of DNA plasmids was done either at time of 
plating via electroporation using the Amaxa Nucleofector 1, or 1-5 days after plating 
using lipofectamine2000.  Cells were treated for the indicated times and concentrations 
with Taxol (Sigma); the tubulin deacetylase inhibitors trichostatin A (TSA; Sigma), or a 
close structural analog of tubacin, MAZ1370, that is more potent in cell-based assays and 
referred to in the text as tubacin for simplicity (R. Maxitschek, personal communication); 
or the GSK3β inhibitor SB216763 (Sigma).   
Microscopy and Image Processing:  Live cell imaging. Cells were plated on 
glass-bottom dishes (MatTek) coated with poly-D-lysine and cultured in glial conditioned 
media.  Cells were maintained at 32-34 degrees C for the duration of recording using an 
objective warmer and a Nikon TE2000 microscope with a Plan-APO 60X/NA 1.4 
objective and Photometrics CS ES2 camera.  Fixed cells. Cells were processed for 
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immunofluorescence as described [32].  Images were taken on Nikon TE2000 
microscope with Photometrics CS ES2 camera or an Olympus BX51 microscope with an 
Olympus DP70 CCD camera.  Images were processed with NIH Image J software, 
Metamorph, or Photoshop.  Neurites were counted positive for JIP1 or CA-Kinesin-1 
accumulation if the fluorescence intensity (due to immunostaining or fluorescent protein 










Figure 5.1: Axons and Stage 2 neurites preferred by Kinesin-1 have higher levels of modified 
microtubules.  (A)  Immunofluorescence of Stage 3 hippocampal neurons probed with antibodies 
to α-tubulin and either acetylated, or polyglutamylated tubulin.  (B) Quantification of the ratio of 
PTMs to total tubulin in axons or minor neurites.  (Student’s T-test: Acetylation p=0.00001; 
Polyglutamylation p=0.0005).  (C)  Immunofluorescence of Stage 2 hippocampal neurons 
expressing CA-Kinesin-1-mCit stained with antibodies to α-tubulin (top) and acetylated α-tubulin 
(middle).  CA-Kinesin-1 accumulates only in a subset of stage 2 neurites (bottom).  (D)  
Quantification of the acetylated α-tubulin to total α-tubulin ratio along the proximal to distal 
length of each stage 2 neurite shown in C.  CA-Kinesin-1 accumulated in neurite 1, which has the 
highest relative level of acetylated tubulin.  (E) Quantification of the ratio of PTMs to total 
tubulin in stage 2 neurites with or without CA-Kinesin-1 accumulation.  (Student’s T-test: 





Figure 5.2: Microtubule acetylation influences JIP1 localization in unpolarized stage 2 
hippocampal neurons but not in polarized stage 3 neurons.  (A and B)  Stage 2 hippocampal 
neurons were treated for 3 hours with DMSO, 125nM TSA, or 5-10µM tubacin.  (A) Cells were 
fixed and stained for antibodies to endogenous JIP1 and acetylated α-tubulin.  Scale=20µM.   
(B)  Quantification of the percent of stage 2 neurites with JIP1 tip accumulation.  Error bars= 
SEM.  Student’s T-test: **p<0.05 *p<0.01.  (C)  Stage 2 cortical cells were treated 3 hours with 
DMSO, 125nM TSA, or 10µM tubacin.  Cells were then collected, lysed, and analyzed by 
western blot using antibodies to acetylated α-tubulin or total α-tubulin.  (D and E)  Stage 3 
hippocampal neurons were treated for 3 hours with DMSO, 125nM TSA, or 10µM tubacin.  (D) 
Cells were fixed and stained for antibodies to endogenous JIP1 and acetylated α-tubulin.  Arrows, 
growth cones of minor neurites.  Arrowheads, axonal growth cones.  Scale=20µM.  (E)  
Quantification of the percent of stage 3 minor neurites and axons with JIP1 tip accumulation.  
Error bars= SEM.  Student’s T-test: p>0.05 for all conditions.  (F)  Stage 3 cortical cells were 
treated 3 hours with DMSO, 125nM TSA, or 10µM tubacin.  Cells were then collected, lysed, and 








Figure 5.3: Microtubule acetylation does not influence CA-Kinesin-1 motors in polarized stage 3 
primary hippocampal neurons.  (A)  Stage 3 hippocampal neuron expressing CA-Kinesin-1 
shown at the indicated times before (-15 min) and after (15, 30, 45 and 60 mins) treatment with 
250nM TSA.  CA-Kinesin-1 does not accumulate in minor neurites upon TSA treatment.  (B) 
Quantification of the experiment in A. (C)  Stage 3 hippocampal cells were treated from 0-2 
hours with 125nM TSA.  Western blots of cell lysates were probed with anti-acetylated α-tubulin 
or total α-tubulin antibodies.  (D)  Stage 3 hippocampal cells were treated for 2-4 hours with 
DMSO, 125nM TSA, or 10µM tubacin.  Cells were then lipofectamine transfected with CA-
Kinesin-1-mCherry and YFP. Cells were allowed to express the truncated kinesin under 
additional treatment for 4-5 hours then fixed and imaged.  Scale=20µM.  (E)  Quantification of 
the percentage of stage 3 minor neurites or stage 5 dendrites that have accumulation of CA-
Kinesin-1-mCherry in growth cones after treatment described in D.  Error bars=SEM.  Students 
T-test: p>0.05 for all conditions.  (F) Quantification of the percentage of hippocampal neurons at 











Figure 5.4: Taxol treatment redirects CA-Kinesin-1 motors to dendrites in polarized cells. (A-C)  
Stage 5 (A) or Stage 3 (B) hippocampal cells were treated for 2-4 hours with DMSO, 10nM or 
100nM taxol.  Cells were then lipofectamine transfected with CA-Kinesin-1-mCherry and YFP. 
Cells were allowed to express the truncated kinesin under additional treatment for 4-5 hours then 
fixed and imaged.  Arrows indict axonal processes leaving the cell body. (C) Quantification of the 
percentage of stage 3 minor neurites or stage 5 dendrites that have accumulation of CA-Kinesin-1 













Figure 5.5:  Within minutes, taxol treatment redirects Kinesin-1 to minor neurites and increases 
the levels of modified microtubules.  (A and C)  Stage 2 (A) or Stage 3 (C) hippocampal neuron 
expressing CA-Kinesin-mCit.  Time lapse before and after 0-30 minutes of treatment with 100nM 
taxol.  CA-Kinesin redistributes to all Stage 2 neurite tips and some Stage3 minor neurites upon 
taxol treatment.  (B) Quantification of the percent of total fluorescence in each stage 2 neurite 
from the cell in A.  (D) Quantification of the percentage of stage 2 neurites or Stage 3 minor 
neurites and axons that have increased CA-Kinesin-mCit accumulation after 1 hour taxol 
treatment.  Error bars=SEM. Student’s T-test *p<0.01 **p<0.05  (E and F)  Time course 
quantification of DMSO (E) or 10nM taxol (F) treatment-induced dendritic accumulation of CA-
Kinesin over a 4 hour treatment period.  (G)  A mix of Stage 2/Stage 3 hippocampal neurons were 
treated for 0-1 hr with 100nM taxol.  Cell were collected and cell lysates were analyzed by 
western blot with antibodies to acetylated α-tubulin, detyrosinated α-tubulin, polyglutamylated 
tubulin, or total β-tubulin.  Scale bars=20µM .  Acknowledgements:  (E) and (F) were contributed 











Figure 5.6:  Taxol treatment causes a redistribution in the localization of JIP1 and the formation 
of multiple axons.  A and C)  Stage 2 (A) or Stage 3 (C) hippocampal neurons were treated for 3 
hours with DMSO, 10nM, or 100 nM taxol then fixed and stained with antibodies to JIP1 and 
acetylated α-tubulin.  Arrows=growth cones of stage 2 neurites or stage 3 minor neurites.  
Arrowheads= axonal growth cones.  Scale=20µM.  B and D)  Quantification of the percentage of 
stage 2 neurites (B) or percentage of stage 3 minor neurites or axons (D) with JIP1 accumulation 
after DMSO or taxol treatment.  Error bars=SEM.  Student’s T-test *p<0.01.  E)  A mix of Stage 
2/Stage 3 cortical neurons were treated for 3hrs with DMSO, 10nM Taxol, or 100nM Taxol.  Cell 
were collected and cell lysates were analyzed by western blot with antibodies to acetylated α-
tubulin, detyrosinated α-tubulin, polyglutamylated tubulin, or total β-tubulin. Polyglutamylated 
lanes are from the same blot.  F and G)  Culturing cells in taxol results in the formation of 
multiple axons.  Hippocampal neurons were cultured in DMSO, 1nM taxol, or 2.5nM taxol from 
time of plating until 6DIV. F)  Cells were fixed and probed with antibodies to Tau or Map2.  
Arrows indict axonal processes leaving the cell body.  G) Quantification of the percentage of 







Figure 5.7: GSK3β inhibition influences Kinesin-1 transport in polarized cells and results in 
increased levels of modified microtubules.  (A and B)  Long-term GSK3β inhibition results in 
multiple axons in many cells.  Hippocampal neurons were cultured in DMSO or 10µM SB216763 
from time of plating until 6DIV.  (A) Cells were fixed and probed with antibodies to Tau or 
Map2.  Arrows indict axonal processes leaving the cell body.  (B) Quantification of the 
percentage of neurons with >1 axon.  Error bars=SEM.  Students T-test:  *p<0.01.  (C)  Kinesin-1 
accumulates in the growth cones of all the axonal processes made by long-term GSK3β 
inhibition.  Hippocampal cells were electroporated with CA-Kinesin-mCit at time of plating and 
cultured in 5µM SB216763 for 6 days.  Cells were then fixed and probed with antibodies to mCit.  
Arrows indict axonal processes leaving the cell body.  (D-E)  Stage 3 hippocampal cells were 
treated for 2-4 hours with DMSO, 5µM or 10µM SB216763.  Cells were then lipofectamine 
transfected with CA-Kinesin-mcherry and YFP. Cells were allowed to express the truncated 
kinesin under additional treatment for 4-5 hours then fixed and imaged.  (F)  Quantification of the 
percentage of stage 3 minor neurites or stage 5 dendrites that have accumulation of CA-Kinesin-
mCherry in growth cones.  Error bars=SEM.  Students T-test: **p<0.05, *p<0.01.  (G and H)  
Stage 2 hippocampal cells were treated for 8 hours with DMSO or 10µM SB216763.  (G) Cells 
were fixed and stained for antibodies to endogenous JIP1 and acetylated α-tubulin.  Scale=20µM.  
(H)  Quantification of the percent of stage 2 neurites with JIP1 tip accumulation.  Error bars= 
SEM.  Student’s T-test: *p<0.01.  (I)  Stage 3 hippocampal neurons were treated for 0-2 hrs with 
5µM SB216763.  Cells were then collected, lysed, and analyzed by western blot with antibodies 
to acetylated α-tubulin, detyrosinated α-tubulin, or total β-tubulin.  (J)  Stage 3 cortical neurons 
were treated for 8 hrs with 5µM or 10µM SB216763.  Cell lysates were then analyzed by western 
blot with antibodies to acetylated α-tubulin, detyrosinated α-tubulin, polyglutamylated tubulin, or 
total β-tubulin. All bands probed with similar antibody came from the same gel. Scale=20µM for 
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Chapter 6:  
Conclusion 
 
The first kinesin motor was identified in squid axons about 20 years ago [1].  
Since then, much work has been done to elucidate the chemo-mechanical properties and 
identity of kinesin superfamily members [2-4].  However many details are still unclear 
regarding the general and specific mechanisms used by individual members of the kinesin 
superfamily for motor regulation; cargo recognition, loading, and unloading; polarized 
sorting; microtubule track selection; and coordination of multiple motors.  The work that 
has been described in Chapters 2-5 of this dissertation, addresses some of the remaining 
questions regarding KIF1A and KIF17 autoinhibition and motility, coordination and 
make-up of Kinein-1/cargo complexes, and Kinesin-1’s polarized sorting in neurons.   
This work has shed light on both general mechanisms conserved among the kinesin 




Autoinhibition of kinesins ensures that in the absence of cargo, motors do not 
hydrolyze excessive ATP in useless motility.  It also allows for temporal and spatial 
control of motor activity ensuring that kinesins are available and ready when needed for 
cargo loading and transport.  As the motor domain is the only region conserved among 
the kinesin superfamily, new regulatory regions and mechanisms must have evolved as 
novel cargo binding and structural domains were added to the basic motor core.  By 
comparing the results from my KIF1A and KIF17 autoinhibition studies with those done 
previously on KIF1A, Osm-3, Kinesin-1, and Gakin/KIF13b, some general mechanisms 
of autoinhibition stand out as being conserved among all or a subset of these studied 
kinesins.
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1) Separate mechanisms mediate inhibition of microtubule binding and processive 
motility. 
Studies using deleted or mutated versions of Kinesin-1 or KIF1A suggest that 
autoinhibition is mediated by two independent mechanisms.  The first mechanism 
prevents the motor from binding microtubules.  In Kinesin-1 this is mediated by the KHC 
tail, but reinforced by the KLC domains [5-8].  In KIF1A it is mediated by the FHA 
domain and CC2 (Chapter 3 and [9, 10]).  The second mechanism prevents the 
coordinated stepping of the two heads in cases where the motor does bypass the first 
inhibitory mechanism.  The proposed model for this motor uncoupling involves an 
unwinding of the neck coiled-coil, allowing for a physical separation of the motor 
domains.  KIF1A prevents processive motility or motor coordination through the 
formation of an intramolecular coiled-coiled between the NC and CC1 of the adjacent 
stalk (Chapter 3 and [9]).  Evidence for this intramolecular coiled-coil has only been seen 
thus far in truncated proteins, so its presence and role in the motor regulation of full-
length KIF1A requires further verification.  In Kinesin-1, the KLC TPR domains push the 
motor domains apart, unwinding the neck in the process [5].  Yet, in the case of fungal 
Kinesin-1 that does not have KLC subunits, the KHC tail has also been suggested to play 
this inhibitory role by binding to a non coiled-coil conformation of the neck [11].  
Although Kinesin-1 and KIF1A utilize both inhibitory schemes in a similar way, it is 
possible other kinesins use only one mechanism, or that the same type of motor activity 
(i.e. microtubule binding or processivity) is inhibited in a slightly different way.   
 
2) Motor function is inhibited via direct contact of the motor or neck domains with 
C-terminal tail or stalk regions 
Evidence from Kinesin-1, KIF17, KIF1A, and Gakin show that the inhibition 
mechanisms outline above are often mediated by direct intramolecular contacts involving 
a small region of the tail or stalk and either the motor or neck domains.  In the case of 
Kinesin-1, a positively charged coiled-coil region of the KHC tail contacts a highly 
negative patch in the neck.  This facilitates a second contact of the IAK tail residues with 
the switch I helix of the motor domain [6, 11-13].  KIF17 also likely employs an 
electrostatic interaction mechanism, as the very positively charged CC2 directly interacts 
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with the motor domain (Chapter 2).  Finally the MBS region of Gakin’s stalk has been 
shown to contact the motor domain inhibiting the microtubule stimulated ATPase activity 
[14].  KIF1A’s intramolecular coiled-coil is the most unique, but once again represents a 
case where the neck is bound by a C-terminal stalk region [9].     
An autoinhibition mechanism mediated by direct contact requires that the motor 
protein has some degree of structural flexibility in order to allow the protein to fold back 
on itself.  Kinesin-1 employs hinges, with glycine and proline residues, in order to break 
up its extended coiled-coil regions permitting the protein to fold lengthwise head to tail 
[12].  Osm-3 (the C. elegans homologue of KIF17) appears to have a similar mechanism, 
as the presence of a 15-20 residue hinge between coiled-coil 1 and 2 is required for 
folding it into a more compact inhibited conformation [15].  Comparison of Osm-3 and 
KIF17 structures and regulatory mechanisms bring some ambiguity to this model of 
Osm-3 inhibition, however, as the hinge region of Osm-3 is right next to and somewhat 
analogous to the CC2 in KIF17 that, in chapter 2, was shown to interact directly with the 
motor domain.  Whether this region in Osm-3 truly acts as a structural hinge or as a direct 
motor regulatory region requires further study.  Electron microscopy studies on 
recombinant KIF1A suggest that rather than folding lengthwise head to tail, KIF1A 
alternatively forms a very compact, more globular structure [16, 17].  As no direct 
contact has been found between the motor domain and the FHA domain, which has been 
shown to inhibit microtubule binding [10], we can only guess at the regulatory 
mechanism.  However, one possibility is that the compact conformation of KIF1A places 
the FHA domain near the motor allowing it to block access of the motor to microtubules 
via steric hindrance.    
 Unanswered Questions.  Although for each motor analyzed thus far, direct 
contact of an inhibitory domain with either the motor or neck domains has been 
discovered, more detailed studies are required to learn the exact contact sites as well as 
the particulars of how these interactions result in inhibited motor functions.   Does 
binding of the stalk/tail region to the motor or neck 1) prevent access of one or both 
motor domains to microtubules 2) prevent the exchange of ADP for ATP from the 
nucleotide binding pocket thus locking the motor in a weak microtubule bound state or 3) 
inhibit ATP hydrolysis.  Additionally do these events occur by directly blocking access to 
 147
the motor’s active sites or through more indirect mechanisms, such as allosteric 
conformational changes?  More structural knowledge of individual stalk/tail regions as 
well as full-length molecules would be helpful to gain understanding of how the motor 
folds on itself and inhibits the motor. 
 
3)  Cargo binding relieves autoinhibition.   
Gakin provides the simplest example thus far where binding of cargo relieves 
motor inhibition.  Binding of a single cargo, Dlg, to the MBP region of Gakin which 
directly interacts with the motor domain, allows the motor to move along microtubules 
and hydrolyze ATP [14].  The FHA domain of Gakin was also identified as a cargo 
binding site for phosphotidylinositol(3,4,5)trisphosphate binding protein (PIP3BP) [18], 
but whether binding to this site also relieves Gakin’s autoinhibitory mechanism remains 
to be seen.  The case of Kinesin-1 reveals some of the complexities of motor/cargo 
complexes as binding of two proteins is necessary to relieve autoinhibition.  FEZ binds to 
KHC’s tail IAK region and JIP1 binds the TPR domains of KLC [19].   Whether other 
cargo proteins can replace the role of FEZ or JIP1 in motor activation requires further 
study.   
Kinesin-1 and Gakin show that inhibitory regions are equivalent to cargo binding 
regions.  How this model will change when considering all cargos and potential binding 
sites remains to be seen.  In the case of KIF17 and KIF1A the potential correlation 
between inhibitory regions and cargo binding domains is lacking primarily due to the 
lack of evidence as to cargo identity and the locations of cargo binding domains.   
Unanswered Questions.  As implied in this discussion, there are still many open 
questions in regards to this cargo mediated activation model.  The biggest hole resides in 
the identity of specific cargos for each motor.  Beyond that, additional questions remain 
such as:   How many separate binding cargos are needed to achieve full activation for 
each motor?  Where on the motor do they bind?  If they don’t bind directly to inhibitory 
regions, how is motor conformation altered in order to achieve activation?  Are there 
proteins that serve solely as motor regulatory proteins rather than cargo that have other 
functions at the transport destination?   
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KIF1A motility:  Long distance, processive movement requires two heads.   
Although KIF1A has motile properties as a monomer, where it can take advantage 
of electrostatic interactions between the positively charged K-loop in its motor domain 
and the negatively charged tubulin tails of the microtubule lattice in order to glide along 
microtubules without the need of ATP [20-22], my results show KIF1A only moves 
efficiently over long-distances as a dimer (Chapter 3 and [23]).  The kinesin motor 
MCAK has also been shown to move in a “biased-diffusion” manner [24].  In both cases, 
the diffusional motion does not require energy, has velocities ranging from very fast to 
very slow, is due to electrostatic interactions, and does not contribute to the force driven 
cellular function of the motor.   Thus for any long range movement, using a hand-over-
hand stepping mechanism, where at least one head is always strongly attached to the 
microtubule ensures that the motor does not dissociate prematurely.   
What then is the role for the added diffusion ability?  The electrostatic interaction 
that permits diffusion likely functions as a tether to accelerate rebinding of the unbound, 
actively stepping motor domain, thus, reducing the chance of complete detachment.  This 
tethering would in general increase the processivity or distance traveled by the motor and 
possibly explain why KIF1A has some of the longest run lengths in single molecule 
motility assays, running up to 10µm in a single run, and on average about double the run 
length of Kinesin-1 (Chapter 3 and [23]).  Indeed a positive correlation between run 
length and strength of electrostatic interactions was clearly demonstrated by Thorn et al 
who saw increased processive run lengths with Kinesin-1 after adding positively charged 
residues to the neck coiled-coil [25].  
Microtubule-based diffusion or tethering may have additional in vivo roles beyond 
increasing processivity.  Vesicles in a cell often undergo “salutatory” motion where they 
have periods of rapid movement followed by pauses where little displacement occurs 
[26].  Pausing is likely a result of motors encountering barriers, or road blocks, in their 
path.  If the motor diffuses along the microtubule in various directions, it may find a way 
to negotiate around the barrier without completely dissociating from the microtubule.   
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Specific future directions for KIF17 
My studies on KIF17 show that the coiled-coil 2 region (CC2) inhibits the 
processive motility of KIF17 by directly binding to the motor domain.  To gain a better 
understanding of how the CC2 region of KIF17 inhibits motor activity, it would be useful 
to narrow down the specific residues in CC2, as well as in the motor domain that mediate 
this interaction.  I identified the region between 738 and 795 as containing the inhibitory 
and motor binding region.  It is unlikely that this entire 57 residue CC2 region is essential 
for motor binding and/or inhibition.  In support of this hypothesis, mutating CC2 reside 
G754 to glutamate or residues 764-772 to alanine was sufficient to relieve motor 
inhibition.  These mutations could have relieved autoinhibition by removing essential 
amino acids necessary for the motor domain/CC2 binding interface or for structural 
conformations necessary to bring essential CC2 region residues into contact with the 
motor domain.  To distinguish these two possibilities it would be necessary to test 
whether a CC2 construct with these mutations is still able to interact with the motor. 
In order to find the minimal region of CC2 that is important for motor domain 
binding and/or autoinhibition a few approaches could be undertaken.  1)  Making more 
mutations within CC2 (such as by spacing alanine mutations in 5 or 10 amino acid 
stretches throughout CC2).  2)  Making truncations that end within the CC2 region (such 
as 1-785 and 1-775).  3) Making KIF17 constructs with small internal deletions within 
CC2.  Or 4) testing short peptides spanning part of the CC2 region for their ability to bind 
the motor domain or inhibit the processive motility of active KIF17 constructs in trans.  
Each of these approaches could point out important and non-essential residues for 
autoinhibition and motor binding.  Once a smaller region of CC2 has been identified, 
crosslinking CC2 peptides to the KIF17 motor domain followed by mass-spectrometry 
and/or cryo-EM could be used similar to the recent study on Kinesin-1 [13] to determine 
where exactly on the motor domain the CC2 region binds.  If it is analogous to Kinesin-1 
[13], the motor’s switch-I region is a likely CC2 binding interface, but other motor 
regions are also possible.   
Another major future question regarding KIF17 autoinhibition is how the motor is 
activated and specifically whether cargo binding is sufficient for this activation.  KIF17’s 
cargo proteins, Mint1 and NXF-2, bind the C-terminal tail [27, 28] that in our studies 
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showed little sign of motor inhibition and certainly no direct motor domain contact.  It is 
possible however, that binding of cargo to this tail region sterically blocks the ability of 
CC2 to contact the motor.  However my studies also suggest that binding of Mint1 alone 
to KIF17 is not sufficient to activate the motor.  Yet, it is possible that other proteins that 
bind Mint1 play a role in KIF17 activation, or alter the conformation of Mint1, such that 
when it is in a multi-protein complex, it is sufficient to activate KIF17.  Thus testing 
whether co-expression of KIF17 with Mint1, mLin2, and mLin7, or alternatively, 
truncated forms of Mint1 are sufficient to activate the motor would be required before a 
role for Mint1 in KIF17 activation could be ruled out.   
Alternatively Mint1 may need other cargo proteins to independently bind KIF17 for 
activation.  Indeed Kinesin-1 requires that two cargo proteins bind in order to release it 
from autoinhibition.  It is possible that CC2 itself serves as a cargo binding region.  As 
more direct binding partners and cargo binding sites are identified for KIF17 it will 
become clearer whether the CC2 regulatory region is itself a cargo binding domain and 
the mechanisms by which KIF17 inhibition is released.   Yeast-two hybrid assays have 
proven very useful in identifying kinesin cargos and thus this experimental method 
should be applied to KIF17’s CC2 region or other domains in order to find novel binding 
partners that can be studied for their role in activating KIF17 for microtubule binding 
and/or motility.   
KIF17’s cargo binding tail (847-1028), although likely not a major player in motor 
autoinhibition, was shown to be necessary for KIF17’s localization to the peripheral tips 
of cilia.  Presumably this cilia accumulation is due to the loading of KIF17 into cilia by 
IFT cargo or IFT machinery that regulates cilia access.  As KIF17 accumulated at the 
peripheral tips of cilia, rather than throughout cilia, this interaction with IFT 
cargo/machinery likely also activated KIF17 motor activity.  However, it has not yet been 
tested whether the motor activity of KIF17 is necessary for this accumulation or whether 
KIF17 is able to hijack a ride on IFT cargo driven by other motors.  Thus testing a motor 
dead KIF17 construct in the cilia localization assay would be helpful.  If a motor dead 
KIF17 is unable to accumulate in cilia, then one could conclude that the IFT machinery 
activates KIF17 to move itself into cilia.  Using the tail of KIF17 as bait in a yeast-two-
hybrid assay using a prey cDNA library from olfactory cells or other cilia containing cells 
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could serve to identify the IFT cargo that KIF17 binds directly to in order to get into cilia 
and/or connect to IFT complexes so it can transport them.  
 
Specific future directions for KIF1A 
 My work on KIF1A shows that it is an autoinhibited motor that moves 
processively as a dimer rather than a monomer.  One limitation to my studies (and indeed 
all previous studies) is that full-length KIF1A is inactive and thus KIF1A’s motile 
properties cannot be studied without making large truncations to remove autoinhibitory 
domains.  My processive KIF1A construct (1-393) includes only about 1/4 of KIF1A’s 
total protein residues.  In order to confirm that full-length KIF1A also moves 
processively as a dimer (and not as a monomer using one-dimensional diffusion), it 
would be helpful to evaluate a full-length KIF1A construct that is relieved of 
autoinhibition.  KIF1A constructs with single point mutations in either the FHA or 
coiled-coil 2 (CC2) domains have been shown to accumulate at neurite tips, suggesting 
that they are processive motors [10].  By testing these full-length, but uninhibited 
constructs in dimerization and one- or two-color single molecule motility assays, I would 
expect the motile properties of full-length KIF1A to look similar to dimeric KIF1A(1-
393) rather than monomeric KIF1A(1-369).  This additional data would more 
conclusively confirm that KIF1A moves processively over long distances as a dimeric 
motor and although it may have some ability to move via one-dimensional diffusion, this 
type of movement is erratic and short in duration and not likely to be the mechanism that 
allows for vesicular transport.   
 My work further shows that KIF1A autoinhibition is mediated by the CC2/FHA 
region that prevents microtubule binding, as well as by the CC1 region which inhibits 
processive motility.  It is likely that CC1 inhibits processive motility by forming an 
intramolecular coiled-coil with the neck coil (NC).  This intramolecular coiled-coil 
conformation rather than an intermolecular coiled-coil conformation would be sufficient 
to separate and uncoordinated the motors domains such that two-headed processive 
motility would be impossible.  Evidence for both intermolecular and intramolecular 
conformations has been seen by cryo-EM, yet only with truncated proteins [9].  Thus it 
remains to be seen whether full-length KIF1A also utilizes the intramolecular NC/CC1 
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conformation to limit processive motility.  The FRET stoichiometry studies shown in 
Chapter 3 do lend support to the hypothesis that the motor domains are separated in the 
full-length dimeric KIF1A molecule; however, more solid proof of the intramolecular 
coil is still necessary.   
Kinesin-1 also has separated motor domains in its autoinhibited conformation.  
This conformation has been validated by a combination of crosslinking studies and FRET 
stoichiometry [5].  A similar type of crosslinking experiment could be applied to KIF1A.  
For Kinesin-1 a cysteine residue was added to the NC such that when two KHC peptides 
dimerized via coiled-coil formation a chemical crosslinker locked the closely located, 
novel cysteines together.  If KIF1A with a cysteine residue added to the NC region 
crosslinked in dimeric form with disulfide linking chemical crosslinkers, an 
intermolecular NC/CC1 conformation would be confirmed.  If no crosslinked product 
was found, an intramolecular NC/CC1 conformation would be plausible.  Utilizing a full-
length, but uninhibited, KIF1A construct (such as a FHA or CC2 mutation) as a positive 
control for the intermolecular conformation would lead to greater proof that a negative 
result in this assay was indicative of an intramolecular NC/CC1 conformation, especially 
if motor-to-motor FRET stoichiometry also revealed a higher FRET value for a mutant, 
uninhibited KIF1A construct compared to the wild-type, autoinhibited KIF1A.   
The most open questions for KIF1A autoinhibition, like that of KIF17 
autoinhibition, is the mechanism by which inhibition is relieved and specifically whether 
cargo binding serves as the switch.  KIF1A has two regions known at this point in time to 
function in cargo binding.  The PH domain and liprin-α binding region.  The C-terminal 
PH domain connects KIF1A to vesicles by binding to phosphotidylinositol (4,5) 
bisphosphate  (PtdIns(4,5)P2) lipids [29, 30].  As there does appear to be some specificity 
in the type of vesicles KIF1A carries, additional regulatory partners must exist to limit 
promiscuous binding.  Indeed protease studies have revealed that protein components 
play a role in KIF1A vesicle binding [29, 30].  Where these essential protein components 
bind is less clear except that the cargo protein, liprin-α, binds to a part of CC2 but 
requires additional C-terminal residues [31]. 
The PH domain and indeed the entire second half of KIF1A has no observable 
motor regulatory role (Chapter 3 and [10]), implying that the model that all cargo binding 
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domains equal inhibitory domains is incorrect.  However, clustering of PtdIns(4,5)P2 
molecules on vesicular membranes does enhance the motile properties of KIF1A, 
suggesting that whatever conformational changes are promoted upon two PH domains 
interacting with lipids in close proximity, help to activate the motor [29].   
 As the liprin-α binding domain overlaps with CC2, binding of liprin-α to CC2 
may be sufficient to relieve KIF1A autoinhibition.  This hypothesis could be easily tested 
by co-expressing liprin-α with full-length KIF1A in COS and/or CAD cells then testing 
whether KIF1A is active for microtubule binding with the SLO/AMPPNP assay or 
whether it can move processively into neurite tips.  If liprin-α is not sufficient to activate 
KIF1A, it may still play a role in motor activation with the help of other cargo binding 
proteins.  As FHA domains are also protein-protein interaction domains, the FHA domain 
of KIF1A is another potential cargo binding region.  It may be very informative to use the 
FHA domain (with or without the CC2 region) as bait in yeast-2 hybrid or GST-pull 
down experiments to search for novel KIF1A cargos and/or regulatory partners. 
  
Important contributions to the field of kinesin regulation 
By providing two more examples of kinesin motors that are regulated by 
autoinhibition, as well as elucidating some of mechanistic details by which this negative 
regulation occurs, my work on KIF17 and KIF1A helps the kinesin field better 
understand how the basic, conserved motor domain of kinesin proteins can be inhibited 
by so many unique stalk/tail regions.  My work on KIF17 shows that processive motility 
is inhibited by the CC2 region directly interacting with the motor.  As the cargo binding 
tail is essential to sorting KIF17 into subcellular compartments such as cilia, KIF17 has a 
level of regulation in addition to autoinhibition that is important for cargo transport.  My 
work on KIF1A shows that this motor is an inhibited dimer, not a monomer as has long 
been proposed and points to the limitations of studying the motile properties of motor 
constructs that are too short or contain inhibitory regions.  Dimerization is necessary for 
long-distance motility, but is not likely a step involved in KIF1A motor activation, with 
the exception that separated motor domains need to be coupled and coordinated before 
productive transport can occur.  The strength of my studies resides in the fact that I used 
both in vivo and in vitro techniques to assay motor inhibition mechanisms.  Thus the 
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conclusions benefit from the fact that proteins were studied in a native environment free 
from many of the troubles of protein purification but also at the single molecule level 
where the properties of individual motors could be analyzed rather than simply looking at 
groups of motors at a steady-state level. 
 
CARGO COMPLEXES 
Kinesin cargos take various forms ranging in size from large organelles, to small 
protein complexes.  For the first 10-15 years after the discovery of kinesin motors, 
attempts to identify direct binding cargos were rather fruitless.  Recently however, there 
has been an explosion in the number of identified direct or indirect binding partners for 
specific kinesins and some of the exact binding mechanisms have been elucidated.  As 
there are at least 13 Kinesin-1 cargo proteins currently known to bind specifically to the 
TPR domains of KLC, not to mention the handful of others that bind KHC’s tail [19, 32-
44], an obvious question arises of how one motor can coordinate and carry out the 
transport of its many different cargoes.  Results described in Chapter 4 and other studies 
suggest that cases of cooperative transport and competition exist. 
In a cooperative transport model, the motor could combine independently binding 
cargo proteins into one multi-protein complex.  This assembly function could bring 
together only specific subgroups of cargo, or allow for endless cargo combinations.  The 
first scenario appears to function in the case of Kinesin-1 cargos JIP1 and JIP3.  Both 
cargo proteins bind to KLC’s TPR domains at independent sites, yet, because they also 
interact with each other they require co-transport within the same complex (Chapter 4, 
[45]).  As JIP1 and JIP3 also function as scaffolding proteins for the kinases and 
substrates of the JNK signaling pathway [46], this same JIP1/JIP3/Kinesin-1 transport 
complex potentially contains may additional proteins, both soluble and transmembrane, 
that may have additional roles in cargo complex formation and/or release [40, 47].    
In a competitive transport model, cargos binding to the same kinesin binding site, 
or to mutually exclusive binding sites may result in cargo competition.  This scenario has 
been shown for the two Kinesin-1 cargos, Alcadein and a JIP1/APP complex [33].  On 
the other hand, my results shown in Chapter 4, as well as data from other research 
groups, show that while over-expression of a single Kinesin-1 binding cargo can saturate 
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and inhibit the transport of its own endogenous counterpart, it does not necessarily 
saturate all other cargos [35, 45].  Thus, competition between cargos is likely limited to 
certain cargo subsets and may often be a negligible factor due to the existence of a large 
pool of inactive kinesins seen in cellular fractionation and autoinhibition studies [1, 12, 
48].  A case where the kinesin pool may be limiting for certain cargos resides in the 
hypothesis that different Kinesin-1 splice variants contain unique cargo binding sites.  
There are two gene isoforms of KLC, KLC1 and 2, and both of these are known to have 
multiple splice variations in the C-terminal cargo binding region [49-51].  Thus cargo that 
bind a specific splice variant may show competition with cargo binding that same splice 
variant but not cargos using other splice variants.  This hypothesis remains to be tested, 
however, due to the lack of evidence for specific cargo that bind specific splice variants.  
Other factors that may be limiting to transport of a specific cargo, or subgroups of cargo, 
would be cooperative binding partners or other accessory proteins used to facilitate 
binding and/or transport.  
 
Specific future directions for Kinesin-1 cargo complexes. 
My work on JIP1/JIP3/Kinesin-1 complexes showed that JIP1 and JIP3 bind 
KLC’s TPR bundle using unique binding sites.  JIP1 binds inside the TPR groove and 
JIP3 binds outside the TPR groove.  As the binding sites of other KLC TPR binding 
proteins have not been mapped in more detail than to the TPR domain in general, it is 
unknown whether other Kinesin-1 cargoes use one of the two TPR binding sites 
identified for JIP1 or JIP3 or whether there are other cargo binding interfaces on the TPR 
bundle.   It would be simple to test other known KLC binding cargos with the KLC 
mutants described in chapter 4 using yeast-two-hybrid or co-immunoprecipitation assays 
in order to further map their binding interfaces.  Additionally, as the error-prone PCR 
mutants generated for binding experiments with JIP1 and JIP3 had multiple point 
mutations, interesting constructs such as 48A should be further investigated and broken 
down into individual point mutations in order to determine which residues make up the 
binding interface and which residues are inconsequential.  
My work additionally shows that JIP1 requires the presence of JIP3 in its Kinesin-
1 transport complex (Chapter 4 and [45]).  Previous studies have additionally shown that 
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it takes at least two proteins, FEZ and JIP1, in order to relieve the autoinhibition state of 
Kinesin-1 [19].    Together these studies exemplify some of the complexities of Kinesin-
1/cargo transport, as at least three Kinesin-1 binding partners likely play a role in 
activating Kinesin-1 for long-distance motility.   Although these three binding partners 
have been shown to be essential in separate studies, it has yet to be shown whether they 
are indeed in the same complex.  Co-immunoprecipitation experiments could be helpful 
in validating the presence of all three Kinesin-1 binding cargos in the same complex.  If 
precipitation of endogenous JIP1 or JIP3 pulled down FEZ or precipitation of 
endogenous FEZ pulled down JIP1 and JIP3 it could be concluded that indeed they are all 
part of the same complex.  Additionally, it has been shown that JIP1 and FEZ can 
activate Kinesin-1 in a single molecule motility assay resulting in more motility events 
than when only Kinesin-1 is added.  As JIP3 is also likely a part of this same complex 
and is necessary for JIP1 transport by Kinesin-1, one would expect that addition of JIP3 
to the JIP1/FEZ/Kinesin-1 mix in a single molecule motility assay may result in even 
more motility events. 
Finally, it is unclear what combinations of other Kinesin-1 cargo may be capable 
of activating Kinesin-1 for microtubule binding or long distance transport.  Can KHC tail 
binding cargos such as FEZ and p120catenin be mixed and matched with KLC binding 
cargos such as JIP1/JIP3 or Kidins220 in order to activate Kinesin-1 or do only certain 
combinations constitute a Kinesin-1 activating cargo complex?  Different Kinesin-1 
cargo combinations could be tested by expressing them together in COS cells and testing 
microtubule binding using an SLO/AMPPNP assay, or alternatively, in vitro microtubule 
binding assays or single molecule motility assays could be done with mixtures of 
Kinesin-1 with different Kinesin-1 cargo combinations.  
 
Important contributions to the field of cargo complexes and general  future 
directions 
Most cargo/Kinesin studies up to this point have focused on the identification of 
cargo and mapping of binding sites.  My work, detailed in Chapter 4, is one of the first to 
investigate the relationships that exists between different cargo proteins that share the 
same motor.  This work showed that JIP1 and JIP3 bind to separate sites on the KLC TPR 
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bundle, yet facilitate each other’s binding and transport.  As JIP1, JIP3, and FEZ are 
necessary to activate Kinesin-1 for long range transport, it is possible that a single 
Kinesin-1 interacting protein, may not be able to act as a full kinesin “cargo”, that is a 
cargo capable of fully activating the motor.  Although more research is still needed to 
identify Kinesin-1 cargo and their indirect or direct binding mechanisms, future research 
in the area of motor/cargo complexes will need to address how multiple interactions 
within a cargo complex, either between cargo and motors, or cargo and cargo, function to 
assemble a complete cargo complex that has the capacity to activate motors for efficient, 
long range transport.   
 
MICROTUBULE PREFERENCE 
Once kinesins are loaded with cargo, they must transport that cargo to its proper 
cellular destination.  Although there are multiple mechanisms that mediate polarized 
membrane sorting, one involves the use of “smart” motors, or motors that have the 
intrinsic ability to move towards one particular cellular destination.  Although all kinesin 
motors have a basic method of directionality dictating whether they move towards the 
plus-end or minus-end of microtubules, some motors appear to have the additional ability 
to move towards particular cellular locations or alternatively to reside in limited cellular 
compartments.  The most evidence for this is in neuronal cells, which have two types of 
processes each requiring very different protein subsets to carry out their particular 
functions, specifically axons and dendrites.  Kinesin-1 has been shown to move 
preferentially into and down the axon process, generally avoiding the more abundant 
dendrites (Chapter 5, [52, 53]).  KIF1A on the other hand, transports down all processes 
showing no apparent partiality [52].  MKLP, KIF21b, and KIF17 have all been shown to 
be enriched in dendrites over axons, and at least in the case of MKLP and KIF21b this 
dendritic localization appears to be due to active motors preferentially moving into the 
dendritic compartments ([27, 53-56], Gary Banker personal communication, and Verhey 
lab unpublished data).  As evidence in support of the “smart” motor model comes 
primarily from studies using constitutively active, truncated kinesin constructs, the 
mechanism mediating preferential sorting to axonal or dendritic compartments is thought 
to reside within the motor/microtubule binding interface [53]. 
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For Kinesin-1 there is a growing body of evidence showing it has the intrinsic 
ability to pick up small variations that appear on only a subset of all possible microtubule 
tracks.  In vitro, Kinesin-1 has been shown to have improved binding and in some reports 
better motility on microtubules post-translationally modified by acetylation, 
detyrosination, or polyglutamylation [57-61] .  In fibroblasts, the subset of microtubules 
used by kinesin-1 is the same subset that is marked by the post-translational 
modifications (PTMs) of acetylation and detyrosination ([60] and Verhey lab unpublished 
data). 
 
Important Contributions and Future Directions on Kinesin-1 and microtubule 
PTMs. 
My results in Chapter 5, show that Kinesin-1’s preference for axonal microtubule 
tracks in polarized neurons, and those of one or a small subset of neurites in unpolarized 
neurons also correlates with higher levels of modified microtubules.  As altering only one 
modification, acetylation, could influence Kinesin-1 transport in unpolarized cells but not 
polarized cells, it is likely that Kinesin-1’s axonal preference resides in the additive or 
synergistic combination of multiple modifications that each slightly enhance Kinesin-1’s 
binding or motile properties on microtubules.   Indeed the drug treatments of taxol, a 
microtubule stabilizing compound, or SB216763, a GSK3β inhibitor, both increased the 
levels of multiple microtubule PTMs throughout axons and dendrites leading to a loss of 
Kinesin-1’s axonal preference.  As GSK3β inhibition is necessary for axon specification 
and maintenance [62], these results further suggest that increased levels of microtubule 
PTMs may be a key factor to axon identity.  Although there is evidence Kinesin-1 is 
directly influenced by microtubule PTMs, we cannot rule out the possibility that the 
axonal signal may consist to some extent on properties secondary to changes in 
microtubule structure such as the presence or absence of MAPs.  However, MAPs have 
also been shown to have a preference for certain microtubule modifications, so their 
polarized compartmentalization may also depend on biochemical cues inherent to the 
microtubules they bind [63, 64].   
It is thus proposed that microtubule modifications make up a tubulin code, similar 
to the modifications on histones [65, 66].  This code would mediate microtubule 
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functions specific to certain subsets of microtubules, such as in directing Kinesin-1 to 
axons.  It is likely that various kinesin superfamily members will react to this tubulin 
PTM code in different ways.  For example, as some smart motors move preferentially 
towards the axon, others move preferentially toward dendrites.  Thus these two sets of 
motors may have opposite binding preferences for modified or unmodified microtubules 
or alternatively no preference at all.  Indeed, in fibroblast cells, KIF1A and KIF17 appear 
to walk on all microtubules regardless of the presence or absence of modifications or 
even whether or not the microtubules are still growing (Verhey lab unpublished data).  
Additionally, in neurons with reduced amounts of α-tubulin polyglutamylation, the 
binding affinity to microtubules was differentially altered for a subset of kinesins and 
MAPs [59]. 
Obviously we are only at the very beginning of validating this tubulin code 
hypothesis and its role in directing kinesin polarized transport in neurons and other cell 
types.  As Kinesin-1 is one of the lone kinesins tested for binding or varied ability to 
move along microtubules with different types of tubulin modifications, other kinesins 
with different sorting patterns need to be investigated in both in vitro biochemical assays 
and in vivo correlative assays.  Indeed, even the sorting preferences of different kinesins 
need further validation.   
Studying the cellular function of microtubule modifications in the past has largely 
been limited by the fact that most of the enzymes that modify tubulin where unknown.  In 
the past few years, the tubulin deacetylase (HDAC6) and the polyglutamylating and 
polyglycylating enzymes (TTLLs) have been discovered.  Thus, the role of 
polyglutamylation on Kinesin-1 transport in neurons can now be tested by over-
expressing or knocking down different combinations of polyglutamylating enzymes and 
determining whether Kinesin-1’s axonal sorting is modified.  Likewise, the role of 
detyrosination in Kinesin-1 polarized axonal transport can be similarly investigated by 
over-expressing TTL, (tubulin tyrosine ligase) the enzyme that replaces the tyrosine 
residue onto the C-terminus of α-tubulin, or by using primary neurons from TTL 
knockout mice.  Experiments such as these will provide much information in the future as 
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